日本臨牀　別冊　神経症候群(第2版)VI

出版社： 日本臨牀社
発行日： 2014-12-20
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 神経症候群（第2版）VI―その他の神経疾患を含めて―
電子書籍版： 2014-12-20 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

20,900 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

20,900 円(税込)

購入する

目次

  • 日本臨牀　別冊　神経症候群（第2版）VI

    ―目次―

    特集　神経症候群（第2版）VI―その他の神経疾患を含めて―

    XIV．てんかん症候群
    　1　てんかん症候群概
    　2　てんかんの疫
    　3　てんかんの分類
    　4　局在関連性(焦点性，局所性，部分性)てんかんおよび症候群
    　5　全般てんかんおよび症候
    　6　焦点性か全般性か決定できないてんかんおよび症候
    　7　特殊症候群
    　8　その他の重要な病態
    　9　てんかんの社会的・精神的側面
    　10　鑑別診断上重要な症候群

    XV．頭痛
    　1　総論
    　2　一次性頭痛
    　3　二次性頭痛
    　4　有痛性脳神経ニューロパチーおよび他の顔面痛

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

XIV てんかん症候群

P.12 掲載の参考文献
1) Fisher RS, et al : Epileptic seizures and epilepsy : definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46 : 470-472, 2005.
PubMed
2) Fisher RS, et al : ILAE official report : a practical clinical definition of epilepsy. Epilepsia 55 (4) : 475-482, 2014.
PubMed
3) ILAE : Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 26 : 268-278, 1985.
 
4) Blume WT, et al : Glossary of ictal semiology. Epilepsia 42 : 1212-1218, 2001.
PubMed
5) Camfield P, et al : Infantile spasms in remission may reemerge as intractable epileptic spasms. Epilepsia 44 : 1592-1595, 2003.
PubMed
6) Goldstein J, Slomski J : Epileptic spasms : a variety of etiologies and associated syndromes. J Child Neurol 23 : 407-414, 2008.
PubMed
7) 清野昌一 : てんかん症候群概論. てんかん症候群 (清野昌一, 太田原俊介編), p 2-20, 医学書院, 1998.
 
8) Berkovic SF, et al : Concept of absence epilepsies : discrete syndromes or biological continuum? Neurology 37 : 993-1000, 1987.
PubMed
9) Gastaut H, et al : Relative frequency of different types of epilepsy : a study employing the classification of the International League Against Epilepsy. Epilepsia 16 (3) : 457-461, 1975.
PubMed
10) Keranen T, et al : Distribution of seizure types in an epileptic population. Epilepsia 29 (1) : 1-7, 1988.
 
11) Ferrie CD : Idiopathic generalized epilepsies imitating focal epilepsies. Epilepsia 46 (Suppl 9) : 91-95, 2005.
 
12) Anne T, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 (4) : 676-685, 2010.
 
P.17 掲載の参考文献
1) Epilepsy Atlas, Epilepsy Care in the World 2005, WHO, Geneva, 2005.
 
2) Oka E, et al : Prevalence of childhood epilepsy and distribution of epileptic syndromes : a population-based survey in Okayama, Japan. Epilepsia 47 : 626-630, 2006.
PubMed
3) Neligan A, et al : The epidemiology of the epilepsies. In : Handbook of Clinical Neurology, Vol 107 (3rd series), Epilepsy, Part I (ed by Stefan H, Theodore WH), p 113-133, Elsevier Science Publishers, Amsterdam, 2012.
 
4) Kotsopoulos IA, et al : Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 43 : 1402-1409, 2002.
PubMed
5) Olafsson E, et al : Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification : a prospective study. Lancet Neurol 4 : 627-634, 2005.
PubMed
6) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From Commission on classification and terminology of the International League Against Epilepsy. Epilepsia 22 : 489-501, 1981.
PubMed
7) Hauser WA, et al : Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota : 1935-1984. Epilepsia 34 : 453-468, 1993.
PubMed
8) Forsgren L, et al : The epidemiology of epilepsy in Europe-a systematic review. Eur J Neurol 12 : 245-253, 2005.
PubMed
9) Olafsson E, et al : Prevalence of epilepsy in a rural Iceland : a population-based study. Epilepsia 40 : 1529-1534, 1999.
 
10) Hauser WA, et al : Prevalence of epilepsy in Rochester, Mennesota : 1940-1980. Epilepsia 32 : 429-445, 1991.
 
11) Berg AT, et al : The risk of seizure recurrence of following a first seizure : a quantitative review. Neurology 41 : 965-972, 1991.
PubMed
12) Annegers JF, et al : Remission of seizures and relapse in patients with epilepsy. Epilepsia 20 : 729-737, 1979.
PubMed
13) Logroscino G, et al : Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 46 (Suppl 11) : 46-48, 2005.
 
14) Walczak TS, et al : Incidence and risk factors in sudden unexpected death in epilepsy : a prospective cohort study. Neurology 56 : 519-525, 2001.
PubMed
15) Bell GS, et al : Suicide in people with epilepsy : how great is the risk? Epilepsia 50 : 1933-1942, 2009.
PubMed
P.24 掲載の参考文献
1) Gastaut H : Clinical and electroencephalographical classification of epileptic disorders. Epilepsia 11 : 102-113, 1970.
 
2) Merlis JK : Proposal for an international classification of the epilepsies. Epilepsia 11 : 114-119, 1970.
PubMed
3) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 : 489-501, 1981. (日本語訳 : てんかん研究 5 : 62, 1987.)
 
4) 日本神経学会てんかん治療ガイドライン2010追補版. [http://neurology-jp.org/guidelinem/tenkan_tuiho.html]
 
5) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndrome. Epilepsia 30 : 389-399, 1989. (日本語訳 : てんかん研究 9 : 84-85, 1991.)
 
6) Engel J : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 : 796-803, 2001.
 
7) Engel J : Report of the ILAE Classification Core Group. Epilepsia 47 : 1558-1568, 2006.
 
8) Berg AT Berkovic SF, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010. (日本語訳 : てんかん研究28 : 515-525, 2011.)
 
P.29 掲載の参考文献
1) Panayiotopoulos CP, et al : Idiopathic focal epilepsies in childhood. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Bureau M, et al), p 217-254, John Libbey Eurotext, Montrouge, 2012.
 
2) Vears DF, et al : Clinical genetic studies in benign childhood epilepsy with centrotemporal spikes. Epilepsia 53 : 319-324, 2012.
PubMed
3) Neubauer BA, et al : Centrotemporal spikes in families with Rolandic epilepsy : linkage to chromosome 15q14. Neurology 51 : 1608-1612, 1998.
PubMed
4) Guerrini R, et al : Autosomal recessive Rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp : delineation of the syndrome and gene mapping to chromosome 16p12-11.2. Ann Neurol 45 : 344-352, 1999.
PubMed
5) Pal DK, et al : Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves. Genes Brain Behav 9 : 1004-1012, 2010.
PubMed
6) Lemke JR, et al : Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 45 : 1067-1072, 2013.
PubMed
7) Panayiotopoulos CP : Benign childhood partial epilepsies ; benign childhood seizure susceptibility syndromes. J Neurol Neurosurg Psychiatry 56 : 2-5, 1993.
PubMed
8) Otsubo H, et al : Malignant rolandic-sylvian epilepsy in children : diagnosis, treatment, and outcome. Neurology 57 : 590-596, 2001.
PubMed
9) Tassinari CA, et al : Epilepsy with continuous spikes and waves during slow sleep : otherwise described as ESES (epilepsy with electrical status epilepticus during slow sleep). In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2d ed (ed by Roger J, et al), p 245-256, John Libbey, London, 1992.
 
10) Panayiotopoulos CP, et al : Benign childhood focal epilepsies : assessment of established and newly recognized syndromes. Brain 131 : 2264-2286, 2008.
PubMed
11) Mico SI, et al : Rolandic epilepsy clinical variants and their influence on the prognosis. Neurologia 27 : 212-215, 2012.
 
12) Camfield CS, Camfield PR : Rolandic epilepsy has little effect on adult life 30 years later. Neurology 82 : 1162-1166, 2014.
PubMed
P.33 掲載の参考文献
1) Panayiotopoulos CP : Benign childhood epilepsy with centrotemporal spikes (Rolandic seizures). In : The Epilepsies, Seizures, Syndromes and Management (ed by Panayiotopoulos CP), p 224-234, Bladin Medical Publishing, Oxford, 2005.
 
2) Gastaut H : A new type of epilepsy : benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr 13 : 13-22, 1982.
PubMed
3) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of international League Against Epilepsy. Epilepsia 30 : 389-399, 1989.
PubMed
4) Panayiotopoulos CP : Vomiting as an ictal manifestation of epileptic seizures and syndromes. J Neurol Neurosurg Psychiatry 51 : 1448-1451, 1988.
PubMed
5) Ferrie CD, et al : Early-onset benign occipital seizure susceptibility syndrome. Epilepsia 38 : 285-293, 1997.
PubMed
6) Oguni H, et al : Study on the early-onset variant of benign childhood epilepsy with occipital paroxysms otherwise described early-onset benign occipital seizure susceptibility syndrome. Epilepsia 40 : 1020-1030, 2001.
 
7) Oguni H, et al : Study on early-onset benign occipital seizure susceptibility syndrome. Pediatr Neurol 25 : 312-318, 2001.
 
8) Panayiotopoulos CP : Extra-occipital benign childhood seizures with ictal vomiting and excellent prognosis. J Neurol Neurosurg Psychiary 66 : 82-85, 1999.
 
9) Engel J Jr : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 : 796-803, 2001.
PubMed
10) 平野嘉子ほか : Panayiotopoulos症候群106例の臨床・脳波学的検討. 日小児会誌 113 (3) : 522-527, 2009.
 
11) Ohtsu M, et al : EEG in children with early-onset benign occipital seizure susceptibility syndrome : Panayiotopoulos syndrome. Epilepsia 44 (3) : 435-442, 2003.
PubMed
12) Covanis A : Panayiotopoulos syndrome : a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder or gastroenteritis. Pediatrics 118 : 1237-1243, 2006.
PubMed
13) Hirano Y, et al : Neurobehavioral abnormalities may correlate with increased seizure burden in children with Panayiotopoulos syndrome. Pediatr Neurol 40 (6) : 443-448, 2009.
PubMed
14) Caraballo, et al : Late onset childhood occipital epilepsy (Gastaut type). In : Benign Focal Epilepsies in Infancy, Childhood and Adolescence (ed by Fejerman N, Caraballo RH), p 145-168, John Libbey Eurotext, London, 2007.
 
15) Oguni H, et al : Symptomatic parieto-occipital epilepsy as sequela of perinatal asphyxia. Pediatr Neurol 38 (5) : 345-352, 2008.
PubMed
P.35 掲載の参考文献
1) Wolf P : Reading epilepsy. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd ed (ed by Roger J, et al), p 281-298, John Libbey, London, 1992.
 
2) Koutroumanidis M, et al : The variants of reading epilepsy : a clinical and video-EEG study of 17 patients with reading-induced seizures. Brain 121 : 1409-1427, 1998.
PubMed
3) Miyamoto A, et al : Ictal HMPAO-single photon emission computed tomography findings in reading epilepsy in a Japanese boy. Epilepsia 36 : 1161-1163, 1995.
 
4) Archer JS, et al : Spike-triggered fMRI in reading epilepsy : involvement of left frontal cortex working memory area. Neurology 60 : 415-421, 2003.
PubMed
5) Op de beeck M, et al : Supplementary motor cortex involvement in reading epilepsy revealed by magnetic source imaging. Epilepsia 52 : e31-e34, 2011.
PubMed
6) Vaudano AE, et al : Networks involved in seizure initiation. A reading epilepsy case studied with EEG-fMRI and MEG. Neurology 79 : 249-253, 2012.
PubMed
7) Gavaret M, et al : Reading epilepsy from the dominant temporo-occipital region. J Neurol Neurosurg Psychiatry 81 : 710-715, 2010.
PubMed
8) Ritaccio AL, et al : The role of dominant premotor cortex and grapheme to phoneme transformation in reading epilepsy. A neuroanatomic, neurophysiologic, and neuropsychological study. Arch Neurol 49 : 933-939, 1992.
PubMed
9) Saenz-Lope E, et al : Primary reading epilepsy. Epilepsia 26 : 649-656, 1985.
PubMed
10) Wolf P, et al : Reading epilepsy : report of five new cases and further considerations on the pathophysiology. Seizure 7 : 271-279, 1998.
PubMed
11) Haykal MA, et al : New observations in primary and secondary reading epilepsy : excellent response to levetiracetam and early spontaneous remission. Epilepsy Behav 23 : 466-470, 2012.
PubMed
P.40 掲載の参考文献
1) Watanabe K, Okumura A : Benign partial epilepsies in infancy. Brain Dev 22 : 296-300, 2000.
PubMed
2) Vigevano F, et al : Benign infantile familial convulsions. Eur J Pediatr 151 : 608-612, 1992.
PubMed
3) Lee WL, et al : Benign familial infantile epilepsy. J Pediatr 123 : 588-590, 1993.
 
4) Okumura A, et al : Benign partial epilepsy in infancy. Arch Dis Child 74 : 19-21, 1996.
 
5) Chen WJ, et al : Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 43 : 1252-1255, 2011.
PubMed
6) Heron SE, et al : PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 90 : 152-160, 2012.
PubMed
7) Okumura A, et al : PRRT2 mutation in Japanese children with benign infantile epilepsy. Brain Dev 35 : 641-646, 2013.
PubMed
8) Herlenius E, et al : SCN2A mutations and benign familial neonatal-infantile seizures : the phenotypic spectrum. Epilepsia 48 : 1138-1142, 2007.
PubMed
9) Zhou X, et al : Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2. Eur J Pediatr 165 : 691-695, 2006.
 
10) Okumura A, et al : Long-term follow-up of patients with benign partial epilepsy in infancy. Epilepsia 47 : 181-185, 2006.
PubMed
11) Okumura A, et al : The clinical characterizations of benign partial epilepsy in infancy. Neuropediatrics 37 : 359-363, 2006.
PubMed
12) Okumura A, et al : Ictal EEG in benign partial epilepsy in infancy. Pediatr Neurol 36 : 8-12, 2007.
PubMed
13) Okumura A, et al : Transiently reduced water diffusion in the corpus callosum in infants with benign partial epilepsy in infancy. Brain Dev 32 : 564-566, 2010.
PubMed
14) Matsufuji H, et al : Low-dose carbamazepine therapy for benign infantile convulsions. Brain Dev 27 : 554-557, 2005.
PubMed
P.45 掲載の参考文献
1) Kojewnikow L : Eine besondere form von corticaler epilepsie. Neurologisches Cebtralblatt 14 : 47-48, 1895.
 
2) Bancaud J : Kojewnikow syndrome (epilepsia partialis continua) in children. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd ed (ed by Roger J, et al), p 363-379, John Libbey, London, 1992.
 
3) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
4) Rasmussen T, et al : Focal seizures due to chronic encephalitis. Neurology 8 : 435-445, 1958.
PubMed
5) Rogers SW, et al : Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265 : 648-651, 1994.
 
6) Bien CG, et al : Destruction of neurons by cytotoxic T cells : a new pathogenic mechanism in Rasmussen's syndrome. Ann Neurol 51 : 311-318, 2002.
PubMed
7) Bien CG, et al : Pathogenesis, diagnosis and treatment of Rasmussen encephalitis : A European consensus statement. Brain 128 : 454-471, 2005.
PubMed
8) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 (4) : 676-685, 2010.
PubMed
9) 高橋幸利ほか : Rasmussen症候群. 小児内科 45 (2) : 416-421, 2013.
Medical*Online
10) Takahashi Y, et al : Genetic variations of immunoregulatory genes associated with Rasmussen syndrome. Epilepsy Res 107 : 238-243, 2013.
PubMed
11) Takahashi Y, et al : A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFα , and granzyme B in CSF. Epilepsia 50 : 1419-1431, 2009.
 
12) Takahashi Y, et al : Epilepsia partialis continua of childhood involving bilateral brain hemispheres. Acta Neurol Scand 96 : 345-352, 1997.
PubMed
13) Yamazaki E, et al : Temporal changes in brain MRI findings in Rasmussen syndrome. Epileptic Disord 13 : 229-239, 2011.
PubMed
14) Takahashi Y, et al : Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 61 (7) : 891-896, 2003.
PubMed
15) Takahashi Y, et al : Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood. Brain Dev 35 : 778-785, 2013.
PubMed
P.50 掲載の参考文献
1) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
2) Engel J : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 : 796-803, 2001.
 
3) Wolf P, Inoue Y : Complex reflex epilepsies. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Bureau M, et al) p 529-543, John Libbey, Montrouge, 2012.
 
4) Critchley M : Musicogenic epilepsy. Brain 60 : 13-27, 1937.
 
5) Wieser HG, et al : Musicogenic epilepsy : review of the literature and case report with ictal single photon emission computed tomography. Epilepsia 38 : 200-207, 1997.
PubMed
6) Tayah TF, et al : Musicogenic seizures can arise from multiple temporal lobe foc : i intracranial EEG analysis of three patients. Epilepsia 47 : 1402-1406, 2006.
 
7) Joynt RJ, et al : Musicogenic epilepsy. JAMA 179 : 501-504, 1962.
PubMed
8) Mehta AD, et al : Seizure propagation in a patient with musicogenic epilepsy. Epilepsy Behav 14 : 421-424, 2009.
 
9) Ottman R, et al : Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 10 : 56-60, 1995.
PubMed
10) Inoue Y, et al : Ictal paraphasia induced by language activity. Epilepsy Res 35 : 69-79, 1999.
PubMed
11) Pisano T, et al : Abnormal phonologic processing in familial lateral temporal lobe epilepsy due to a new LGI1 mutation. Epilepsia 46 : 118-123, 2005.
PubMed
12) Ohkawa T, et al : Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33 (46) : 18161-18174, 2013.
PubMed
13) Inoue Y, et al : Epilepsy with praxis-induced seizures. In : Epileptic Seizures and Syndromes (ed by Wolf P), p 81-91, John Libbey, London, 1994.
 
14) Inoue Y, Zifkin B : Praxis induction and thinking induction : One or two mechanisms? A controversy. In : Reflex Epilepsies-Progress in Understandinged (by Wolf P, et al), p 41-55, John Libbey, London, 2004.
 
15) Cirignotta R, et al : Epileptic seizures during card games and draughts. Epilepsia 21 : 137-140, 1980.
 
16) Ferlazzo E, et al : Cortical triggers in generalized reflex seizures and epilepsies. Brain 128 : 700-710, 2005.
PubMed
P.56 掲載の参考文献
1) Rosenow F, Noachtar S : Mesial temporal lobe epilepsy : natural history and seizure semiology. In : The Mesial Temporal Lobe Epilepsies (ed by Rosenow F, et al), p 59-70, John Libby Eurotext, Montrouge, 2011.
 
2) So N : Epileptic auras. In : Wyllie's Treatment of Epilepsy : Principles and Practice, 5th ed (ed by Wyllie E), p 144-152, Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia, 2011.
 
3) Luders H, et al : Modern technology calls for a modern approach to classification of epileptic seizures and the epilepsies. Epilepsia 53 (3) : 405-411, 2012.
PubMed
4) Wiebe S, et al : A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 345 (5) : 311-318, 2001.
 
P.59 掲載の参考文献
1) Manford M, et al : The national general practice study of epilepsy. The syndromic classification of the international league against epilepsy applied to epilepsy in a general population. Archiv Neurol 49 : 801-808, 1992.
 
2) 武田洋司 : 前頭葉てんかん. てんかん学用語事典 (日本てんかん学会用語事典編集委員会編), p 70-71, 日本てんかん学会, 2006.
 
3) 三原忠紘 : 前頭葉てんかんの手術. 難治性てんかんの外科治療 プラクティカル・ガイドブック (大槻泰介ほか編), p 183-118, 診断と治療社, 2007.
 
4) Jeha LE, et al : Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain 130 : 574-584, 2007.
PubMed
5) 日本てんかん学会 : 前頭葉てんかん. てんかん専門医ガイドブック (日本てんかん学会編), p 253-254, 診断と治療社, 2014.
 
6) 三原忠紘, 松田一巳 : 前頭葉てんかんの発作症状. 外科てんかん学入門, p 27-28, 創造出版, 2008.
 
7) Carreno M, et al : Complex motor behaviors in temporal lobe epilepsy. Neurology 65 : 1805-1807, 2005.
PubMed
8) Ryvlin P, et al : Nocturnal hypermotor seizures, suggesting frontal lobe epilepsy, can originate in the insula. Epilepsia 47 : 755-765, 2006.
PubMed
9) Williamson PD, et al : Anatomic classification of focal epilepsies, frontal lobe epilepsy. In : Epilepsy : A Comprehensive Text Booked (by Engel J Jr), p 2468-2470, Wolters Kluwer, Philadelphia, 2008.
 
10) Laskowitz DT, et al : Syndrome of frontal lobe epilepsy : characteristics and surgical management. Neurol 45 : 780-787, 1995.
 
11) Beleza P, et al : Interictal rhythmical midline theta differentiates frontal from temporal lobe epilepsies. Epilepsia 50 : 550-555, 2009.
PubMed
12) Bautista RE, et al : EEG findings in frontal lobe epilepsies. Neurology 50 : 1765-1771, 1998.
PubMed
13) 日本てんかん学会 : 神経画像. てんかん専門医ガイドブック (日本てんかん学会編), p 117-120, 診断と治療社, 2014.
 
14) 日本てんかん学会 : 機能画像. てんかん専門医ガイドブック (日本てんかん学会編), p 121-126, 診断と治療社, 2014.
 
15) 日本てんかん学会 : 外科治療総論. てんかん専門医ガイドブック (日本てんかん学会編), p 180-183, 診断と治療社, 2014.
 
P.65 掲載の参考文献
1) Penfield W, Jasper H : Epilepsy and Functional Anatomy of Human Brain, Little Brown & Co, Boston, 1954.
 
2) Luders H, et al : The second sensory area in humans : evoked potentials and electrical stimulation studies. Ann Neurol 17 : 177-184, 1985.
PubMed
3) Sveinbjornsdottir S, Duncan JS : Parietal and occipital lobe epilepsy : a review. Brain 34 : 493-521, 1993.
PubMed
4) Salanova V, et al : Parietal lobe epilepsy. Clinical manifestations and outcome in 82 patients treated surgically between 1929 and 1988. Brain 118 : 607-627, 1995.
PubMed
5) Williamson PD, et al : Parietal lobe epilepsy : diagnostic considerations and results of surgery. Ann Neurol 31 : 193-201, 1992.
PubMed
6) Cascino GD, et al : Parietal lobe lesional epilepsy : electroclinical correlation and operative outcome. Epilepsia 34 : 522-527, 1993.
PubMed
7) Ho SS, et al : Parietal lobe epilepsy : clinical features and seizure localization by ictal SPECT. Neurology 44 : 2277-2284, 1994.
PubMed
8) Mauguiere F, Courjon J : Somatosensory epilepsy. A review of 127 cases. Brain 101 : 307-332, 1978.
PubMed
9) Gibbs FA, Gibbs EL : Atlas of Electroencephalography, Vol. 2 : Epilepsy, p 2210-2225, Addison-Wesley Press, Cambridge, 1953.
 
10) Manford M, et al : National General Practice Study of Epilepsy (NGPSE) : partial seizure patterns in a general population. Neurology 42 : 1911-1917, 1992.
 
11) Siegel AM, et al : Localized pain associated with seizures originating in the parietal lobe. Epilepsia 40 : 845-855, 1999.
PubMed
12) Kim DW, et al : Parietal lobe epilepsy : the semiology, yield of diagnostic workup, and surgical outcome. Epilepsia 45 : 641-649, 2004.
PubMed
P.71 掲載の参考文献
1) Duvernoy H : Brain anatomy. In : Magnetic Resonance in Epilepsy. Neuroimaging Techniques (ed by Kuzniecky RI, Jackson GD), 2nd ed, p 26-97, Elsevier, Amsterdam, 2005.
 
2) Kuzniecky RI, Jackson GD : Extratemporal lobe epilepsy. In : Magnetic Resonance in Epilepsy. Neuroimaging Techniques (ed by Kuzniecky RI, Jackson GD), 2nd ed, p 117-196, Elsevier, Amsterdam, 2005.
 
3) Kuzniecky RI : Symptomatic occipital lobe epilepsy. Epilepsia 39 (Suppl 4) : S23-31, 1998.
 
4) Panayiotopoulos CP : Occipital lobe epilepsies. In : A Clinical Guide to Epileptic Syndromes and their Treatment (ed by Panayiotopoulos CP), 2nd ed, p 413-422, Springer, London, 2007.
 
5) Panayiotopoulos CP : Benign Childhood Partial Seizures and Related Epileptic Syndromes, John Libbey & Co, London, 1999.
 
6) Kuzniecky R, et al : Occipital lobe developmental malformations and epilepsy : clinical spectrum, treatment, and outcome. Epilepsia 38 : 175-181, 1997.
PubMed
7) Manfild M, et al : The national general practice study of epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol 49 : 801-808, 1992.
 
8) Plazzi G, et al : Occipital lobe epilepsy : a chronic condition related to transient occipital lobe involvement in eclampsia. Epilepsia 35 : 644-647, 1994.
PubMed
9) Lawn N, et al : Eclampsia, hippocampal sclerosis, and temporal lobe epilepsy : accident or association? Neurology 62 : 1352-1356, 2004.
PubMed
10) Salanova V, et al : Occipital lobe epilepsy : electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Surgery of occipital lobe epilepsy. Brain 115 (Pt 6) : 1655-1680, 1992.
 
11) Welch KM : Pathogenesis of migraine. Semin Neurol 17 : 335-341, 1997.
PubMed
12) Ogunyemi A, Adams D : Migraine-like syndromes triggered by occipital lobe seizures : response to sumatriptan. Can J Neurol Sci 25 : 151-153, 1998.
 
13) Panayiotopoulos CP : "Migralepsy" and the significance of differentiating occipital seizures from migraine. Epilepsia 47 : 806-808, 2006.
PubMed
14) Panayiotopoulos CP : Visual phenomena and headache in occipital epilepsy : a review, a systematic study and differentiation from migraine. Epileptic Disord 1 : 205-216, 1999.
PubMed
15) Yun CH, et al : Prognostic factors in neocortical epilepsy surgery : multivariate analysis. Epilepsia 47 : 574-579, 2006.
PubMed
P.74 掲載の参考文献
1) 三春範夫 : 新生児けいれん. 日産婦会誌 57 : 123-127, 2005.
 
2) Leppert M, et al : Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature 337 : 647-648, 1989.
PubMed
3) Biervert C, et al : A potassium channel mutation in neonatal human epilepsy. Science 279 : 403-406, 1998.
PubMed
4) Ishii A, et al : Genetic analysis of PRRT2 for infantile epilepsy, infantile convulsions with choreoathetosis syndrome, and benign convulsion with mild gastroenteritis. Brain Dev 35 : 524-530, 2013.
PubMed
5) Weckhuysen S, et al : KCNQ2 encephalopathy : emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol 71 : 15-25, 2012.
PubMed
6) Plouin P, et al : Benign familial and non-familial neonatal seizures. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Bureau M, et al), p 77-88, John Libbey Eurotext, 2013.
 
7) Bellini G, et al : KCNQ2-Related Disorders. In : GeneReviewsTM (ed by Pagon RA, et al) [Internet]. University of Washington, Seattle ; 1993-2013, 2010 Apr 2 [7updated 2013 Apr 11]
 
8) Wakai S, et al : Classification of familial neonatal convulsions. Lancet 344 : 1376, 1994.
PubMed
9) Singh NA, et al : A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18 : 25-29, 1998.
 
10) Charlier C, et al : A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18 : 53-55, 1998.
 
P.77 掲載の参考文献
1) Dehan M, et al : Les convulsions du cinquieme jour de vie : un nouveau syndrome? Arch Fr Pediatr 34 (8) : 730-742, 1977.
PubMed
2) Pryor DS : Fifth day fits : a syndrome of neonatal convulsions. Arch Dis Child 56 : 753-758, 1981.
PubMed
3) Plouin P : Benign idiopathic neonatal seizures. In : Atlas of Epilepsies, p 839-842, Springer-Verlag, London, 2010.
 
4) Watanabe K, et al : Epilepsies of neonatal onset : seizure type and volution. Dev Med Child Neurol 41 : 318-322, 1999.
 
5) Goldberg HJ : Fifth day fits : an acute zinc deficiency syndrome? Arch Dis Child 57 : 633-635, 1982.
PubMed
6) Ishii A, et al : KCNQ2 abnormality in BECTS : Benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2. Epilepsy Res 102 : 122-125, 2012.
PubMed
7) Weckhuysen S, et al : KCNQ2 encephalopathy : emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol 71 : 15-25, 2012.
PubMed
8) Kato M, et al : Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia 54 : 1282-1287, 2013.
PubMed
9) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
10) 奥村彰久, 渡邊一功 : X. てんかん症候群 全般てんかんおよび症候群 良性新生児けいれん. 別冊日本臨牀 神経症候群 VI, p 58-60, 日本臨牀社, 2002.
 
11) Plouin P : Benign familial neonatal convulsions and benign idiopathic neonatal convulsions. In : Epilepsy : A Comprehensive Textbooked. (by Engel J, Pedley A), p 2247-2255, Lippincott-Raven, Philadelphia, 1997.
 
12) Plouin P, et al : Benign familial and non-familial neonatal seizures. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Bureau M, et al), p 455-505, Joh Libbey Eurotext, Montrouge, 2012.
 
13) Panayiotopoulos CP : Benign neonatal seizure (non-familial). In : A Clinical Guide to Epileptic Syndromes and their Treatment, 2nd ed (ed by Panayiotopoulos CP), p 250-252, Springer, 2010.
 
14) Yamamoto H, et al : Epilepsies and epileptic syndromes starting in the neonatal period. Brain Dev 33 : 213-220, 2011.
PubMed
P.84 掲載の参考文献
1) Ohtsuka Y, et al : Classification of epilepsies and epileptic syndromes of childhood according to the 1989 ILAE classification. J Epilepsy 6 (4) : 272-276, 1993.
 
2) Caraballo RH, et al : Myoclonic epilepsy in infancy : an electroclinical study and long-term follow-up of 38 patients. Epilepsia 54 (9) ; 1606-1612, 2013.
 
3) Auvin S, et al ; Epilepsy Study Group of the French Pediatric Nuerology Society : Benign myoclonic epilepsy in infants : electroclinical features and long-term follow-up of 34 patients. Epilepsia 47 (2) : 387-393, 2006.
 
4) Darra F, et al : Benign myoclonic epilepsy in infancy (BMEI) : a longitudinal electroclinical study of 22 cases. Epilepsia 47 (Suppl 5) : 31-35, 2006.
 
5) Galletti F, et al : Familial occurrence of benign myoclonus of early infancy. Epilepsia 30 (5) : 579-581, 1989.
PubMed
6) Deprez L, et al : Genetics of epilepsy syndrome starting in the first year of life. Neurology 72 : 273-281, 2009.
PubMed
7) Capovilla G, et al : Photosensitive benign myoclonic epilepsy in infancy. Epilepsia 48 (1) : 96-100, 2006.
 
8) Ricci S, et al : Reflex myoclonic epilepsy in infancy : a new age-dependent idiopathic syndrome related to startle reaction. Epilepsia 34 (4) : 342-348, 1995.
 
9) Mangano S, et al : Benign myoclonic epilepsy in infancy followed by childhood absence epilepsy. Seizure 20 : 727-730, 2011.
PubMed
10) Mangano S, et al : Benign myoclonic epilepsy in infancy : neuropsychological and behavioral outcome. Brain Dev 27 (3) : 218-223, 2005.
PubMed
11) Lin Y, et al : Benign myoclonic epilepsy in infants : video-EEG features and long-term follow-up. Neuropediatrics 29 (5) : 268-271, 1998.
PubMed
12) Zuberi SM, O'Regan ME : Developmental outcome in benign myoclonic epilepsy in infancy and reflex myoclonic epilepsy in infancy : a literature review and six new cases. Epilepsy Res 70 : S110-115, 2006.
PubMed
13) Gaspard N, et al : "Benign" myoclonic epilepsy of infancy as the initial presentation of glucose transporter-1 deficiency. Epileptic Disord 13 (3) : 300-303, 2011.
PubMed
14) Rossi PG, et al : Benign myoclonic epilepsy : long-term follow up of 11 new cases. Brain Dev 19 : 473-479, 1997.
 
P.88 掲載の参考文献
1) Hirsch E, Panayiotopoulos CP : Childhood absence epilepsy and related syndromes. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 315-335, John Libbey, Montrouge, 2005.
 
2) Proposal for revised classification of epilepsies and epileptic syndrome. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30 : 389-399, 1989.
PubMed
3) Panayiotopoulos CP : Typical absence seizures and related epileptic syndromes. Epilepsia 49 : 2131-2139, 2008.
PubMed
4) Crunelli V, Leresche N : Childhood absence epilepsy : genes, channels, neurons and networks. Nat Rev Neurosci 3 : 371-382, 2002.
PubMed
5) Maljevic S, et al : A mutation in the GABA-A receptor alpha-1-subunit is associated with absence epilepsy. Ann Neurol 59 : 983-987, 2006.
PubMed
6) Singh B, et al : Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Hum Mutat 28 : 524-525, 2007.
PubMed
7) Chioza BA, et al : Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14. Epilepsy Res 87 : 247-255, 2009.
PubMed
8) Everett KV, et al : Linkage and association analysis of CACNG3 in childhood absence epilepsy. Eur J Hum Genet 15 : 463-472, 2007.
PubMed
9) Kostopoulos GK : Spike-and-wave discharges of absence seizures as a manifestation of sleep spindles : the continuing development of a hypothesis. Clin Neurophysiol 111 (Suppl 2) : S27-S38, 2000.
 
10) 丸栄一ほか : てんかんの病態生理-抑制から発作へ-. 神経研究の進歩 48 : 917-926, 2004.
 
11) Moeller F, et al : Simultaneous EEG-fMRI in drug-naive children with newly diagnosed absence epilepsy. Epilepsia 49 : 1510-1519, 2008.
PubMed
12) Danielson NB, et al : The default mode network and altered consciousness in epilepsy. Behav Neurol 24 : 55-65, 2011.
PubMed
13) Blumenfeld H, et al : Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 49 : 400-409, 2008.
 
14) Dezsi G, et al : Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy. Epilepsia 54 : 635-643, 2013.
PubMed
15) Berg At, et al : Long-term seizure remission in childhood absence epilepsy : might initial treatment matter? Epilepsia 55 : 551-557, 2014.
PubMed
P.92 掲載の参考文献
1) Gelisse P, et al : Juvenile absence epilepsy. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Wolf P, et al), p 329-339, John Libbey, Montrouge, 2012.
 
2) Panayiotopoulos CP, Obeid T : Juvenile myoclonic epilepsy : an autosomal recessive disease. Ann Neurol 25 : 440-443, 1989.
PubMed
3) Marini C, et al : Genetic architecture of idiopathic generalized epilepsy : clinical genetic analysis of 55 multiplex families. Epilepsia 45 : 467-478, 2004.
PubMed
4) Winawer MR, et al : Genetic influences on myoclonic and absence seizures. Neurology 61 : 1576-1581, 2003.
PubMed
5) Ngomba R, et al : Metabotropic glutamate receptors in the thalamocortical network : strategic targets for the treatment of absence epilepsy. Epilepsia 52 : 1211-1222, 2011.
PubMed
6) Yalcin O, et al : An association analysis at 2q36 reveals a new candidate susceptibility gene for juvenile absence epilepsy and/or absence seizures associated with generalized tonic-clonic seizures. Epilepsia 52 : 975-983, 2011.
PubMed
7) Thomas P, et al : Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 129 : 1281-1292, 2006.
PubMed
8) Gelisse P, et al : Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 45 : 1282-1286, 2004.
PubMed
9) Agathonikou A, et al : Typical absence status in adults : diagnostic and syndromic considerations. Epilepsia 39 : 1265-1276, 1998.
PubMed
10) Pnayiotopoulos CP : Reflex seizures and related epileptic syndrome. In : A Clinical Guide to Epileptic Syndromes and Their Treatment (ed by Pnayiotopoulos CP), p 513-517, Springer, London, 2010.
 
11) Wheless JW, et al : Treatment of pediatric epilepsy : European expert opinion, 2007. Epileptic Disord 9 : 353-412, 2007.
PubMed
12) Crespel A, et al : Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology 65 : 762-764, 2005.
PubMed
13) Velizarova R, et al : Zonisamide for refractory juvenile absence epilepsy. Epilepsy Res 108 : 1263-1266, 2014.
PubMed
14) Auvin S, et al : Aggravation of absence seizure related to levetiracetam. Eur J Paediatr Neurol 15 : 508-511, 2011.
PubMed
15) Seneviratne U, et al : The prognosis of idiopathic generalized epilepsy. Epilepsia 53 : 2079-2090, 2012.
PubMed
16) Janz D : The idiopathic generalized epilepsies of adolescence with childhood and juvenile age of onset. Epilepsia 38 : 4-11, 1997.
PubMed
P.96 掲載の参考文献
1) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
2) Thomas P, et al : Juvenile myoclonic epilepsy. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, p 305-328, John Libbey Eurotext, Montrouge, 2012.
 
3) Janz D : Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 72 : 449-459, 1985.
PubMed
4) Cossette P, et al : Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31 : 184-189, 2002.
 
5) Suzuki T, et al : Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 36 : 842-849, 2004.
PubMed
6) Obeid T, Panayiotopoulos CP : Juvenile myoclonic epilepsy : a study in Saudi Arabia. Epilepsia 29 : 280-282, 1988.
PubMed
7) Asconape J, Penry JK : Some clinical and EEG aspects of benign juvenile myoclonic epilepsy. Epilepsia 25 : 108-114, 1984.
PubMed
8) Kimura S, Kobayashi T : Two patients with juvenile myoclonic epilepsy and nonconvulsive status epilepticus. Epilepsia 37 : 275-279, 1996.
PubMed
9) Delgado-Escueta AV, Enrile-Bacsal F : Juvenile myoclonic epilepsy of Janz. Neurology 34 : 285-294, 1984.
PubMed
10) Sharpe DV, et al : Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure 17 : 64-68, 2008.
PubMed
11) Sousa PS, et al : Topiramate for the treatment of juvenile myoclonic epilepsy. Arq Neuropsiquiatr 63 : 733-737, 2005.
 
12) Kothare SV, et al : Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 6 : 267-270, 2004.
PubMed
13) Genton P, et al : Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 55 : 1106-1109, 2000.
PubMed
14) Camfield CS, Camfield PR : Juvenile myoclonic epilepsy 25 years after seizure onset : a population-based study. Neurology 73 : 1041-1045, 2009.
PubMed
15) Geithner J, et al : Predictors for long-term seizure outcome in juvenile myoclonic epilepsy : 25-63 years of follow-up. Epilepsia 53 : 1379-1386, 2012.
PubMed
P.102 掲載の参考文献
1) Holtkamp M, et al : Long-term outcome in epilepsy with grand mal on awakening : forty years of follow-up. Ann Neurol 75 : 298-302, 2014.
PubMed
2) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
3) Janz D : Epilepsy with grand mal on awakening and sleep-waking cycle. Clin Neurophysiol 111 (Suppl 2) : S103-S110, 2000.
 
4) Janz D : The idiopathic generalized epilepsies of adolescence with childhood and juvenile age of onset. Epilepsia 38 : 4-11, 1997.
PubMed
5) Greenberg DA, et al : The genetics of idiopathic generalized epilepsies of adolescent onset : differences between juvenile myoclonic epilepsy and epilepsy with random grand mal and with awakening grand mal. Neurology 45 : 942-946, 1995.
PubMed
6) Gardiner M : Genetics of idiopathic generalized epilepsies. Epilepsia 46 (Suppl 9) : 15-20, 2005.
 
7) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
8) Nicolson A, et al : The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry 75 : 75-79, 2004.
PubMed
9) Haug K, et al : Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 33 : 527-532, 2003.
PubMed
10) Unterberger I, et al : Idiopathic generalized epilepsies with pure grand mal : clinical data and genetics. Epilepsy Res 44 : 19-25, 2001.
 
11) Duron RM, et al : Seizure of idiopathic generalized epilepsies. Epilepsia 46 (Suppl 9) : 34-47, 2005.
 
12) Genton P, et al : Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 55 : 1106-1109, 2000.
PubMed
13) Sullivan JE, Dlugos DJ : Idiopathic Generalized Epilepsy. Curr Treat Options Neurol 6 : 231-242, 2004.
PubMed
P.104 掲載の参考文献
1) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
2) 井上有史 : 上記以外の特発性全般てんかん. てんかん症候群 (清野昌一, 大田原俊輔編), p 225-229, 医学書院, 1998.
 
3) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
4) 岡英次 : 岡山県における小児てんかんの実態・神経疫学的研究. 脳と発達 34 : 95-102, 2002.
 
5) Asadi-Pooya AA, et al : A clinical study of syndromes of idiopathic (genetic) generalized epilepsy. J Neurol Sci 324 : 113-117, 2013.
PubMed
6) Gilliam F, et al : Adult myoclonic epilepsy : a distinct syndrome of idiopathic generalized epilepsy. Neurology 55 : 1030-1033, 2000.
PubMed
7) Greenberg DA, et al : The genetics of idiopathic generalized epilepsies of adolescent onset : differences between juvenile myoclonic epilepsy and epilepsy with random grand mal and with awakening grand mal. Neurology 45 : 942-946, 1995.
PubMed
8) Seneviratne U, et al : The prognosis of idiopathic generalized epilepsy. Epilepsia 53 : 2079-2090, 2012.
PubMed
P.109 掲載の参考文献
1) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
2) Jerome Engel J : 国際抗てんかん連盟分類・用語作業部会報告 : てんかん発作とてんかんの診断大要案. てんかん研究 21 : 242-251, 2003.
 
3) Fisher RS, et al : ILAE Official Report : a practical clinical definition of epilepsy. Epilepsia 55 : 475-482, 2014.
PubMed
4) Wolf P, Koepp M : Chapter 16-Reflex epilepsies. In : Handbook of Clinical Neurology, Vol 107 (ed by Hermann S, William HT), p 257-276, Elsevier, Edinburgh, London , New York, Oxford, Philadelphia, St Louis, Sydney, Toronto, 2012.
 
5) 井上有史 : 特発性てんかんにおける誘発発作. Epilepsy 2 : 121-126, 2008.
Medical*Online
6) Radhakrishnan K, et al : Pattern-sensitive epilepsy : electroclinical characteristics, natural history, and delineation of the epileptic syndrome. Epilepsia 46 : 48-58, 2005.
PubMed
7) Panayiotopoulos CP : Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia 46 (Suppl 9) : 57-66, 2005.
 
8) Wolf P, Inoue Y : Complex reflex epilepsies. In : Epileptic Syndromes in Infancy, Childhood and Adloscence, 5th ed (ed by Bureau P, et al), p 529-543, John Libbey, Montrouge, 2012.
 
9) Yacubian EM, Wolf P : Praxis induction. Definition, relation to epilepsy syndromes, nosological and prognostic significance. A focused review. Seizure 23 : 247-251, 2014.
PubMed
10) Matsuoka H, et al : Neuropsychological EEG activation in patients with epilepsy. Brain 123 (Pt 2) : 318-330, 2000.
 
11) Inoue Y, et al : Epilepsy with praxis-induced seizures. In : Epileptic Seizures and Syndromes (ed by Wolf P), p 81-91, John Libbey, London, 1994.
 
12) Woods RJ, Gruenthal M : Cognition-induced epilepsy associated with specific emotional precipitants. Epilepsy Behav 9 : 360-362, 2006.
PubMed
13) Ferlazzo E, et al : Cortical triggers in generalized reflex seizures and epilepsies. Brain 128 : 700-710, 2005.
PubMed
14) Kasteleijn-Nolst Trenite DG : Provoked and reflex seizures : surprising or common? Epilepsia 53 (Suppl 4) : 105-113, 2012.
PubMed
15) da Silva Sousa P, et al : Self-perception of factors that precipitate or inhibit seizures in juvenile myoclonic epilepsy. Seizure 14 : 340-346, 2005.
PubMed
P.114 掲載の参考文献
1) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
2) Dulac O, Tuxhorn I : Infantile spasms and West syndrome. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 53-72, John Libbey Eurotext, Montrouge, 2005.
 
3) Lux AL, Osborne JP : A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome : consensus statement of the West Delphi group. Epilepsia 45 : 1416-1428, 2004.
PubMed
4) Trevathan E, et al : The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 40 : 748-751, 1999.
PubMed
5) Luthvigsson P1, et al : Epidemiologic features of infantile spasms in Iceland. Epilepsia 35 : 802-805, 1994.
 
6) 浜野晋一郎ほか : West症候群の死亡に関する臨床的検討. 日小児会誌 108 : 859-863, 2004.
 
7) Kato M, et al : Polyalanine expansion of ARX associated with cryptogenic West syndrome. Neurology 61 : 267-268, 2003.
PubMed
8) Watanabe K, et al : Symptomatology of infantile spasms. Brain Dev 23 : 453-466, 2001.
PubMed
9) Gaily EK, et al : Asymmetric and asynchronous infantile spasms. Epilepsia 36 : 873-882, 1995.
PubMed
10) Fusco L, Vigevano F : Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia 34 : 671-678, 1993.
PubMed
11) Watanabe K, et al : Reappraisal of interictal electroencephalograms in infantile spasms. Epilepsia 34 : 679-685, 1993.
PubMed
12) Riikonen R : Long-term outcome of patients with West syndrome. Brain Dev 23 : 683-687, 2001.
PubMed
13) 伊藤正利ほか : ウエスト症候群の診断治療ガイドライン. てんかん研 24 : 68-73, 2006.
 
14) Go CY, et al : Evidence-based guideline update : medical treatment of infantile spasms. Neurology 78 : 1974-1980, 2012.
PubMed
15) 浜野晋一郎 : ACTH. 臨床てんかん学 (兼本浩祐編), 医学書院, 2014. (印刷中)
 
P.121 掲載の参考文献
1) VanStraten AF, Ng YT : Update on the management of Lennox-Gastaut syndrome. Pediatr Neurol 47 : 153-161, 2012.
PubMed
2) Arzimanoglou A, et al : Lennox-Gastaut syndrome : a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8 : 82-93, 2009.
PubMed
3) Goldsmith IL, et al : Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome : effect of incorporating MRI head imaging in defining the cryptogenic subgroup. Epilepsia 41 : 395-399, 2000.
PubMed
4) Yagi K : Evolution of Lennox-Gastaut syndrome : a long-term longitudinal study. Epilepsia 37 (Suppl 3) : 48-51, 1996.
 
5) Aicardi J, Gomes A : The Lennox-Gastaut syndrome : Clinical and electroencephalographic features. In : The Lennox-Gastaut Syndrome (ed by Niedermeyer E, Degen R), p 25-46, Alan R. Liss, New York, 1988.
 
6) Heiskala H : Community-based study of Lennox-Gastaut syndrome. Epilepsia 38 : 526-531, 1997.
PubMed
P.125 掲載の参考文献
1) Harper JR : True myoclonic epilepsy in childhood. Arch Dis Child 43 : 28-35, 1968.
PubMed
2) Doose H, et al : Centrencephalic myoclonic-astatic petit mal. Neuropediatrie 2 : 59-78, 1970.
 
3) Aicardi J, Chevrie JJ : Myoclonic epilepsies of childhood. Neuropediatrie 3 : 177-190, 1971.
 
4) Doose H : Myoclonic astatic epilepsy of early childhood. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd revised ed (ed by Roger J, et al), p 103-114, John Libbey, London, 1992.
 
5) Dravet C, et al : Benign myoclonic epilepsy in infants. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd revised ed (ed by Roger J, et al), p 67-74, John Libbey, London, 1992.
 
6) Dravet C, et al : Severe myoclonic epilepsy in infants. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd revised ed (ed by Roger J, et al), p 75-88, John Libbey, London, 1992.
 
7) Kaminska A, et al : Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 36 : 15-29, 1999.
PubMed
8) Oguni H, et al : A video-EEG analysis of drop seizures in myoclonic astatic epilepsy of early childhood (Doose syndrome). Epilepsia 33 : 805-813, 1992.
PubMed
9) Oguni H, et al : Idiopathic myoclonic-astatic epilepsy of early childhood-nosology based on electrophysiologic and long-term follow-up study of patients. Adv Neurol 95 : 157-174, 2005.
PubMed
10) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
11) Doose H, Baier WK : Genetic factors in epilepsies with primarily generalized minor seizures. Neuropediatrics 18 : 1-64, 1987.
 
12) Nabbout R, et al : Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res 56 (2-3) : 127-133, 2003.
 
13) Mullen SA, et al : Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol 68 : 1152-1155, 2011.
PubMed
14) Itoh Y, et al : Study of epileptic drop attacks in symptomatic epilepsy of early childhood-Differences from those in myoclonic-astatic epilepsy. Brain Dev, 2014. (電子版, 印刷中)
 
15) Moeller F, et al : EEG-fMRI in myoclonic astatic epilepsy (Doose syndrome). Neurology 82 : 1508-1513, 2014.
PubMed
P.129 掲載の参考文献
1) Tassinari CA, et al : Study on spike and wave discharges in man. II. Clinical and electroencephalographic aspects of myoclonic absences. Rev Neurol 121 : 379-383, 1969. [in French]
 
2) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
3) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
4) Bureau M, Tassinari CA : Epilepsy with myoclonic absences. Brain Dev 27 : 178-184, 2005.
PubMed
5) Bureau M, Tassinari CA : Syndrome of myoclonic absences. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 337-344, John Libbey Eurotext, Montrouge, 2005.
 
6) 池田浩子ほか : ミオクロニー欠神てんかんの臨床症状と経過. 脳と発達 43 : 14-18, 2011.
Medical*Online
7) Elia M, et al : Myoclonic absence-like seizures and chromosome abnormality syndromes. Epilepsia 39 : 660-663, 1998.
PubMed
8) Cherian A, et al : Epilepsy with myoclonic absences in siblings. Brain Dev 2014. (in press)
 
9) Klitten LL, et al : A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia 52 : e190-193, 2011.
 
10) 伊藤進ほか : 小児てんかんにおけるてんかん性ミオクローヌスとてんかん性スパスムのポリグラフ比較研究. 臨床脳波 49 : 762-767, 2007.
Medical*Online
11) Ikeda A, et al : Clonic convulsion caused by epileptic discharges arising from the human supplementary motor area as studied by subdural recording. Epileptic Disord 1 : 21-26, 1999.
PubMed
12) Hirsch E, Panayiotopoulos CP : Childhood absence epilepsy and related syndromes. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 315-336, John Libbey Eurotext, Montrouge, 2005.
 
13) Beaumanoir A, Blume W : The Lennox-Gastaut syndrome. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 125-148, John Libbey Eurotext, Montrouge, 2005.
 
14) Thomas P, et al : Juvenile myoclonic epilepsy. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 367-388, John Libbey Eurotext, Montrouge, 2005.
 
15) Hausler M, et al : Epilepsy with myoclonic absences-favourable response to add-on rufinamide treatment in 3 cases. Neuropediatrics 42 : 28-29, 2011.
PubMed
16) 小国弘量 : ミオクロニー欠神てんかん. 小児内科 27 : 60-63, 1995.
 
P.134 掲載の参考文献
1) Aicardi J, Ohtahara S : Severe neonatal epilepsies with suppression-burst pattern. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 39-50, John Libbey Eurotext, Montrouge, 2005.
 
2) Aicardi J : Early myoclonic encephalopathy (neonatal myoclonic encephalopathy). In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd ed (ed by Roger J, et al), p 13-23, John Libbey, London, 1992.
 
3) Oka E, et al : Neuroepidemiological study of childhood epilepsy by application in international classification of epilepsies and epileptic syndromes (ILAE 1989). Epilepsia 36 : 658-661, 1995.
PubMed
4) Djukic A, et al : Early myoclonic encephalopathy (neonatal myoclonic encephalopathy). In : Epilepsy. A Comprehensive Textbook, 2nd ed (ed by Engel J Jr, Pedley TA), p 2297-2301, Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, 2008.
 
5) Dalla Bernardina B, et al : Early myoclonic epileptic encephalopathy (EMEE). Eur J Pediatr 140 : 248-252, 1983.
PubMed
6) Backx L, et al : Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4. Eur J Hum Genet 17 : 378-382, 2009.
PubMed
7) 須貝研司 : 早期ミオクロニー脳症 (EME). 厚生労働科学研究費補助金 (難治性疾患等克服研究事業) 稀少難治性てんかんに関する調査研究平成25年度総括・分担研究報告書 (研究代表者 大槻泰介), p 18-20, 2014.
 
8) Watanabe S, et al : Schinzel-Giedion syndrome : a further cause of early myoclonic encephalopathy and vacuolating myelinopathy. Brain Dev 34 : 151-155, 2012.
PubMed
9) Cohen R, et al : Two siblings with early infantile myoclonic encephalopathy due to mutation in the gene encoding mitochondrial glutamate/H + symporter SLC25A22. Eur J Paediatr Neurol. 2014 Jul 5. pii : S 1090-379 (814) 00111-1. doi : 10.1016/j.ejpn.2014.06.007. [Epub ahead of print]
 
10) Kato M, et al : PIGA mutations cause early-onset epileptic encephalopathies and distinctive features. Neurology 82 : 1587-1596, 2014.
PubMed
11) Cusmai R, et al : Ketogenic diet in early myoclonic encephalopathy due to nonketotic hyperglycinemia. Eur J Paediatr Neurol 16 : 509-513, 2012.
PubMed
12) Hamosh A, et al : Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 121 : 131-135, 1992.
 
13) Jan MM, et al : Topiramate for the treatment of infants with early myoclonic encephalopathy. Neurosciences (Riyadh) 8 : 110-112, 2003.
PubMed
14) Nakano K, et al : Successful treatment of early myoclonic encephalopathy using lidocaine and carbamazepine. Epileptic Disord 15 : 352-357, 2013.
PubMed
P.139 掲載の参考文献
1) 大田原俊輔ほか : 特異な年齢依存性てんかん性脳症the early-infantile epileptic encephalopathy with suppression-burstに関する研究. 脳と発達 8 : 270-280, 1976.
 
2) Ohtahara S, et al : The early-infantile epileptic encephalopathy with suppression-burst : developmental aspects. Brain Dev 9 : 371-376, 1987.
PubMed
3) Ohtsuka Y, et al : Developmental aspects of epilepsy with special reference to age-dependent epileptic encephalopathy. Jpn J Psychiatry Neurol 40 : 307-313, 1986.
PubMed
4) Ohtahara S, Yamatogi Y : Epileptic encephalopathy in early infancy with suppression-burst. J Clin Neurophysiol 20 : 398-407, 2003.
 
5) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
6) Fullston T, et al : Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C > G /p.Y27X). Eur J Hum Genet 18 : 157-162, 2010.
 
7) Aicardi J, Ohtahara S : Severe neonatal epilepsies with suppression-burst pattern. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 39-50, John Libbey Eurotext, Montrouge, 2005.
 
8) Kato M, et al : A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome). Am J Hum Genet 81 : 361-366, 2007.
 
9) Saitsu H, et al : De novo mutations in the gene encoding STXBP 1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet 40 : 782-788, 2008.
 
10) Saitsu H, et al : Whole exome sequencing identifies KCNQ2 mutations in Ohtahara syndrome. Ann Neurol 72 : 298-300, 2012.
PubMed
11) Nakamura K, et al : Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. Neurology 81 : 992-998, 2013.
PubMed
12) Ohtahara S, Yamatogi Y : Ohtahara syndrome : with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res 70 (Suppl 1) : S58-S67, 2006.
 
13) 大塚頌子ほか : Early-infantile epileptic encephalopathy with suppression-burstの経年的病像変容に関する検討. 臨床脳波 27 : 86-96, 1985.
Medical*Online
P.143 掲載の参考文献
1) DeMyer W, et al : The face predicts the brain : Diagnostic significance of median facial anomalies for holoprosencephaly (arhinencephaly). Pediatrics 34 : 256-263, 1964.
PubMed
2) 熊谷公明 : Holoprosencephalyの臨床的重要性. 脳と発達 3 : 28-42, 1971.
 
3) Matsunaga E, Shiota K : Holoprosencephaly in human embryos : epidemiologic studies of 150 cases. Teratology 16 : 261-272, 1977.
PubMed
4) Dubourg C, et al : Holoprosencephaly. Orphanet J Rare Dis 2 : 8, 2007.
PubMed
5) 新川詔夫 : 全前脳症シークエンス. 頭部顔面の異常を主徴とする症候群. 新先天奇形症候群アトラス (梶井正ほか編), p 9-11, 南江堂, 1998.
 
6) Pulitzer SB, et al : Prenatal MR findings of the middle interhemispheric variant of holoprosencephaly. AJNR Am J Neuroradiol 25 : 1034-1036, 2004.
PubMed
7) Hahn JS, Plawner LL : Evaluation and management of children with holoprosencephaly. Pediatr Neurol 31 : 79-88, 2004.
PubMed
8) Levey EB, et al : Management of children with holoprosencephaly. Am J Med Genet C Semin Med Genet 154C : 186-190, 2010.
 
9) Hahn JS, et al : Electroencephalography in holoprosencephaly : findings in children without epilepsy. Clin Neurophysiol 114 : 1908-1917, 2003.
PubMed
10) 渡辺一功 : 脳形成異常. 新生児脳波入門, p 163, 新興医学出版社, 2002.
 
11) 渡辺一功ほか : 単脳室前脳症 (Holoprosencephaly) における脳波所見. 臨床脳波 3 : 180-187, 1976.
 
12) Watanabe K, et al : The evolution of neurophysiological features in holoprosencephaly. Neuropadiatrie 7 : 19-41, 1976.
 
13) 中村幸介ほか : 全前脳胞症における難治てんかんに対するlevetiracetamの有効性. てんかん研究 (Suppl) 31 : 446, 2013.
 
14) Okazaki K, et al : High-dose lorazepam for convulsive status epilepticus in an infant with holoprosencephaly. Pediatr Int 52 : 664-667, 2010.
 
P.148 掲載の参考文献
1) Aicardi J : Aicardi syndrome. Brain Dev 27 : 164-171, 2005.
PubMed
2) Fukuyama Y : A special note on terminology of West syndrome and infantile spasms. Brain Dev 23 : 442, 2001.
PubMed
3) 加藤光広 : Aicardi症候群の全国疫学調査. Aicardi症候群の遺伝的要因の実態 平成22年度厚生労働科学研究費補助金総括・分担研究報告書 (三宅紀子編), p 10-12, 2011.
 
4) Molina JA, et al : Aicardi syndrome in two sisters. J Pediatr 115 : 282-283, 1989.
PubMed
5) Ropers HH, et al : Agenesis of corpus callosum, ocular, and skeletal anomalies (X-linked dominant Aicardi's syndrome) in a girl with balanced X/3 translocation. Hum Genet 61 : 364-368, 1982.
 
6) Costa T, et al : Monozygotic twins discordant for Aicardi syndrome. J Med Genet 34 : 688-691, 1997.
PubMed
7) Gobbi G, et al : Periodic spasms : an unclassified type of epileptic seizure in childhood. Dev Med Child Neurol 29 : 766-775, 1987.
PubMed
8) Hopkins B, et al : Neuroimaging aspects of Aicardi syndrome. Am J Med Genet A 146A : 2871-2878, 2008.
PubMed
9) Rosser TL, et al : Aicardi syndrome : spectrum of disease and long-term prognosis in 77 females. Pediatr Neurol 27 : 343-346, 2002.
PubMed
P.151 掲載の参考文献
1) Kato M, Dobyns WB : Lissencephaly and the molecular basis of neuronal migration. Hum Mol Genet 12 (Suppl 1) : R89-R96, 2003.
 
2) Barkovich AJ, et al : A developmental and genetic classification for malformations of cortical development : update 2012. Brain 135 : 1348-1369, 2012.
PubMed
3) de Rijk-van Andel JF, et al : Epidemiology of lissencephaly type I. Neuroepidemiology 10 : 200-204, 1991.
PubMed
4) 厚生省「脳形成異常の発生機序に関する臨床的・基礎的研究」研究班 (島田司巳班長) : 皮質形成異常-基礎と臨床-, p 42-50, 1998.
 
5) Boycott KM, et al : Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am J Hum Genet 77 : 477-483, 2005.
PubMed
6) Keays DA, et al : Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell 128 : 45-57, 2007.
PubMed
7) Riviere JB, et al : De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat Genet 44 : 440-444, S441-442, 2012.
 
8) Kato M, et al : Mutation of the doublecortin gene in male patients with double cortex syndrome : somatic mosaicism detected by hair root analysis. Ann Neurol 50 : 547-551, 2001.
PubMed
9) Kato M, Dobyns WB : X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy : proposal for a new term, "interneuronopathy". J Child Neurol 20 : 392-397, 2005.
PubMed
10) Kato M, et al : Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum Mutat 23 : 147-159, 2004.
PubMed
11) 加藤光広 : 神経細胞移動障害の分子機構. 日小児会誌 111 : 1361-1374, 2007.
 
12) Kitamura K, et al : Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 32 : 359-369, 2002.
 
13) Marsh E, et al : Targeted loss of Arx results in a developmental epilepsy mouse model and reca pitulates the human phenotype in heterozygous females. Brain 132 : 1563-1576, 2009.
 
14) 加藤光広 : 大脳皮質形成異常. 小児神経の画像診断-脳脊髄から頭頸部・骨軟部まで- (大場洋編), p 232-249, 学研メディカル秀潤社, 2010.
 
P.155 掲載の参考文献
1) Dobyns WB, et al : Malformations of cortical development. In : Swaiman's Pediatric Neurology, 5th ed (ed by Swaiman KF, et al), p 202-231, Elsevier, Saunders, 2012.
 
2) Pilz D, et al : Neuronal migration, cerebral cortical development, and cerebral cortical anomalies. J Neuropathol Exp Neurol 61 : 1-11, 2002.
PubMed
3) 厚生労働省 : 精神神経疾患研究委託事業「脳形成異常の発生機序に関する臨床的・基礎的研究」研究班, 皮質形成異常-基礎と臨床-, p 41-50, 1998.
 
4) 加藤光広 : 神経細胞移動障害の分子機構. 日小児会誌 111 : 1361-1374, 2007.
 
5) 五十嵐愛子ほか : DCX遺伝子変異の体細胞モザイクを認めた脳室周囲帯状異所性灰白質. 脳と発達 45 : 371-374, 2013.
 
6) Tanaka T, et al : Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron 41 : 215-227, 2004.
PubMed
7) Kato M, et al : A novel mutation of the doblecortin gene in Japanese patients with X-linked lissencephaly and subcortical band heterotopia. Hum Genet 104 : 341-344, 1999.
 
8) Matsumoto N, et al : Mutation analysis of the DCX gene and genotype/phenotype correlation in subcortical band heterotopia. Eur J Hum Genet 9 : 5-12, 2001.
PubMed
9) Kato M, et al : Mutation of the Doublecortin gene in male patients with double cortex syndrome : somatic mosaicism detected by hair root analysis. Ann Neurol 50 : 547-551, 2001.
PubMed
10) Bai J, et al : RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci 6 : 1277-1283, 2003.
PubMed
11) Cardoso C, et al : Clinical and molecular basis of classical lissencephaly : Mutations in the LIS1 gene (PAFAH1B1). Hum Mutat 19 : 4-15, 2002.
 
12) Guerrini R, Carrozzo R : Epilepsy and genetic malformations of the cerebral cortex. Am J Med Genet 106 : 160-173, 2001.
PubMed
13) Barkovich AJ, Kuziecky RI : Gray matter heterotopia. Neurology 55 : 1603-1608, 2000.
 
14) Bernasconi A, et al : Surgical resection for intractable epilepsy in "double cortex" syndrome yields inadequate results. Epilepsia 42 : 1124-1129, 2001.
PubMed
15) Manent JB, et al : Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder. Nat Med 15 : 84-90, 2009.
 
P.160 掲載の参考文献
1) 大越優美, 林雅晴 : 神経皮膚症候群-結節性硬化症. 小児神経学 (有馬正高監, 加我牧子, 稲垣真澄編), p 148-152, 診断と治療社, 2008.
 
2) Bourneville DM : Sclerose tubereuse des circonvolutions cerebrales : Idiotie et epilepsie hemiplegique. Arch Neurol (Paris) 1 : 81-91, 1880.
 
3) 林雅晴 : 結節性硬化症. 希少難治てんかん診療マニュアル (大槻泰介ほか編), p 76-78, 診断と治療社, 2013.
 
4) Ohno A, et al : Molecular epidemiology of tuberous sclerosis. In : Phacomatosis in Japan-Epidemiology, Clinical Picture and Molecular Biology (ed by Niimura M, et al), p 53-59, Japan Scientific Societies Press, Karger, Tokyo, 1999.
 
5) 水口雅 : 結節性硬化症にともなう自閉症の薬物治療. 日小児会誌 117 : 1686-1693, 2013.
 
6) Mizuguchi M : Abnormal giant cells in the cerebral lesions in tuberous sclerosis. Cong Anom 47 : 2-8, 2007.
 
7) 岡本信彦 : 結節性硬化症. 小児内科 43 : 1468-1470, 2011.
 
8) Curatolo P, Moavero R : mTOR inhibitor in tuberous sclerosis complex. Curr Neuropharmacol 10 : 404-415, 2012.
PubMed
9) Holthausen H, et al : Structural (symptomatic) focal epilepsies of childhood. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Bureau M, et al), p 455-505, John Libbey Eurotext, Montrouge, 2012.
 
10) Peng ZF, et al : Efficacy and safety of sirolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis : a systemic review. J Urol 192 : 1424-1430, 2014.
PubMed
11) Northrup H, Krueger DA ; International Tuberous Sclerosis Complex Consensus Group : Tuberous sclerosis complex diagnostic criteria update : recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49 : 243-254, 2013.
 
12) Krueger DA, Northrup H ; International Tuberous Sclerosis Complex Consensus Group : Tuberous sclerosis complex surveillance and management : recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49 : 255-265, 2013.
 
13) Sato A, et al : Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex. Nat Commun 3 : 1292, 2012.
PubMed
14) 安藤直樹ほか : 結節性硬化症に伴うWest症候群に対するvigabatrinの有効性について. 脳と発達 42 : 444-448, 2010.
Medical*Online
P.165 掲載の参考文献
1) Thomas-Sohl KA, et al : Sturge-Weber syndrome : a review. Pediatr Neurol 30 : 303-310, 2004.
PubMed
2) 竹下研三ほか : 1974年から1983年迄の鳥取県における先天異常調査. 先天異常 24 : 395-402, 1984.
 
3) Shirley MD, et al : Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368 : 1971-1979, 2013.
PubMed
4) Tallman B, et al : Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics 87 : 323-327, 1991.
PubMed
5) 糸数直哉 : Sturge-Weber症候群. 小児の診断治療指針第4版 (「小児内科」「小児外科」編集委員会共編), p 690-691, 東京医学社, 2012.
 
6) 新島新一ほか : Sturge-Weber症候群. 小児中枢神経疾患の画像診断2008 (「小児内科」「小児外科」編集委員会共編), p 262-266, 東京医学社, 2007.
 
7) Bourgeois M, et al : Surgical treatment of epilepsy in Sturge-Weeber syndrome in children. J Neurosurg 106 (1 Suppl) : 20-28, 2007.
 
P.168 掲載の参考文献
1) Kuzniecky R, et al : Congenital bilateral perisylvian syndrome : study of 31 patients. Lancet 341 : 608-611, 1993.
PubMed
2) Mariani C, et al : Bilateral perisylvian softenings : bilateral anterior opercular syndrome (Foix-Chavany-Marie syndrome). J Neurol 223 : 269-284, 1980.
PubMed
3) Worster-Drought C : Speech disorders of children of school age. Med Press 230 : 419-426, 1953.
 
4) Williams R, et al : The cellular pathology of microgyria : a Golgi analysis. Acta Neuropathol 36 : 269-283, 1976.
PubMed
5) Barth P, van der Harten J : Parabiotic twin syndrome with topical isocortical disruption and gastroschisis. Acta Neuropathol 67 : 345-349, 1985.
PubMed
6) Roll P, et al : SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 15 : 1195-1207, 2006.
PubMed
7) Brooks AS, et al : Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am J Hum Genet 77 : 120-126, 2005.
PubMed
8) Piao X, et al : G protein-coupled receptor-dependent development human frontal cortex. Science 303 : 2033-2036, 2004.
 
9) Glaser T, et al : PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet 7 : 463-471, 1994.
 
10) Baala L, et al : Homozygous silencing of T-box transcription factor EOMES leads to microcephaly with polymicrogyria and corpus callosum agenesis. Nat Genet 39 : 454-456, 2007.
PubMed
11) Paisan-Ruiz C, et al : Homozygosity mapping through whole genome analysis identifies a COL18A1 mutation in an Indian family presenting with an autosomal recessive neurological disorder. Am J Med Genet 150B : 993-997, 2009.
 
12) Aligianis IA, et al : Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome. Nat Genet 37 : 221-223, 2005.
PubMed
13) Jaglin XH, et al : Mutations in the β-tubulin gene TUBB2B result in asymmetrical polymicrogyria. Nat Genet 41 : 746-752, 2009.
 
14) Kuzniecky R, et al : The epileptic spectrum in the congenital bilateral perisylvian syndrome. Neurology 44 : 379-385, 1994.
PubMed
15) Takano T, et al : Congenital polymicrogyria including the perisylvian region in early childhood. Congenit Anom 50 : 64-67, 2010.
PubMed
16) Saporta A, et al : Arcuate fasciculus and speech in congenital bilateral perisylvian syndrome. Pediatr Neurol 44 : 270-274, 2011.
PubMed
P.176 掲載の参考文献
1) Flores-Sarnat I : Hemimegalencephaly : part 1. Genetic, clinical, and imaging aspects. J Child Neurol 17 : 373-384, 2002.
PubMed
2) Sasaki M, et al : Clinical aspects of hemimegalencephaly by means of nationwide survey. J Child Neurol 20 : 337-341, 2005.
PubMed
3) Lee JH, et al : De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 44 : 941-945, 2012.
PubMed
4) Sato N, et al : Aberrant midsagittal fiber tracts in patients with hemimegalencephaly. AJNR Am J Neuroradiol 29 : 823-827, 2008.
PubMed
5) Sato N, et al : Hemimegalencephaly : a study of abnormalities occurring outside the involved hemisphere. AJNR Am J Neuroradiol 28 : 678-682, 2007.
PubMed
6) Sakuma H, et al : Longitudinal MR findings in a patient with hemimegalencephaly associated with tuberous sclerosis. Brain Dev 27 : 458-461, 2005.
 
7) Nonoda Y, et al : Activation of microglia/macrophages expressing phosphorylated S6 ribosomal protein in a case of hemimegalencephaly with progressive calcification and atrophy. J Neurol Sci 287 : 52-59, 2009.
 
8) 吉岡誠一郎ほか : 緩徐進行性腫大を呈した片側巨脳症の1例. 脳と発達 39 : 432-435, 2007.
Medical*Online
9) Riviere J, et al : De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 44 : 934-940, 2012.
 
10) Nakamura K, et al : AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes : MCAP and MPPH. Clin Genet 85 : 396-398, 2014.
PubMed
11) Honda R, et al : Long-term developmental outcome after early hemispherotomy for hemimegalencephaly in infants with epileptic encephalopathy. Epilepsy Behav 29 : 30-35, 2013.
PubMed
12) Bulteau C, et al : Epilepsy surgery for hemispheric syndromes in infants : Hemimegalencephaly and hemispheric cortical dysplasia. Brain Dev 35 : 742-747, 2013.
PubMed
13) Otsuki T, et al : Surgical management of cortical dysplasia in infancy and early childhood. Brain Dev 35 : 802-809, 2013.
PubMed
P.180 掲載の参考文献
1) Taylor DC, et al : Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 34 : 369-387, 1971.
 
2) Mischel PS, et al : Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal grading system. J Neuropathol Exp Neurol 54 : 17-53, 1995.
 
3) Yagishita A, et al : Focal cortical dysplasia : appearance on MRI images. Radiology 203 : 553-559, 1997.
PubMed
4) Duong T, et al : Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol 87 (Suppl 7) : 493-530, 1994.
 
5) Crino PB, et al : Internexin, Map1B and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol 93 : 619-627, 1997.
PubMed
6) Yamanouchi H, et al : Enhanced expression of microtubule-associated protein-2 in large neurons of cortical dysplasia. Ann Neurol 39 : 57-61, 1996.
PubMed
7) Yamanouchi H, et al : Early forms of microtubule-associated proteins are strongly expressed in cortical dysplasia. Acta Neuropathol 95 : 466-470, 1998.
PubMed
8) Vital A, et al : Glial and neuronoglial malformative lesions associated with medically intractable epilepsy. Acta Neuropathol 87 : 196-201, 1994.
PubMed
9) Yagishita A, et al : Hemimegalencephaly : signal changes suggesting abnormal myelination on MRI. Neuroradiology 40 : 734-738, 1998.
PubMed
10) Blumcke I, et al : The clinicopathologic spectrum of focal cortical dysplasias : a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52 : 158-174, 2011.
 
11) Coras R, et al : Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasia. Epilepsia 53 : 1341-1348, 2012.
PubMed
12) 新井信隆 : てんかん原性脳形成異常の病理診断分類-現状を正しく理解するためのガイド. Brain & Nerve 65 : 531-540, 2013.
 
P.184 掲載の参考文献
1) Blumcke I, et al : The clinicopathologic spectrum of focal cortical dysplasia : a consensus classification proposed by an ad hoc Task Forece of the ILAE diagnostic methods commission. Epilepsia 52 : 158-174, 2011.
 
2) Nordborg C, et al : Mild cortical dysplasia in patients with intractable epil partial seizures : a histologial study. Adv Epileptol 16 : 29-33, 1987.
 
3) Armstrong DD : The neuropathology of temporal lobe epilepsy. J Neuropathol Exp Neurol 52 : 433-443, 1993.
PubMed
4) Wolf HK, et al : Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol 52 : 499-506, 1993.
 
5) Wolf HK, et al : Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol 54 : 689-697, 1995.
PubMed
6) Wolf HK, et al : Neuropathochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropahtol Exp Neurol 54 : 689-697, 1995.
PubMed
7) Arai N, et al : Peculiar form of cerebral microdysgenesis characterized by white matter neurons with perineuronal and perivascular flial satellitosis. Pathol Int 53 : 345-352, 2003.
 
8) Branstom T, et al : The range of disorders of cortical organization in surgically treated epilepsy patients. In : Dysplasia of Cerebral Cortex and Epilepsy (ed by Guerrini R, et al), p 57-64, Raven Press, New York, 1996.
 
9) Kasper BS, et al : Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol 58 : 22-28, 1999.
PubMed
10) Meencke HJ, Janz D : Neuropathological findings in primary generalized epilepsy : a study of eight cases. Epilepsia 25 : 8-21, 1984.
PubMed
11) Meencke HJ : Pathology of childhood epilepsies. Cleve Clin J Med 56 (S) : S111-S120, 1989.
 
12) Hardiman O, et al : Microdysgenesis in resected temporal neocortex. Neurology 38 : 1041-1047, 1988.
PubMed
13) Lyon G, Gastaut H : Considerations on the significance attributed to unusual cerebral histological findings recently described in eight patients with primary generalized epilepsy. Epilepsia 26 : 365-367, 1985.
PubMed
14) Kaufmann WE, Galaburda AM : Cerebrocortical microdysgenesis in neurologically normal subjects. Neurology 39 : 238-244, 1989.
PubMed
15) Emery JA, et al : White matter neuronal heterotopia in temporal lobe epilepsy : a morphometric and immunohistochemical study. J Neuropathol Exp Neurol 56 : 1276-1282, 1997.
PubMed
16) 田邉豊, 新井信隆 : てんかん焦点部における微小形成不全の形態と機能. 神経研究の進歩 49 : 779-789, 2005.
 
17) Adachi Y, et al : White matter abnormalities in the anterior temporal lobe suggests the side of the seizure foci in temporal lobe epilepsy. Neuroradiol 48 : 460-464, 2006.
 
P.189 掲載の参考文献
1) Kawamura T, et al : Cerebral abnormalities in lumbosacral neural tube closure defect : MR imaging evaluation. Childs Nerv Syst 17 : 405-410, 2001.
PubMed
2) Bartoshesky LE, et al : Seizures in children with meningomyelocele. Am J Dis Child 139 : 400-402, 1985.
PubMed
3) Verhoef M, et al : Secondary impairments in young adults with spina bifida. Dev Med Child Neurol 46 : 420-427, 2004.
PubMed
4) Hosking GP : Fits in hydrocephalic children. Arch Dis Child 49 : 633-635, 1974.
PubMed
5) Talwar D, et al : Epilepsy in children with meningomyelocele. Pediatr Neurol 13 : 29-32, 1995.
PubMed
6) Klepel H, Freitag G : Spina bifida occulta in epilepsy syndromes. Neurology 42 : 126-127, 1992.
PubMed
7) Bourgeois M, et al : Epilepsy in children with shunted hydrocephalus. J Neurosurg 90 : 274-281, 1999.
PubMed
8) Chadduck W, Adametz J : Incidence of seizures in patients with myelomeningocele : a multifactorial analysis. Surg Neurol 30 : 281-285, 1988.
PubMed
9) Keene DL, Ventureyra EC : Hydrocephalus and epileptic seizures. Childs Nerv Syst 15 : 158-162, 1999.
PubMed
10) Copeland GP, et al : The incidence of epilepsy after ventricular shunting operations. Surg Neurol 17 : 279-281, 1981.
 
11) Leggate J, et al : Epilepsy following ventricular shunt placement. J Neurosurg 68 : 318-319, 1988.
PubMed
12) Dan N, Wade M : The incidence of epilepsy after ventricular shunting procedures. J Neurosurg 65 : 19-21, 1986.
 
13) Blaauw G : Hydrocephalus and epilepsy. Z Kinderchir 25 : 341-345, 1978.
 
14) Yoshida, et al : Epilepsy in patients with spina bifida in the lumbosacral resion. Neurosurg Rev 29 : 327-332, 2006.
 
15) Cameron AH : The spinal cord lesion in spina bifida cystica. Lancet 271 : 171-174, 1957.
 
P.194 掲載の参考文献
1) Rahman S, et al : Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol 55 : 23-36, 2013.
PubMed
2) Liver MO : Epilepsies in inborn errors of metabolism. In : Epileptic Syndromes in infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), 423-440, John Libbey Eurotext, Montrouge, 2005.
 
3) Rake JP, et al ; European Study on Glycogen Storage Disease Type I (ESGSD I) : Guidelines for management of glycogen storage disease type I-European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161 (Suppl 1) : S112-119, 2002.
 
4) Kishnani PS, et al : Glycogen storage disease type III diagnosis and management guidelines. Genet Med 12 : 446-463, 2010.
PubMed
5) Hendrickx J, et al : Clinical, biochemical and molecular findings in a patient with X-linked liver glycogenosis followed for 40 years. Eur J Pediatr 157 : 919-923, 1998.
 
6) Sugie H : A novel missense mutation (837T→C) in the phosphoglycerate kinase gene of a patient with a myopathic form of phosphoglycerate kinase deficiency. J Child Neurol 13 : 95-97, 1998.
 
7) Kikawa Y, et al : Identification of genetic mutations in Japanese patients with fructose-1,6-bisphosphatase deficiency. Am J Hum Genet 61 : 852-861, 1997.
PubMed
P.203 掲載の参考文献
1) Hamash A, et al : Nonketotic hyperglycinemia. In : The Metabolic & Molecular Bases of Inherited Metabolic Disease, 8th ed, Vol. 2 (ed by Scriver CR, et al), p 2065-2078, McGraw-Hill, New York, 2001.
 
2) Kure S, et al : Rapid diagnosis of glycine encephalopathy by 13C-glycine breath test. Ann Neurol 59 : 862-867, 2006.
PubMed
3) 三渕浩ほか : メープルシロップ尿症の予後とマス・スクリーニング. 小児内科 36 : 1881-1886, 2004.
 
4) Jan W, et al : MR diffusion and MR spectroscopy of maple syrup urine disease during acute metabolic compensation. Neuroradiology 45 : 393-399, 2003.
 
5) Hunt, et al : Pyridoxine dependency : report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 13 (2) : 140-145, 1954.
 
6) Mills PB, et al : Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12 (3) : 307-309, 2006.
PubMed
7) Tan WH, et al : Isolated sulfite oxidase deficiency : a case report with a novel mutation and review of the literature. Pediatrics 116 (3) : 757-766, 2005.
PubMed
8) Dublin Ab, et al : Isolated sulfite oxidase deficiency : MR imaging features. AJNR Am J Neuroradiol 23 (3) : 484-485, 2002.
PubMed
9) Eichler F, et al : Proton magnetic resonance spectroscopy and diffusion-weighted imaging in isolated sulfite oxidase deficiency. J Child Neurol 21 (9) : 801-805, 2006.
PubMed
10) 新宅治夫 : 小児神経伝達物質病の診断基準の作成と患者数の実態調査に関する研究報告. 厚生労働科学研究補助金 難治性疾患克服事業 平成21年度総括・分担研究報告書, p 1-83, 2010.
 
11) Reis J, et al : GABAB-ergic motor cortex dysfunction in SSADH deficiency. Neurology 79 (1) : 47-54, 2012.
PubMed
12) Levy HL, et al : Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria : a phase III randomised placebo-controlled study. Lancet 370 (9578) : 504-510, 2007.
 
13) Phillips MD : Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR Am J Neuroradiol 22 (8) : 1583-1586, 2001.
PubMed
14) Kono K : Diffusion-weighted MR imaging in patients with phenylketonuria : relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 236 (2) : 630-636, 2005.
PubMed
15) 特殊ミルク共同安全開発委員会 : PKU女性の妊娠 (マターナルPKU) の問題. 改訂2008 食事療法ガイドブック, p 13-14, 恩寵財母子愛育会特殊ミルク事務局, 2008.
 
P.211 掲載の参考文献
1) Seashore MR : The Organic Acidemias : An Overview. GeneReviewsTM [Internet] (ed by Pagon RA, et al), University of Washington, Seattle, 2009.
 
2) Kompare M, Rizzo WB : Mitochondrial fatty-acid oxidation disorders. Semin Pediatr Neurol 15 : 140-149, 2008.
PubMed
3) Bennett MJ : Pathophysiology of fatty acid oxidation disorders. J Inherit Metab Dis 33 : 533-537, 2010.
PubMed
4) 山口清次 (編) : タンデムマス・スクリーニングガイドブック, p 152, 診断と治療社, 2013.
 
5) Yamaguchi S, et al : Expanded newborn mass screening with MS/MS and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in Japan. 日本マス・スクリーニング学会誌 23 : 270-276, 2013.
 
6) 山口清次 (編) : 有機酸代謝異常ガイドブック, p 195, 診断と治療社, 2011.
 
7) Thomas B, et al : MRI of childhood epilepsy due to inborn errors of metabolism. Am J Rad 194 : W367-W374, 2010.
 
8) Yu JY, Pearl PL : Metabolic causes of epileptic encephalopathy. Epilepsy Res Treat 2013 : 124934, 2013.
PubMed
9) Stoffels M, Simon A : Hyper-IgD syndrome or mevalonate kinase deficiency. Curr Opin Rheumatol 23 : 419-423, 2011.
 
10) Tiranti1 V, et al : Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15 : 200-205, 2009.
 
11) Akiyama T, et al : A Japanese adult case of guanidinoacetate methyltransferase deficiency. JIMD Rep 12 : 65-69, 2014.
PubMed
P.216 掲載の参考文献
1) 鈴木洋一 : ビタミン代謝異常症 : 概論. 別冊日本臨牀 先天代謝異常症候群 (第2版) 下, p 267-277, 日本臨牀社, 2012.
 
2) 内藤悦雄 : 先天性高乳酸血症の診断と治療. 日重症心身障害会誌 37 : 21-26, 2012.
 
3) 内藤悦雄 : ビタミンB1依存症. 別冊日本臨牀 先天代謝異常症候群 (第2版) 下, p 308-311, 日本臨牀社, 2012.
 
4) Naito E, et al : Concomitant administration of sodium dichloroacetate and thiamine in West syndrome caused by thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 171 : 56-59, 1999.
PubMed
5) Naito E, et al : Gender-specific occurrence of West syndrome in patients with pyruvate dehydrogenase complex deficiency. Neuropediatrics 32 : 295-298, 2001.
PubMed
6) Naito E, et al : Molecular analysis of abnormal pyruvate dehydrogenase in a patient with thiamine-responsive congenital lactic acidemia. Pediatr Res 36 : 340-346, 1994.
 
7) Naito E, et al : Biochemical and molecular analysis of an X-linked case of Leigh syndrome associated with thiamin-responsive pyruvate dehydrogenase deficiency. J Inherit Metab Dis 20 : 539-548, 1997.
 
8) Naito E, et al : Biochemical and molecular analysis of 14 patients with thiamine-responsive pyruvate dehydrogenase deficiency. Am. Society Human Gene 56th annual Meeting, p 269, 2006.
 
9) Naito E, et al : Diagnosis and molecular analysis of three male patients with thiamine-responsive pyruvate dehydrogenase complex deficiency. J Neurol Sci 201 : 33-37, 2002.
PubMed
10) DiRocco M, et al : Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency. Eur J Paediatr Neurol 4 : 115-117, 2000.
 
11) Lee EH, et al : A Korean female patient with thiamine-responsive pyruvate dehydrogenase complex deficiency due to a novel point mutation (Y161C) in the PDHA1 gene. J Korean Med Sci 21 : 800-804, 2006.
 
12) Sedel F, et al : Thiamine responsive pyruvate dehydrogenase deficiency in an adult with peripheral neuropathy and optic neuropathy. J Neurol Neurosurg Psychiatry 79 : 846-847, 2008.
 
13) Stockler S, et al : Pyridoxine dependent epilepsy and antiquitin deficiency : clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 104 : 48-60, 2011.
PubMed
14) Mills PB, et al : Mutation in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12 : 307-309, 2006.
PubMed
15) Kanno J, et al : Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis. Mol Genet Metab 91 : 384-389, 2007.
PubMed
P.222 掲載の参考文献
1) 別冊日本臨牀 先天代謝異常症候群 (第2版), p 459-617, 日本臨牀社, 2012.
 
2) 井田博幸 : 酵素欠損症-神経系を中心に-. Brain Medical 24 : 61-68, 2012.
 
P.226 掲載の参考文献
1) 埜中征哉 : ミトコンドリア病. 臨床のための筋病理 (第4版), p 162-186, 日本医事新報社, 2011.
 
2) 小牧宏文 : ミトコンドリア病. 小児科診療 3 : 523-529, 2009.
Medical*Online
3) 小牧宏文, 後藤雄一 : ミトコンドリア病の遺伝子診断. 小児科診療 64 : 1533-1538, 2001.
Medical*Online
4) Chinnery PF : Mitochondrial Disorders Overview. In : GeneReviews(R) [Internet] (ed by Pagon RA, et al), p 1993-2014, University of Washington, Seattle, 2000 Jun 08. [updated 2010 Sep 16]
 
5) 難病情報センターミトコンドリア病. [http://www.nanbyou.or.jp/entry/335]
 
6) Mitomap. [http://www.mitomap.org/MITOMAP]
 
7) Koopman WJ, et al : Monogenic mitochondrial disorders. N Engl J Med 366 : 1132-1141, 2012.
PubMed
8) Chinnery PF, Hudson G : Mitochondrial genetics. Br Med Bull 106 : 135-159, 2013.
PubMed
9) 森雅人ほか : ミトコンドリア病. 小児科診療 1 : 11-19, 2013.
Medical*Online
10) 村山圭ほか : ミトコンドリア病 (ミトコンドリア呼吸鎖異常症)-最も頻度の高い先天代謝異常症-. 小児科臨床 63 : 2071-2079, 2010.
Medical*Online
11) 逸見祥司, 砂田芳秀 : 慢性進行性外眼筋麻痺症候群 (CPEO) /Kearns-Sayre症候群 (KSS). Clinical Neuroscience 30 : 1016-1019, 2012.
 
12) 飯塚高浩 : 脳卒中様発作を伴うミトコンドリア脳筋症 (MELAS). Clinical Neuroscience 30 : 1020-1026, 2012.
 
13) 水谷真之, 水澤英洋 : 赤色ぼろ線維を伴うミオクローヌスてんかん (MERRF). Clinical Neuroscience 30 : 1027-1029, 2012.
 
14) 竹下絵里, 小牧宏文 : Leigh脳症. Clinical Neuroscience 30 : 1030-1033, 2012.
 
15) 古賀靖敏 : ミトコンドリア病. 小児科臨床 63 : 1913-1924, 2010.
Medical*Online
P.236 掲載の参考文献
1) 下澤伸行 : Zellweger症候群. 別冊日本臨牀 先天代謝異常症候群 (下), p 398-404, 日本臨牀社, 2012.
 
2) Takahashi Y, et al : Epilepsy in peroxisomal diseases. Epilepsia 38 : 182-188, 1997.
PubMed
3) Liang JS, Lu JF : Peroxisomal disorders with infantile seizures. Brain Dev 33 : 777-782, 2011.
PubMed
4) Matsui S, et al : Newly identified milder phenotype of peroxisome biogenesis disorder caused by mutated PEX3 gene. Brain Dev 35 : 842-848, 2013.
PubMed
5) Poll-The BT, et al : Peroxisome biogenesis disorders with prolonged survival : phenotypic expression in a cohort of 31 patients. Am J Med Genet A 126A : 333-338, 2004.
 
6) White AL1, et al : Natural history of rhizomelic chondrodysplasia punctata. Am J Med Genet A 118A : 332-342, 2003.
 
7) Bams-Mengerink AM, et al : The neurology of rhizomelic chondrodysplasia punctata. Orphanet J Rare Dis 8 : 174, 2013.
PubMed
8) Ferdinandusse S, et al : Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 28 : 904-912, 2007.
PubMed
9) Ferdinandusse S, et al : Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann Neurol 59 : 92-104, 2006.
PubMed
10) Corzo D, et al : Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E : a novel neonatal phenotype similar to peroxisomal biogenesis disorders. Am J Hum Genet 70 : 1520-1531, 2002.
PubMed
11) Iwasa M, et al : Contiguous ABCD1 DXS1357E deletion syndrome : report of an autopsy case. Neuropathology 33 : 292-298, 2013.
PubMed
12) Moser HW, et al : X-linked adrenoleukodystrophy. In : The Metabolic and Molecular Basis of Inherited Disease (ed by Scriver CR, et al), p 3257-3301, McGraw-Hill, New York, 2001.
 
13) Brownstone E, et al : Epilepsy in adult X-linked adrenoleukodystrophy due to the deletion c.1415-1416delAG in exon 5 of the ABCD1-gene. Gene 513 : 71-74, 2013.
 
14) Ferdinandusse S, et al : Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 24 : 188-191, 2000.
PubMed
15) Haugarvoll K, et al : MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis 8 : 1, 2013.
PubMed
P.240 掲載の参考文献
1) 児玉浩子 : 先天性銅代謝異常症の進歩と課題. 脳と発達 44 : 107-112, 2012.
Medical*Online
2) Gu YH, et al : Congenital abnormalities in Japanese patients with Menkes disease. Brain Dev 34 : 746-749, 2012.
PubMed
3) Bahi-Buisson N, et al : Epilepsy in Menkes disease : analysis of clinical stages. Epilepsia 47 (2) : 380-386, 2006.
PubMed
4) Gu YH, et al : Lactate and pyruvate levels in blood and cerebrospinal fluid in patients with Menkes disease. J Pediatr 164 (4) : 890-894, 2014.
PubMed
5) Ogawa E, Kodama H : Effects of disulfiram treatment in patients with Menkes disease and occipital horn syndrome. J Trace Elem Med Biol 26 : 102-104, 2012.
PubMed
6) 小沢浩ほか : 日本におけるMenkes病20例の症状・治療の実態. 日小児会誌 113 (8) : 1234-1237, 2009.
 
7) Kaler SG, et al : Neonatal diagnosis and treatment of Menkes disease. N Engl J Med 358 (6) : 605-614, 2012.
 
8) 八木麻理子ほか : 家族歴にMenkes病を認める新生児3例の臨床像の検討. 脳と発達 46 : 26-29, 2014.
Medical*Online
9) 芳野信 : モリブデン補因子欠損症. 別冊日本臨牀 先天代謝異常症候群 (第2版) 下, p 252-254, 日本臨牀社, 2012.
 
10) Kishikawa M, et al : Detection by mass spectrometry of highly increased amount of S-sulfonated transthyretin in serum from a patient with molybdenum cofactor deficiency. Pediatr Res 47 : 492-494, 2000.
PubMed
11) Reiss J and Hahnewald R : Molybdenum cofactor deficiency : mutations in GPHN, MOCS1, and MOCS2. Hum Mutat 32 : 10-18, 2010.
 
12) Reiss J, et al : A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am J Hum Genet 68 : 208-213, 2001.
 
13) Johnson JL, Duran M : Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In : The Metabolic & Molecular Bases of Inherited Disease, 8th ed (ed by Scriver RS, et al), p 3163-3177, McGraw-Hill, New York, 2001.
 
14) Veldman A, et al : Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics 125 : e1249-1254, 2010.
PubMed
P.246 掲載の参考文献
1) Lanska MJ, et al : A population-based study of neonatal seizures in Fayette Country, Kentucky. Neurology 45 : 724-732, 1995.
 
2) Volpe JJ : Neonatal seizures. In : Neurology of the Newborn, 4th ed, p 178-214, WB Saunders, Philadelphia, 2001.
 
3) 早川昌弘 : 症候からみた小児の診断学 新生児特有の症候 けいれん. 小児科診療 70 (増刊) : 172-175, 2007.
 
4) Murray DM, et al : Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 93 : 187-191, 2008.
 
5) 奥村彰久 : 小児疾患診療のための病態生理 新生児疾患 新生児発作 (新生児けいれん). 小児内科 41 (増刊) : 102-108, 2009.
 
6) Mizrahi EM, Kellaway P : Diagnosis and Management of Neonatal Seizures, Lippincott-Raven, Philadelphia. 1997.
 
7) Kellaway P, Hrachovy RA : Status epilepticus in newborns : a perspective on neonatal seizures. Adv Neurol 34 : 93-99, 1983.
PubMed
P.251 掲載の参考文献
1) Fujiwara T, et al : Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 126 : 531-546, 2003.
PubMed
2) Dravet C, et al : Dravet syndrome (severe myoclonic epilepsy in infancy). In : Epileptic Syndromes in Infancy, Childhood and Adolescence (ed by Bureau M, et al), 5th ed, p 125-156, John Libbey Eurotext, Paris, 2012.
 
3) Claes L, et al : De novo mutations in the sodium-channel gene SCN1A causes severe myoclonic epilepsy of infancy. Am J Hum Genet 68 : 1327-1332, 2001.
PubMed
4) Carvill GL, et al : GABRA1 and STXBP1 : novel genetic causes of Dravet syndrome. Neurology 82 : 1245-1253, 2014.
PubMed
5) Hattori J, et al : A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 49 : 626-633, 2008.
PubMed
6) Laux L, Blackford R : The ketogenic diet in Dravet syndrome. J Child Neurol 28 : 1041-1044, 2013.
PubMed
7) Zamponi N, et al : Clinical course of young patients with Dravet syndrome after vagal nerve stimulation. Eur J Paediatr Neurol 15 : 8-14, 2011.
PubMed
8) Chipaux M, et al : Unusual consequences of status epilepticus in Dravet syndrome. Seizure 19 : 190-194, 2010.
 
9) Takayama R, et al : Long-term course of Dravet syndrome : a study from an epilepsy center in Japan. Epilepsia 55 : 528-538, 2014.
PubMed
10) Sakauchi M, et al : Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia 52 : 1144-1149, 2011.
PubMed
P.255 掲載の参考文献
1) Patry G, et al : Subclinical electrical status epilepticus induced by sleep in children. Arch Neurol 24 : 242-252, 1971.
PubMed
2) Engel J : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of the ILAE task force on classification and terminology. Epilepsia 42 : 796-803, 2001.
 
3) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30 : 389-399, 1989.
PubMed
4) Bureau M : Continuous spikes and waves during slow sleep (ESES) : definition of the syndrome. In : Continuous Spikes and Waves during Slow Sleep. Electrical Status Epilepticus during Slow Sleep (ed by Beaumanoir A, et al), p 17-26, John Libbey, London, 1995a.
 
5) Bureau M : Outstanding cases of ESES and LKS : analysis of the data sheets provided by the participants. In : Continuous Spikes and Waves during Slow Sleep. Electrical Status Epilepticus during Slow Sleep (ed by Beaumanoir A, et al), p 213-216, John Libbey, London, 1995b.
 
6) Morikawa T, et al : Clinical relevance of continuous spike-waves during slow wave sleep. In : Advances in Epileptology (ed by Manelis S, et al), p 359-363, Raven Press, New York, 1989.
 
7) Kobayashi K, et al : Epilepsy and sleep : with special reference to nonconvulsive status epilepticus with continuous diffuse spike-wave during slow-wave sleep. No To Hattatsu (Tokyo) 22 : 136-142, 1990.
 
8) Kramer U, et al : Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 50 : 1517-1524, 2009.
PubMed
9) Sanchez Fernandez I, et al : Treatment for continuous spikes and waves during sleep (CSWS) : Survey on treatment choices in North America. Epilepsia 55 : 1099-1108, 2014.
PubMed
10) Loddenkemper T, et al : Epilepsy surgery in children with electrical status epilepticus in sleep. Neurosurgery 64 : 328-337, 2009.
PubMed
11) Tassinari CA : Encephalopathy related to status epilepticus during slow sleep (ESES) including Landau-Kleffner syndrome. In : Epileptic Syndromes in Infancy, Childhood and Adolescence (ed by M Bureau, et al), p 255-277, John Libbey Eurotext, Montrouge, 2012.
 
P.259 掲載の参考文献
1) Landau WM, Kleffner FR : Syndrome of acquired aphasia with convulsive disorders in children. Neurology 7 : 523-530, 1957.
PubMed
2) Doose H, Baier WK : Benign partial epilepsy and related conditions : multifactorial pathogenesis with hereditary impairment of brain maturation. Eur J Pediatr 49 : 152-158, 1989.
 
3) Dulac O : Epileptic encephalopathy. Epilepsia 42 (Suppl 3) : 23-26, 2001.
 
4) Kaga M, et al : Epidemiological study of Landau-Kleffner syndrome (LKS). Brain Dev 36 (4) : 284-286, 2014.
PubMed
5) Datta AN, et al : BECTS evolving to Landau-Kleffner Syndrome and back by subsequent recovery : a longitudinal language reorganization case study using fMRI, source EEG, and neuropsychological testing. Epilepsy Behav 27 (1) : 107-114, 2013.
PubMed
6) Hughes JR : A review of the relationships between Landau-Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep. Eilepsy Behav 20 (2) : 247-253, 2011.
 
7) Seri S, et al : Spike-induced interference in auditory sensory processing in Landau-Kleffner syndrome. Electroencephalogr Clin Neurophysiol 108 : 506-510, 1998.
PubMed
8) Giovanardi RP, et al : Landau-Kleffner syndrome (LKS) : long-time follow-up and links with electrical status epilepticus during sleep (ESES). Brain Dev 21 : 90-98, 1999.
 
9) Genton P, et al : Continuous focal discharges in REM sleep in a case of Landau-Kleffner syndrome : a 3-year follow-up. In : Continuous Spikes and Waves during Slow Sleep. Electrical Status Epilepticus during Slow Sleep (ed by Beaumanoir A, et al), p 155-159, John Libbey, London, 1995.
 
10) Paetau R : Sounds triggers spikes in the Landau-Kleffner syndrome. J Clin Neurophysiol 11 : 231-241, 1994.
PubMed
11) 平岩里佳ほか : 脳磁図による電流源解析を行ったLandau-Kleffner症候群の2症例. てんかん研究 15 : 140-145, 1997.
 
12) Mantovani JF, Landau WM : Acquired aphasia with convulsive disorder : course and prognosis. Neurology 30 : 524-529, 1980.
PubMed
13) Dugas, et al : Late onset acquired epileptic aphasia In : Continuous Spikes and Waves during Slow Sleep. Electrical Status Epilepticus during Slow Sleep (ed by Beaumanoir A, et al), p 143-147, John Libbey, London, 1995.
 
14) Bishop DV : Age of onset and outcome in acquired aphasia with convulsive disorder (Landau-Kleffner syndrome). Dev Med Child Neurol 27 : 705-712, 1985.
PubMed
15) Duran MH, et al : Landau-Kleffner syndrome : long-term follow-up. Brain Dev 31 (1) : 58-63, 2009.
PubMed
P.265 掲載の参考文献
1) 福山幸夫ほか : 熱性けいれんの指導ガイドライン. 小児科臨床 49 : 207-215, 1996.
Medical*Online
2) Kira K, et al : Genetic susceptibility to simple febrile seizures : interleukin-1beta promoter polymorphisms are associated with sporadic cases. Neurosci Lett 26 : 239-244, 2005.
 
3) Fukuda M, et al : Interleukin-1beta enhances susceptibility to hyperthermia-induced seizures in developing rats. Seizure 18 : 211-214, 2009.
PubMed
4) Ishizaki Y, et al : Interleukin-10 is associated with resistance to febrile seizures : genetic association and experimental animal studies. Epilepsia 50 : 761-767, 2009.
PubMed
5) Barone SR, et al : Human herpesvirus-6 infection in children with first febrile seizures. J Pediatr 127 : 95-97, 1995.
PubMed
6) Epstein LG, et al : Human herpesvirus 6 and 7 in febrile status epilepticus : The FEBSTAT study. Epilepsia 53 : 1481-1488, 2012.
PubMed
7) Subcommittee on Febrile Seizures ; American Academy of Pediatrics : Clinical practice guideline-Febrile seizures : Guideline for the neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics 127 : 389-394, 2011.
 
8) Pavlidou E, et al : Prognostic factors for subsequent epilepsy in children with febrile seizures. Epilepsia 54 : 2101-2107, 2013.
PubMed
9) Hesdorffer DC, et al : Distribution of febrile seizure duration and associations with development. Ann Neurol 70 : 93-100, 2011.
PubMed
10) Seinfeld S, et al : Emergency management of febrile status epilepticus : results of the FEBSTAT study. Epilepsia 55 : 388-395, 2014.
PubMed
11) Offringa M, Newton R : Prophylactic drug management for febrile seizures in children. Cochrane database Syst Rev 18 : CD003031, 2012.
PubMed
12) Lewis DV, et al : Hippocampal sclerosis after febrile status epilepticus : the FEBSTAT study. Ann Neurol 75 : 178-185, 2014.
PubMed
13) Nordli DR, et al : Acute EEG findings in children with febrile status epilepticus. Results of the FEBSTAT study. Neurology 79 : 2180-2186, 2012.
PubMed
14) 熱性けいれん診療ガイドライン策定委員会 (委員長 : 夏目淳) : ワークショップ : 熱性けいれん診療ガイドライン策定 : 委員会案とパブリックコメント. 脳と発達 46 : S166-S169, 2014.
 
15) Scheffer IE, et al : Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 20 : 479-490, 1997.
 
P.270 掲載の参考文献
1) Fisher RS, et al : A practical clinical definition of epilepsy. Epilepsia 55 : 475-482, 2014.
PubMed
2) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
3) Beghi E, et al : Recommendation for a definition of acute symptomatic seizure. Epilepsia 51 : 671-675, 2010.
PubMed
4) 大石実 : 急性症候性発作. Clin Neurosci 29 : 97-99, 2011.
 
5) 大石実 : 身体疾患における抗てんかん薬管理. Epilepsy 6 (Suppl) : 25-29, 2012.
 
6) 大石実 : 鑑別診断. 日本臨牀 72 : 839-844, 2014.
Medical*Online
7) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
8) Shorvon SD : The etiologic classification of epilepsy. Epilepsia 52 : 1052-1057, 2011.
PubMed
9) Berg AT, Scheffer IE : New concepts in classification of the epilepsies : entering the 21st century. Epilepsia 52 : 1058-1062, 2011.
PubMed
10) 大石実 : アルコールと臨床検査 6. 中 枢神経系の障害. Medical Technology 37 : 1061-1066, 2009.
 
11) Choi JY, et al : A pathophysiologic approach for subacute encephalopathy with seizures in alcoholics (SESA) syndrome. J Clin Neurosci 21 : 1649-1652, 2014.
 
12) Lee WT : Disorders of amino acid metabolism associated with epilepsy. Brain Dev 33 : 745-752, 2011.
PubMed
13) Tsuyusaki Y, et al : Paradoxical increase in seizure frequency with valproate in nonketotic hyperglycinemia. Brain Dev 34 : 72-75, 2012.
PubMed
14) WHO Department of Mental Health and Substance Abuse, et al : Guidelines on Neonatal Seizures, World Health Organization, Geneva, 2011.
 
15) Loman AMW, et al : Neonatal seizures : Aetiology by means of a standardized work-up. Eur J Paediatr Neurol 18 : 360-367, 2014.
PubMed
P.274 掲載の参考文献
1) Luders HO, et al : The epileptogenic zone : general principles. Epileptic Disord 8 (Suppl 2) : S1-9, 2006.
 
2) Morrell F : Secondary epileptogenesis in man. Arch Neurol 42 : 318-335, 1985.
PubMed
3) Wilder BJ : The mirror focus and secondary epileptogenesis. Int Rev Neurobiol 45 : 435-446, 2001.
PubMed
4) 亀山茂樹, 柿田明美 : てんかんの画像と病理 1. 限局性皮質形成異常focal cortical dysplasia. 脳神経外科 35 : 615-622, 2007.
 
5) 亀山茂樹, 柿田明美 : てんかんの画像と病理 3. Dysembryoplastic neuroepithelial tumorと腫瘍性病変. 脳神経外科 35 : 833-841, 2007.
 
6) Blumcke I, et al : The clinicopathologic spectrum of focal cortical dysplasias : a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 52 : 158-174, 2011.
 
7) 亀山茂樹, 柿田明美 : てんかんの画像と病理 4. 結 節性硬化症. 脳神経外科 35 : 1027-1035, 2007.
 
8) Masuda H, et al : Clinical patterns and pathophysiology of hypermotor seizures : an ictal SPECT study. Epileptic Disord 14 : 32-40, 2012.
PubMed
9) 亀山茂樹ほか : 新皮質てんかんの外科治療ガイドライン. てんかん研究 23 : 167-170, 2005.
 
10) Luyken C, et al : The spectrum of long-term epilepsy-associated tumors : long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44 : 822-830, 2003.
PubMed
11) Tellez-Zenteno JF, et al : Surgical outcomes in lesional and non-lesional epilepsy : a systematic review and meta-analysis. Epilepsy Res 89 : 310-318, 2010.
PubMed
P.280 掲載の参考文献
1) Shorvon S, Ferlisi M : The treatment of super-refractory status epilepticus : a critical review of available therapies and a clinical treatment protocol. Brain 134 : 2802-2818, 2011.
 
2) Brophy GM, et al : Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17 : 3-23, 2012.
PubMed
3) Singh RK, et al : Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology 74 : 636-642, 2010.
PubMed
4) Mizuguchi M, et al : Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 115 : 45-56, 2007.
PubMed
5) Nabbout R, et al : Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 51 : 2033-2037, 2010.
PubMed
6) Sakuma H, et al : Acute encephalitis with refractory, repetitive partial seizures (AERRPS) : a peculiar form of childhood encephalitis. Acta Neurol Scand 121 : 251-256, 2010.
PubMed
7) EFA Working Group on Status Epilepticus : Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on status epilepticus. JAMA 270 : 854-859, 1993.
 
8) Shorvon S, et al : Task Force on Status Epilepticus of the ILAE Commission for European Affairs : The drug treatment of status epilepticus in Europe : consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 49 : 1277-1285, 2008.
 
9) National Institute for Health and Clinical Excellence : The epilepsies : the diagnosis and management of the epilepsies in adults and children in primary and secondary care. [www.nice.org.uk/cg137]
 
10) 日本神経学会 : てんかん治療ガイドライン. [http://www.neurology-jp.org/guidelinem/tenkan.html]
 
11) Appleton R, et al : The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party. Arch Dis Child 83 : 415-419, 2000.
PubMed
12) 大澤真木子 : けいれん重積の治療. 脳と発達 39 : 185-192, 2007.
Medical*Online
13) 森島恒雄ほか : 厚生労働省インフルエンザ脳症研究班. インフルエンザ脳症ガイドライン改訂版, 2009. [http://www.mhlw.go.jp/kinkyu/kenkou/influenza/hourei/2009/09/dl/info0925-01.pdf]
 
14) Hayashi K, et al : Efficacy of intravenous midazolam for status epilepticus in childhood. Pediatr Neurol 36 : 355-372, 2007.
 
15) Misra UK, et al : Levetiracetam versus lorazepam in status epilepticus : a randomized, open labeled pilot study. J Neurol 259 : 645-648, 2012.
PubMed
P.286 掲載の参考文献
1) Walker M, et al : Nonconvulsive status epilepticus : Epilepsy Research Foundation workshop reports. Epileptic Disord 7 : 253-259, 2005.
PubMed
2) Kikumoto K, et al : Complex partial status epilepticus in children with epilepsy. Brain Dev 31 : 148-157, 2009.
PubMed
3) 池田仁, 井上有史 : 成人における非けいれん性てんかん重積. 臨床脳波 53 : 150-157, 2009.
 
4) Korff CM, Nordli Jr DR : Diagnosis and management of nonconvulsive status epilepticus in children. Nat Clin Pract Neurol 3 (9) : 505-516, 2007.
 
5) Ferrie CD, et al : Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies : a consensus view. Epilepsia 48 : 1165-1172, 2007.
PubMed
6) Thomas P, et al : "De novo" absence status of late onset : report of 11 cases. Neurology 42 : 104-110, 1992.
PubMed
7) DeLorenzo RJ, et al : Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 39 : 833-849, 1998.
PubMed
8) Towne AR, et al : Prevalance of nonconvlusive status epilepticus in comatose patients. Neurology 54 : 340-345, 2000.
PubMed
9) 大塚頌子ほか : フローチャートでわかる小児てんかん診療ガイド (大塚頌子編), 診断と治療社, p 1-281, 2011.
 
10) Dravet C, et al : Severe myoclonic epilepty in infanc (yDravet syndrome). In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 89-113, John Libbey Eurotext, London, 2005.
 
11) Boyd SG, et al : The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr 147 : 508-513, 1988.
PubMed
12) Inoue Y, et al : Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 120 : 939-953, 1997.
PubMed
13) Thomas P, et al : Nonconvulsive status epilepticus of frontal origin. Neurology 52 : 1174-1183, 1999.
PubMed
14) Sutter R, Kaplan PW : Electroencephalographic criteria for nonconvulsive status epilepticus : Synopsis and comprehensive survey. Epilepsia 53 (Suppl 3) : 1-51, 2012.
 
15) 非けいれん性重積状態. てんかん専門医ガイドブック (日本てんかん学会編), p 173-175, 診断と治療社, 2014.
 
P.290 掲載の参考文献
1) 高橋幸利ほか : 光感受性てんかんの診断・治療に関するガイドライン. てんかん研究 23 : 171-175, 2005.
 
2) Waltz S, et al : The different patterns of the photoparoxysmal response ; a genetic study. Electroencephalogr Clin Neurophysiol 83 : 138-145, 1992.
PubMed
3) Draft international standard : Ergonomics of Human System Interaction-Part 391 ; Requirements, analysis and compliance test methods for the reduction of photosensitive seizures. ISO/DIS 9241-391.2, 2014.
 
4) Binnie CD, Jeavons PM : Photosensitive epilepsies. In : Epileptic Syndromes in Infancy, Childhood and Adolescence (ed by Roger J, et al), p 299-305, John Libbey, London, 1992.
 
5) Eeg-Olofsson O, et al : The development of the electroencephalogram in normal children from the age of 1 through 15 years ; paroxysmal activity. Neuropaediatrie 2 : 375-404, 1971.
 
6) Kasteleijn-Nolst Trenite DG : Photosensitivity in epilepsy. Electrophysiological and clinical correlates. Acta Neurol Scand 125 (Suppl) : 3-149, 1989.
PubMed
7) 舟塚真, 福山幸夫 : 小児の光過敏性てんかんの臨床と脳波. 臨床脳波 35 : 807-811, 1993.
 
8) Yagi K, et al : Clinical features in patients with ESGS-A collaborative study involving 10 institutions in Japan-. ESGS国内共同研究会報告書 ; 電子ゲーム誘発発作に関する研究, p 100-103, ESGS国内共同研究班 (委員長山内俊雄), 1999.
 
9) Jeavons PM : Photosensitive epilepsy. In : A Textbook of Epilepsy, 2nd ed (ed by Laidlaw J, Richens A), p 192-211, Churchill Livingstone, Edinburgh-London-New York, 1982.
 
10) Wilkins AJ, et al : Visually-induced seizures. Prog Neurobiol 15 : 85-117, 1980.
PubMed
11) Doose H, et al : Observations in photosensitive children with and without epilepsy. Z Kinderheilkd 107 : 26-41, 1969.
PubMed
12) 舟塚真ほか : テレビアニメ「ポケットモンスター」視聴中に多発した, けいれん発作などの健康被害に関するアンケート調査報告 第2報. 日児誌 106 : 52-59, 2002.
 
13) Funatsuka M, et al : Study on photo-pattern sensitivity on patients with electronic screen game-induced seizures (ESGS) : Effects of spatial resolution, brightness, and pattern movement. Epilepsia 42 : 1185-1197, 2001.
 
14) Funatsuka M, et al : Analysis of photo-pattern sensitivity in patients with Pokemon-related symptoms. Pediatr Neurol 28 : 28-36, 2003.
PubMed
15) Panayiotopoulos CP : Effectiveness of photic stimulation on various eye-states in photosensitive epilepsy. J Neurol Sci 23 : 165-173, 1974.
PubMed
16) Kasteleijn-Nolst Trenite DGA : Reflex seizures induced by intermittent light stimulation. In : Reflex Epilepsies and Reflex Seizures. Advances in Neurology, Vol 75 (ed by Zifkin BC, et al), p 99-121, Lippincott-Raven, Philadelphia, 1998.
 
17) Harding GFA, Jeavons PM : Photosensitive epilepsy. In : New Edition Clinics in Developmental Medicine No. 133, p 86-90, Mac Keith Press, London, 1994.
 
18) Shirakawa S, et al : A study of the effect of color photostimulation from a cathode-ray tube (CRT) display on photosensitive patients : The effect of alternating red-cyan flicker stimulation. Epilepsia 42 : 922-929, 2001.
 
19) Takahashi T, Tsukahara Y : Pocket Monster incident and low luminance visual stimuli ; Special reference to deep red flicker stimulation. Acta Paediatr Jpn 40 : 631-637, 1998.
PubMed
20) 日本放送協会, 日本民間放送連盟 : アニメーション等の映像手法について. 「アニメーション等の映像手法に関するガイドライン」および「NHK施行内規」, p 2-3, 日本放送協会, 1998.
 
21) Meador KJ, et al : Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study) : A prospective observational study. Lancet Neurol 12 : 244-252, 2013.
PubMed
22) Harding GFA, et al : Persistence of photosensitivity. Epilepsia 38 : 663-669, 1997.
 
P.294 掲載の参考文献
1) Gastaut H, et al : Symptomatic partial epilepsies with secondary bilateral synchrony : differentiation from symptomatic generalized epilepsies of the Lennox-Gastaut type. In : Presurgical Evaluation of Epileptics (ed by Wieser HG, Elger CE), p 308-316, Springer-Verlag, Berlin, 1987.
 
2) Gastaut H, Zifkin BG : Secondary bilateral synchrony and Lennox-Gastaut syndrome. In : The Lennox-Gastaut Syndrome (ed by Niedermeyer E, Degen R), p 221-242, Alan R. Liss, New York, 1988.
 
3) Blume WT, Pillay N : Electrographic and clinical correlates of secondary bilateral synchrony. Epilepsia 26 : 636-641, 1985.
PubMed
4) Jasper HH : Etude anatomo-physiologique des epilepsies. Electroencephalogr Clin Neurophysiol Suppl 2 : 99-111, 1951.
 
5) Tukel K, Jasper H : The electroencephalogram in parasagittal lesions. Electroencephalogr Clin Neurophysiol 4 : 481-494, 1952.
PubMed
6) Penfield W, Jasper H : Epilepsy and the Functional Anatomy of the Human Brain, Little Brown, Boston, 1954.
 
7) Gabor AJ, Marsan CA : Co-existence of focal and bilateral diffuse paroxysmal discharges in epileptics. Clinical-electrographic study. Epilepsia 10 : 453-472, 1969.
PubMed
8) Bancaud J, et al : "Generalized" epileptic seizures elicited by electrical stimulation of the frontal lobe in man. Electroencephalogr Clin Neurophysiol 37 : 275-278, 1974.
PubMed
9) Gotman J : Interhemispheric relations during bilateral spike-and-wave activity. Epilepsia 22 : 453-466, 1981.
PubMed
10) Kobayashi K, et al : Primary and secondary bilateral synchrony in epilepsy : differentiation by estimation of interhemispheric small time differences during short spike-wave activity. Electroencephalogr Clin Neurophysiol 83 : 93-103, 1992.
PubMed
11) 重村淳ほか : 二次性両側同期の等価電流双極子解析. 臨床脳波 44 : 691-696, 2002.
Medical*Online
12) Chang EF, et al : Magnetic source imaging for the surgical evaluation of electroencephalography-confirmed secondary bilateral synchrony in intractable epilepsy. J Neurosurg 111 : 1248-1256, 2009.
PubMed
13) Aghakhami Y, et al : Cortical and thalamic fMRI responses in partial epilepsy with focal and bilateral synchronous spikes. Clin Neurophysiol 117 : 177-191, 2006.
 
14) Oguni H, et al : Effect of anterior callosotomy on bilaterally synchronous spike and wave and other EEG discharges. Epilepsia 35 : 505-513, 1994.
PubMed
P.298 掲載の参考文献
1) Girard JM, et al : Progressive myoclonus epilepsy. In : Handbook of Clinical Neurology, 3rd Series (ed by Aminoff MJ, et al), p 1731-1736, Elsevier, Amsterdam, 2013.
 
2) Monagha TS, Delanty N : Lafora disease : epidemiology, pathophysiology and management. CNS Drugs 24 : 549-561, 2010.
 
3) Singh S, et al : Mutetions in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population. J Hum Genet 50 : 347-352, 2005.
 
4) 山田通夫 : 古典的なミオクローヌスてんかん. 神経研究の進歩 28 : 714-723, 1984.
 
P.302 掲載の参考文献
1) Marseille Consensus Group : Classification of progressive myoclonus epilepsies and related disorders. Ann Neurol 28 : 113-116, 1990.
 
2) Shahwan A, et al : Progressive myoclonic epilepsies : a review of genetic and therapeutic aspects. Lancet Neurol 4 : 239-248, 2005.
PubMed
3) Lalioti MD, et al : Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy. Nature 386 : 847-851, 1997.
PubMed
4) 近藤孝之ほか : 振戦様ミオクローヌスと稀発大発作とをみとめたUnverricht-Lundborg病の成人例. 臨床神経 49 : 43-47, 2009.
 
5) Kagitani-Shimono K, et al : Unverricht-Lundborg disease with cystatin B gene abnormalities. Pediatr Neurol 26 : 55-60, 2002.
PubMed
6) Magaudda A, et al : Unverricht-Lundborg disease, a condition with self-limited progression : long-term follow-up of 20 patients. Epilepsia 47 : 860-866, 2006.
PubMed
7) Chew NK, et al : The natural history of Unverricht-Lundborg disease : a report of eight genetically proven cases. Mov Disord 23 : 107-113, 2008.
PubMed
8) Canafoglia L, et al : Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease. Neurology 63 : 2309-2315, 2004.
PubMed
9) Forss N, et al : Lack of activation of human secondary somatosensory cortex in Unverricht-Lundborg type of progressive myoclonus epilepsy. Ann Neurol 49 : 90-97, 2001.
PubMed
10) Ferlazzo E, et al : Long-term evolution of EEG in Unverricht-Lundborg disease. Epilepsy Res 73 : 219-227, 2007.
PubMed
11) Kobayashi K, et al : Decreased cortical excitability in Unverricht-Lundborg disease in the long-term follow-up : a consecutive SEP study. Clin Neurophysiol 122 : 1617-1621, 2011.
 
12) Kobayashi K, et al : Long-term follow-up of cortical hyperexcitability in Japanese Unverricht-Lundborg disease. Seizure 23 : 746-750, 2014.
PubMed
13) Koskenkorva P, et al : Motor cortex and thalamic atrophy in Unverricht-Lundborg disease : voxel-based morphometric study. Neurology 73 : 606-611, 2009.
PubMed
14) Koskenkorva P, et al : Sensorimotor, visual, and auditory cortical atrophy in Unverricht-Lundborg disease mapped with cortical thickness analysis. AJNR Am J Neuroradiol 33 : 878-883, 2012.
PubMed
15) Eldridge R, et al : "Baltic" myoclonus epilepsy : hereditary disorder of childhood made worse by phenytoin. Lancet 2 : 838-842, 1983.
PubMed
16) Cochius J, et al : Sweat gland vacuoles in Unverricht-Lundborg disease : a clue to diagnosis? Neurology 44 : 2372-2375, 1994.
PubMed
17) Canafoglia L, et al : Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations. Epilepsia 53 : 2120-2127, 2012.
PubMed
P.305 掲載の参考文献
1) Naito H, Oyanagi S : Familial myoclonus epilepsy and choreoathetosis : hereditary dentatorubral-pallidoluysian atrophy. Neurology 32 : 798-809, 1982.
PubMed
2) 内藤明彦 : 歯状核赤核淡蒼球ルイ体萎縮症 (DRPLA) の臨床像と分類. 神経内科 32 : 450-456, 1990.
 
3) 内藤明彦 : DRPLAの臨床像と病型分類. DRPLA-臨床神経学から分子医学まで (辻省次ほか編), p 13-32, 医学書院, 1997.
 
4) Koide R, et al : Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6 : 9-13, 1994.
PubMed
5) 内藤明彦ほか : 優性遺伝型進行性ミオクローヌスてんかんの2家系. 精神経誌 74 : 871-897, 1972.
 
6) 稲月原ほか : 本邦における遺伝性歯状核赤核淡蒼球ルイ体萎縮症 (DRPLA) の地理的分布と新潟県におけるDRPLAの有病率. 精神医学 32 : 1135-1138, 1990.
 
7) Ikeuchi T, et al : Dentatorubral-pallidoluysian atrophy (DRPLA) : clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. Ann Neurol 37 : 769-775, 1995.
 
8) The Huntington's Disease Collaborative Research Group : A novel gene containing a trinucleotide repeat that is expanded unstable on Huntington's disease chromosomes. Cell 72 : 971-983, 1993.
 
9) Fukuhara N, et al : Myoclonus epilepsy associated with ragged-red fibers (mitochondrial abnormalities) : Disease entity or syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 47 : 117-133, 1980.
 
10) Shoffner JM, et al : Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA1ys mutation. Cell 61 : 931-937, 1990.
PubMed
11) Yoneda M, et al : A common mitochondrial DNA mutation in the tRNA1ys of patients with myoclonus epilepsy ragged-red fibers. Biochem Int 21 : 789-796, 1990.
PubMed
12) Pennacchio LA, et al : Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1), Science 271 : 1731-1734, 1996.
PubMed
13) 和知学ほか : シスタチンB遺伝子の変異が確認されたUnverricht-Lundborg病の2症例. てんかん研究 16 : 100-108, 1998.
 
14) Carpenter S, et al : Sweat gland duct cells in Lafora disease : diagnosis by skin biopsy. Neurology 31 : 1564-1568, 1981.
PubMed
P.310 掲載の参考文献
1) Foroud T, et al : Differences in duration of Huntington's disease based on age at onset. J Neurol Neurosurg Psychiatry 66 : 52-56, 1999.
PubMed
2) Nance MA, Myers RH : Juvenile onset Huntington's disease-clinical and research perspectives. Ment Retard Dev Disabil Res Rev 7 : 153-157, 2001.
PubMed
3) Gonzalez-Alegre P, Afifi AK : Clinical characteristics of childhood-onset (juvenile) Huntington disease : report of 12 patients and review of the literature. J Child Neurol 21 : 223-229, 2006.
PubMed
4) Cloud LJ, et al : Seizures in juvenile Huntington's disease : frequency and characterization in a multicenter cohort. Mov Disord 27 : 1797-1800, 2012.
 
5) van der Burg JM, et al : Beyond the brain : widespread pathology in Huntington's disease. Lancet Neurol 8 : 765-774, 2009.
PubMed
6) Li H, et al : Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25 : 385-389, 2000.
PubMed
7) Lin YF, et al : Huntingtin-associated protein-1 deficiency in orexin-producing neurons impairs neuronal process extension and leads to abnormal behavior in mice. J Biol Chem 285 : 15941-15949, 2010.
PubMed
8) Duyao M, et al : Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 4 : 387-392, 1993.
PubMed
9) Telenius H, et al : Molecular analysis of juvenile Huntington disease : the major influence on (CAG) n repeat length is the sex of the affected parent. Hum Mol Genet 2 : 1535-1540, 1993.
 
10) Ranen NG, et al : Anticipation and instability of IT-15 (CAG) n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet 57 : 593-602, 1995.
 
11) 長谷川一子 : ハンチントン病update. MDSJ Letters 4 : 4-9, 2011.
 
P.313 掲載の参考文献
1) Park JK, et al : Myoclonic epilepsy in Gaucher disease : genotype-phenotype insights from a rare patient subgroup. Pediatr Res 53 : 387-395, 2003.
PubMed
2) Tajima A, et al : Gaucher disease patient with myoclonic epilepsy and a novel mutation. Pediatr Neurol 42 : 65-68, 2010.
 
3) Kowarz L, et al : Gaucher mutation N188S is associated with myoclonic epilepsy. Hum Mutat 26 : 271-273, 2005.
PubMed
4) Vaca GF, et al : Gaucher disease : successful treatment of myoclonic status epilepticus with levetiracetam. Epileptic Disord 14 : 155-158, 2012.
PubMed
5) Suzuki Y : Chaperone therapy update : Fabry disease, GM1-gangliosidosis and Gaucher disease. Brain Dev 35 : 515-523, 2013.
PubMed
P.318 掲載の参考文献
1) Roy A, et al : GM2 gangliosidosis. In : The Online Metabolic and Molecular Bases of Inherited Disease, 2012.
 
2) Tay W : Symmetrical changes in the region of the yellow spot in each eye of an infant. Trans Opthamol Soc UK 1 : 155-157, 1881.
 
3) Sachs B : On arrested cerebral development, with special reference to its cortical pathology. J Nerv Ment Dis 14 : 541-553, 1887.
 
4) Sakuraba H, et al : GM2 gangliosidosis AB variant : clinical and biochemical studies of a Japanese patient. Neurology 52 : 372-377, 1999.
PubMed
5) Inui K, et al : Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyranoside for the diagnosis of GM2 gangliosidoses in leukocytes. Clin Genet 26 : 318-321, 1984.
PubMed
6) Tanaka A, et al : The major mutation among Japanese patients with infantile Tay-Sachs dis ease : a G-to-T transversion at the acceptor site of intron 5 of the beta-hexosaminidase alpha gene. Biochem Biophys Res Commun 192 : 539-546, 1993.
 
7) Berkovic S-F : Progressive myoclonus epilepsies. In : Epilepsy ; A Comprehensive Textbook (ed by Engel J Jr, Pedley T-A), p 2525-2536, Lippincott Wiliams & Wilkins, A Wolters Kluwer Business, Philadelphia, 2008.
 
8) Clarke JT, et al : An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants). Mol Genet Metab 102 : 6-12, 2011.
PubMed
P.323 掲載の参考文献
1) d'Azzo A, et al : Galactosialidosis. In : The Metabolic & Molecular Bases of Inherited Disease, Vol III (ed by Scriver CR, et al), p 3811, McGraw-Hill, New York, 2001.
 
2) Galjart N J, et al : Expression of a cDNA encoding the human 'protective protein' associated with lysosomal beta-galactosidase and neuraminidase : homology to yeast proteases. Cell 54 : 755-764, 1988.
PubMed
3) Shimmoto M, et al : Protective protein gene mutations in galactosialidosis. J Clin Invest 91 : 2393-2398, 1993.
PubMed
4) Zhou XY, et al : Molecular and biochemical analysis of protective protein/cathepsin A mutations : correlation with clinical severity in galactosialidosis. Hum Mol Genet 5 : 1977-1987, 1996.
PubMed
5) Caciotti A, et al : Galactosialidosis : review and analysis of CTSA gene mutations. Orphanet J Rare Dis 8 : 114, 2013.
PubMed
6) Takano T, et al : Galactosialidosis : clinical and molecular analysis of 19 Japanese patients. Brain Dysfunct 4 : 271-280, 1991.
 
7) Kase R, et al : Galactosialidosis : simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities. Biochem Biophys Res Commun 172 : 1175-1179, 1990.
PubMed
8) Richard C, et al : Molecular pathology of galactosialidosis in a patient affected with two new frameshift mutations in the cathepsin A/protective protein gene. Hum Mutat 11 : 461-469, 1998.
 
9) Ruf S, et al : Novel β-amino acid derivatives as inhibitors of cathepsin A. J Med Chem 55 : 7636-7649, 2012.
 
10) Schreuder HA : Crystal structure of cathepsin A, a novel target for the treatment of cardiovascular diseases. Biochem Biophys Res Commun 445 : 451-456, 2014.
PubMed
11) Jackman HL, et al : A peptidase in human platelets that deamidates tachykinins. Probable identity with the lysosomal "protective protein". J Biol Chem 265 : 11265-11272, 1994.
 
12) Itoh K, et al : Endothelin-1 in the brain of patients with galactosialidosis : Its abnormal increase and distribution pattern. Ann Neurol 47 : 122-126, 2000.
PubMed
13) Seyrantepe V, et al : Enzymatic activity of lysosomal carboxypeptidase (cathepsin A) is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 117 : 1973-1981, 2008.
PubMed
14) Pshezhetsky AV, Hinek A : Serine carboxypeptidases in regulation of vasoconstriction and elastogenesis. Trends Cardiovasc Med 19 : 11-17, 2009.
 
15) Hu, et al : Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis. Mol Ther 20 : 267-274, 2008.
 
P.328 掲載の参考文献
1) Thomas GH : Disorders of glycoprotein degradation : α-mannosidosis, β-mannosidosis, fucosidosis, and sialidosis. In : The Metabolic and Molecular Bases of Inherited Disease (ed by Scriver CR, et al), p 3507-3533, McGraw-Hill, New York, 2001.
 
2) d'Azzo A, et al : Galactosialidosis. In : The Metabolic and Molecular Bases of Inherited Disease (ed by Scriver CR, et al), p 3811-3826, McGraw-Hill, New York, 2001.
 
3) Kornfeld S, Sly WS : I-cell disease and pseudo-Hurler polydystrophy : disorders of lysosomal enzyme phosphorylation and localization. In : The Metabolic and Molecular Bases of Inherited Disease (ed by Scriver CR, et al), p 3469-3482, McGraw-Hill, New York, 2001.
 
4) Bonten E, et al : Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis. Genes Dev 10 : 3156-3169, 1996.
PubMed
5) Pshezhetsky AV, et al : Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet 15 : 316-320, 1997.
PubMed
6) Naganawa Y, et al : Molecular and structural studies of Japanese patients with sialidosis type 1. J Hum Genet 45 : 241-249, 2000.
PubMed
7) Itoh K, et al : Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes. J Hum Genet 47 : 29-37, 2002.
PubMed
8) Lukong KE, et al : Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex. Hum Mol Genet 9 : 1075-1085, 2000.
PubMed
9) Hitaoka S, et al : Modeling of Human Neuraminidase-1 and Its Validation by LERE-Correlation Analysis. Chem-Bio Informatics Journal 13 : 30-40, 2013.
 
10) Pattison S, et al : Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression. Hum Mutat 23 : 32-39, 2004.
PubMed
11) de Geest N, et al : Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice. Hum Mol Genet 11 : 1455-1464, 2002.
PubMed
12) Yogalingam G, et al : Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 15 : 74-86, 2008.
PubMed
13) Annunziata I, et al : Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis. Nat Commun 4 : 2734-2757, 2013.
 
14) Gascon G, et al : Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. Ann Neurol 24 : 453-455, 1988.
PubMed
15) Wang D, et al : Short-term, high dose enzyme replacement therapy in sialidosis mice. Mol Genet Metab 85 (3) : 181-189, 2005.
PubMed
P.330 掲載の参考文献
1) Williams RE, Mole SE : New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79 : 183-191, 2012.
PubMed
2) Steinfeld R, et al : Late infantile neuronal ceroid lipofuscinosis : quantitative description of the clinical course in patients with CLN2 mutations. Am J Med Genet 112 : 347-354, 2002.
PubMed
3) Jalanko A, Braulke T : Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 793 : 697-709, 2009.
 
4) Kollmann K, et al : Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta 1832 : 1866-1881, 2013.
PubMed
5) Schulz A, et al : NCL diseases-clinical perspectives. Biochim Biophys Acta 1832 : 1801-1806, 2013.
PubMed
6) NCL Resource-A gateway for Batten disease. [http://www.ucl.ac.uk/ncl/]
 
7) Lojewski X, et al : Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 23 : 2005-2022, 2014.
PubMed
P.332 掲載の参考文献
1) Williams RE, Mole SE : New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79 : 183-191, 2012.
PubMed
2) Wisneiwski KE, et al : Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses : review of data and observations. Am J Med Genet 42 : 525-532, 1992.
PubMed
3) Jalanko A, Braulke T : Neuronal ceroid lipofuscinoses. Biochim Biophys Acta 793 : 697-709, 2009.
 
4) Kollmann K, et al : Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochim Biophys Acta 1832 : 1866-1881, 2013.
PubMed
5) Kousi M, et al : Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 33 : 42-63, 2012.
PubMed
6) Schulz A, et al : NCL diseases-clinical perspectives. Biochim Biophys Acta 1832 : 1801-1806, 2013.
PubMed
7) Lojewski X, et al : Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 23 : 2005-2022, 2014.
PubMed
P.337 掲載の参考文献
1) Mink JW, et al : Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol 28 : 1101-1105, 2013.
PubMed
2) Mole SE, et al : Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6 : 107-126, 2005.
PubMed
3) Williams RE, et al : Diagnosis of the neuronal ceroid lipofuscinoses : an update. Biochim Biophys Acta 762 : 865-872, 2006.
 
4) Vesa J, et al : Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376 : 584-587, 1995.
PubMed
5) Kohlschutter A, Schulz A : Towards understanding the neuronal ceroid lipofuscinoses. Brain Dev 31 : 499-502, 2009.
PubMed
6) Das AK, et al : Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum Mol Genet 10 : 1431-1439, 2001.
PubMed
7) van Diggelen OP, et al : Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency : first adult-onset patients of a childhood disease. Ann Neurol 50 : 269-272, 2001.
PubMed
8) Arsov T, et al : Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6. Am J Hum Genet 88 : 566-573, 2011.
PubMed
9) Gao H, et al : Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet 70 : 324-335, 2002.
 
10) Siintola E, et al : Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin. Clin Genet 68 : 167-173, 2005.
PubMed
11) Boehme DH, et al : A dominant form of neuronal ceroid-lipofuscinosis. Brain 94 : 745-760, 1971.
PubMed
12) Noskova L, et al : Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am J Hum Genet 89 : 241-252, 2011.
PubMed
13) Schmitz F, et al : CSPalpha-deficiency causes massive and rapid photoreceptor degeneration. Proc Natl Acad Sci USA 103 : 2926-2931, 2006.
PubMed
14) Smith KR, et al : Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis. Hum Mol Genet 22 : 1417-1423, 2013.
PubMed
15) Hu J, et al : Intravenous high-dose enzyme replacement therapy with recombinant palmitoyl-protein thioesterase reduces visceral lysosomal storage and modestly prolongs survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Mol Genet Metab 107 : 213-221, 2012.
 
P.343 掲載の参考文献
1) Hirvasniemi A, et al : Northern epilepsy syndrome : an inherited childhood onset epilepsy with associated mental deterioration. J Med Genet 31 : 177-182, 1994.
PubMed
2) Ranta S, Lehesjoki AE : Northern epilepsy, a new member of the NCL family. Neurol Sci 21 : S43-S47, 2000.
PubMed
3) Lauronen L, et al : Northern epilepsy syndrome (NES, CLN8)-MRI and electrophysiological studies. Eur J Paediatr Neurol 5 (Suppl A) : 167-173, 2001.
 
4) Hirvasniemi A, et al : Northern epilepsy syndrome : clinical course and the effect of medication on seizures. Epilepsia 36 : 792-797, 1995.
PubMed
5) Tahvanation E, et al : The gene for a recessively inherited human childhood progressive epilepsy with mental retardation. Maps to the distal short arm of chromosome 8. Proc Natl Acad Sci USA 19 : 91, 1994.
 
6) Ranta S, et al : Studies of homogenous populations : CLN 5 and CLN 8. Adv Genet 45 : 123-140, 2001.
 
7) Lang AH, et al : Neurophysiological findings in the Northern epilepsy syndrome. Acta Neutrol Scand 95 : 1-8, 1997.
 
8) Hirvasniemi A, Karumo J : Neutroradiological findings in the northern epilepsy syndrome. Acta Neurol Scand 90 : 388-393, 1994.
PubMed
9) Striano P, et al : Clinical and electrophysiological features of epilepsy in Italian patients with CLN8 mutations. Epilepsy Behav 10 (1) : 187-191, 2007.
PubMed
10) Ranta S, Topcu M : Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 23 (4) : 300-305, 2004.
 
P.348 掲載の参考文献
1) Fukuhara N, et al : Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities) : disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci 47 : 117-133, 1980.
 
2) 福原信義 : 福原病. Brain and Nerve 60 : 53-58, 2008.
 
3) Yoneda M, et al : A common mitochondrial DNA mutation in the t-RNA (Lys) of patients with myoclonus epilepsy associated with ragged-red fibers. Biochem Int 21 : 789-796, 1990.
 
4) Shoffner JM, et al : Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA (Lys) mutation. Cell 61 : 931-937, 1990.
PubMed
5) Shoffner JM, Wallace DC : Mitochondrial genetics : principles and practice. Am J Hum Genet 51 : 1179-1186, 1992.
PubMed
6) Tanno Y, et al : Uniform tissue distribution of tRNA (Lys) mutation in mitochondrial DNA in MERRF patients. Neurology 43 : 1198-1200, 1993.
PubMed
7) Yoneda M, et al : Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol Cell Biol 14 : 2699-2712, 1994.
PubMed
8) Remes AM, et al : Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Neurology 64 : 976-981, 2005.
 
9) Hirano M, DiMauro S : Clinical features of mitochondrial myopathies and encephalomyopathies. In : Handbook of Muscle Disease (ed by Lane RJM), p 479-504, Marcel Dekker, New York, 1996.
 
10) 武田茂樹ほか : Ragged-red fiberを伴うミオクローヌスてんかん (福原病) の1剖検例. 脳と神経 39 : 1171-1179, 1987.
 
11) Fukuhara N : Clinicopathological features of MERRF. Muscle Nerve 3 : S90-94, 1995.
PubMed
12) Yoneda M, et al : Simple detection of tRNA (Lys) mutation in myoclonus epilepsy associated with ragged-red fibers (MERRF) by polymerase chain reaction with a mismatched primer. Neurology 41 : 1838-1840, 1991.
PubMed
13) Mancuso M, et al : Phenotypic heterogeneity of the 8344A > G mtDNA "MERRF" mutation. Neurology 80 : 2049-2054, 2013.
PubMed
14) Zeviani M, et al : A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA (Lys) gene. Eur J Hum Genet 1 : 80-87, 1993.
PubMed
15) Crest C1, et al : Levetiracetam in progressive myoclonic epilepsy : an exploratory study in 9 patients. Neurology 62 : 640-643, 2004.
 
P.353 掲載の参考文献
1) Van Hove JL, Lohr NJ : Metabolic and monogenic causes of seizures in neonate and young infants. Mol Genet Metab 104 : 214-230, 2011.
 
2) Ficicioglu C, Bearden D : Isolated neonatal seizures : when to suspect inborn errors of metabolism. Pediatr Neurol 45 : 283-291, 2011.
PubMed
3) 小児神経の画像診断-脳脊髄から頭頸部・骨軟部まで- (大場洋編), 秀潤社, 2010.
 
4) 呉繁夫 : 非ケトーシス高グリシン血症. 小児疾患診療のための病態生理2 (「小児内科」「小児外科」編集委員会共編), p 355-358, 東京医学社, 2009.
 
5) de Koning TJ, Klomp LWJ : Serine-deficiency syndromes. Curr Opin Neurol 17 : 197-204, 2004.
PubMed
6) Tsuji M, et al : A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy. J Inherit Metab Dis 33 : 85-90, 2010.
PubMed
7) Pearl PL : New treatment paradigms in neonatal metabolic epilepsies. J Inherit Metab Dis 32 : 204-213, 2009.
PubMed
8) Gropman AL, et al : Neurological implications of urea cycle disorders. J Inherit Metab Dis 30 : 865-879, 2007.
PubMed
9) Yu JY, Pearl PL : Metabolic causes of epileptic encephalopathy. Epilepsy Res Treat 2013 : 124934, 2013.
PubMed
10) Bayram E, et al : Molybdenum cofactor deficiency : review of 12 cases (MoCD and review). Eur J Pediatr Neurol 17 : 1-6, 2013.
 
11) 鴨田知博 : フルクトース-1,6-ビスホスファターゼ欠損症. 別冊日本臨牀 先天代謝異常症候群 (第2版) (上), p 104-108, 日本臨牀社, 2012.
 
12) Brockmann K : The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31 : 545-552, 2009.
PubMed
13) Molinari F, et al : Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet 76 : 334-339, 2005.
PubMed
14) Serrano M, et al : Genetic causes of cerebral folate deficiency : clinical, biochemical and therapeutic aspects. Drug Discov Today 17 : 1299-1306, 2012.
PubMed
15) Siintola E, et al : Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129 : 1438-1445, 2006.
PubMed
16) 下澤伸行 : ツェルウェガー (Zellweger) 症候群. 別冊日本臨牀 先天代謝異常症候群 (第2版) (下), p 398-404, 日本臨牀社, 2012.
 
P.358 掲載の参考文献
1) Nordli DR, De Vivo DC : Inherited metabolic disorders. In : Epilespy : A Comprehensive Textbook, 2nd ed (ed by Engel J, Pedley TA), p 2603-2630, Lippincott-Williams & Wilkins, Philadelphia, 2008.
 
2) Freeze HH, et al : Neurology of inherited glycosylation disorders. Lancet Neurol 11 (5) : 453-466, 2012.
PubMed
3) Vigevano F, et al : Therapeutic approach to epileptic encephalopathies. Epilepsia 54 (Suppl 8) : 45-50, 2013.
 
P.362 掲載の参考文献
1) Papetti L, et al : Metabolic epilepsy : an update. Brain Dev 35 : 827-841, 2013.
PubMed
2) Wolf NI, et al : Epilepsy in inborn errors of metabolism. Epileptic Disord 7 : 67-81, 2005.
PubMed
3) Shields WD : Infantile spasms : little seizures, BIG consequences. Epilepsy Curr 6 : 63-69, 2006.
PubMed
4) Gkampeta A, Pavlou E : Infantile spasm (West syndrome) in children with inborn errors of metabolism : a review of the literature. J Child Neurol 27 : 1295-1301, 2012.
PubMed
5) Zhongshu Z, et al : Clinical analysis of West syndrome associated with phenylketonuria. Brain Dev 23 : 552-557, 2001.
PubMed
6) Markand ON, et al : Nonketotic hyperglycinemia : electroencephalographic and evoked potential abnormalities. Neurology 32 : 151-156, 1982.
PubMed
7) Naito E, et al : Gender-specific occurrence of West syndrome in patients with pyruvate dehydrogenase complex deficiency. Neuropediatrics 32 : 295-298, 2001.
PubMed
8) 内藤逸夫ほか : 13年間ジクロロ酢酸ナトリウム療法を続けたG291R変異を有するピルビン酸脱水素酵素複合体欠損症の1女児例. 徳島赤十字病医誌 12 : 59-64, 2007.
 
9) Rutledge SL, et al : Pyruvate carboxylase deficiency : acute exacerbation after ACTH treatment of infantile spasms. Pediatr Neurol 5 : 249-252, 1989.
PubMed
10) Bindu PS, et al : Electro-clinical features and magnetic resonance imaging correlates in Menkes disease. Brain Dev 35 : 398-405, 2013.
PubMed
11) Prasad AN, et al : Menkes disease and infantile epilepsy. Brain Dev 33 : 866-876, 2011.
PubMed
12) 八木麻理子ほか : Menkes病における臨床像は, 遺伝子型と銅補充療法開始時期により異なる. 脳と発達 46 : 227-228, 2014.
Medical*Online
13) Blanco-Barca O, et al : Mitochondrial encephalomyopathies and West's syndrome : a frequently underdiagnosed association. Rev Neurol 39 : 618-623, 2004.
PubMed
14) Robinson B-H : Lactic acidemia (disorders of pyruvate carboxylase, puruvate dehydrogenase). In : The Metabolic and Molecular Bases of Inherited Disease, 7th ed (ed by Scriver CR, et al), p 1478-1499, McGraw-Hill, New York, 1995.
 
P.370 掲載の参考文献
1) Patry G, et al : Subclinical "electrical status epilepticus" induced by sleep in children. Arch Neurol 24 : 242-252, 1971.
PubMed
2) Tassinari CA, et al : Electrical status epilepticus during sleep in children (ESES). In : Sleep and Epilepsy (ed by Sterman MB, et al), p 465-479, Academic Press, London and New York, 1982.
 
3) Engel J Jr : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of the ILAE task force on classification and terminology. Epilepsia 42 : 796-803, 2001.
PubMed
4) Fernandez IS, et al : The tower of Babel : survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia 54 : 741-750, 2013.
 
5) Tassinari CA, et al : Epilepsy with continuous spike and waves during slow sleep-otherwise described as ESES (epilepsy with electrical status epilepticus during slow sleep). In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd ed (ed by Roger J, et al), p 245-256, John Libbey, London, 1992.
 
6) Tassinari CA, et al : Encephalopathy related to status epilepticus during slow sleep (ESES) including Landau-Kleffner syndrome. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 5th ed (ed by Bureau M, et al), p 255-275, John Libbey, Montrouge, 2012.
 
7) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 : 389-399, 1989.
PubMed
8) Cantalupo G, et al : In search for the Rosetta Stone for ESES. Epilepsia 54 : 766-767, 2013.
PubMed
9) Morikawa T, et al : Long-term outcome of four children with continuous spike-waves during sleep. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd ed (ed by Roger J, et al), p 257-265, John Libbey, London, 1992.
 
10) Galanopoulou AS, et al : The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 22 : 279-295, 2000.
PubMed
11) Kobayashi K, et al : Nonconvulsive status epilepticus with continuous diffuse spike-and-wave discharges during sleep in childhood. Jpn J Psychiatr Neurol 42 : 509-514, 1988.
 
12) Panayiotopoulos CP : Epilepsy with continuous spikes and waves during slow sleep (ECSWS) or epilepsy with electrical status epilepticus during slow sleep (ESESS). In : Benign Childhood Partial Seizures and Related Epileptic Syndromes (ed by Panayiotopoulos CP), p 348-355, John Libbey, London, 1999.
 
13) 岡英次 : ESES症候群 概論. 別刷日本臨牀 神経症候群 VI-てんかん症候群-, p 288-290, 日本臨牀社, 2002.
 
14) Scheltens-de Boer M : Guidelines for EEG in encephalopathy related to ESES/CSWS in children. Epilepsia 50 (Suppl 7) : 13-17, 2009.
 
15) Landau WM, Kleffner FR : Syndrome of acquired aphasia with convulsive disorder in children. Neurology 7 : 523-530, 1957.
PubMed
16) 大田原俊輔 : ESES症候群. 医学のあゆみ 183 : 96-102, 1997.
 
17) Kellermann K : Recurrent aphasia with subclinical bioelectric status epilepticus during sleep. Eur J Pediatr 128 : 207-212, 1978.
PubMed
18) Perez ER, et al : Mental and behavioural deterioration of children with epilepsy and CSWS : acquired epileptic frontal syndrome. Dev Med Child Neurol 35 : 661-674, 1993.
 
19) Shafrir Y, Prensky AL : Acquired epileptiform opercular syndrome : a second case report, review of the literature, and comparison to the Landau-Kleffner syndrome. Epilepsia 36 : 1050-1057, 1995.
 
20) Aicardi J, Chevrie JJ : Atypical benign partial epilepsy of childhood. Dev Med Child Neurol 24 : 281-292, 1982.
PubMed
21) Hahn A, et al : Atypical "benign" partial epilepsy or pseudo-Lennox syndrome. Part I : symptomatology and long-term prognosis. Neuropediatrics 32 : 1-8, 2001.
 
22) Kikumoto K, et al : EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome. Epileptic Disord 8 : 53-56, 2006.
PubMed
23) Caraballo RH, et al : Atypical evolution in childhood epilepsy with occipital paroxysms (Panayiotopoulos type). Epileptic Disord 3 : 157-162, 2001.
PubMed
24) 大塚頌子ほか : 小児期におけるnon-convulsive status epilepticusの特異型に関する研究. てんかん研究 1 : 107-115, 1983.
 
25) 大守伊織ほか : Epileptic negative myoclonus. 脳波と筋電図 24 : 164, 1996.
Medical*Online
26) 大塚頌子 : てんかん性陰性ミオクローヌスを伴う非けいれん性てんかん重積状態. 別冊日本臨牀 神経症候群 VI-てんかん症候群-, p 291-295, 日本臨牀社, 2002.
 
27) Ohtsuka Y, et al : Childhood-onset epilepsy associated with polymicrogyria. Brain Dev 24 : 758-765, 2002.
PubMed
28) 西林尚祐 : 徐波睡眠期に持続性棘徐波を示すてんかんの縦断的研究. てんかん研究 14 : 1-11, 1996.
 
29) Ohtsuka Y, et al : Nonconvulsive status epilepticus in childhood localization-related epilepsy. Epilepsia 40 : 1003-1010, 1999.
PubMed
30) Ohtsuka Y, et al : Treatment of intractable childhood epilepsy with high-dose valproate. Epilepsia 33 : 158-164, 1992.
PubMed
31) Inutsuka M, et al : Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders. Brain Dev 28 : 281-286, 2006.
PubMed
32) De Negri M, et al : Treatment of electrical status epilepticus by short diazepam (DZP) cycles after DZP rectal bolus test. Brain Dev 17 : 330-333, 1995.
PubMed
33) Kramer U, et al : Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 50 : 1517-1524, 2009.
PubMed
34) Shields WD, Saslow E : Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 33 : 1487-1489, 1983.
PubMed
35) Tononi G, Cirelli C : Sleep function and synaptic homeostasis. Sleep Med Rev 10 : 49-62, 2006.
 
36) Holmes GL, Lenck-Santini P : Role of interictal epileptiform abnormalities in cognitive impairment. Epilepsy Behav 8 : 504-515, 2006.
PubMed
37) Filippini M, et al : Neuropsychological approaches to epileptic encephalopathies. Epilepsia 54 (Suppl 8) : 38-44, 2013.
 
38) Shahani BT, Young RR : Physiological and pharmacological aids in the differential diagnosis of tremor. J Neurol Neurosurg Psychiatry 39 : 772-783, 1976.
 
39) Tassinari CA, et al : Epileptic negative myoclonus. In : Negative Motor Phenomena (ed by Fahn S, et al), p 181-197, Lippincott-Raven, Philadelphia, 1995.
 
40) Rubboli G, et al : Frontal inhibitory spike component associated with epileptic negative myoclonus. Electroencephalogr Clin Neurophysiol 95 : 201-205, 1995.
PubMed
41) Rubboli G, et al : Negative myoclonus induced by cortical electrical stimulation in epileptic patients. Brain 129 : 65-81, 2006.
PubMed
42) Guerrini R, et al : Epileptic negative myoclonus. Neurology 43 : 1078-1083, 1993.
PubMed
43) Tachikawa E, et al : Acquired epileptiform opercular syndrome : a case report and results of single photon emission computed tomography and computer-assisted electroencephalographic analysis. Brain Dev 23 : 246-250, 2001.
PubMed
44) Pera MC, et al : Long-term evolution of neuropsychological competences in encephalopathy with status epilepticus during sleep ; a variable prognosis. Epilepsia 54 (Suppl 7) : 77-85, 2013.
 
45) 小林勝弘ほか : てんかんと睡眠-徐波睡眠中連続的棘徐波を示す非けいれん性てんかん重積状態を中心に-. 脳と発達 22 : 136-142, 1990.
 
P.375 掲載の参考文献
1) Fejerman N : Benign childhood epilepsy with centrotemporal spikes. In : Epilepsy. A Comprehensive Textbook, 2nd ed (ed by Engel J Jr, Pedley TA), p 2369-2377, Lippincott Williams & Wilkins, Philadelphia, 2008.
 
2) Al-Twaijri WA, Shevell MI : Atypical benign epilepsy of childhood with rolandic spikes : features of a subset requiring more than one medication for seizure control. J Child Neurol 17 : 901-904, 2002.
 
3) Hahn A, et al : Atypical "benign" partial epilepsy or pseudo-Lennox syndrome. Part I : symptomatology and long-term prognosis. Neuropediatrics 32 : 1-8, 2001.
 
4) Massa R, et al : EEG criteria predictive of complicated evolution in idiopathic rolandic epilepsy. Neurology 57 : 1071-1079, 2001.
PubMed
5) Kanemura H, Aihara M : Growth disturbance of frontal lobe in BCECTS presenting with frontal dysfunction. Brain Dev 31 : 771-774, 2009.
PubMed
6) Kanemura H, et al : Do sequential EEG changes predict atypical clinical features in rolandic epilepsy? Dev Med Child Neurol 54 : 912-917, 2012.
PubMed
7) Chevalier H, et al : Impulsivity and control of inhibition in benign focal childhood epilepsy (BFCE). Brain Cogn 43 : 86-90, 2000.
PubMed
8) Berroya AG, et al : Speech and language deterioration in benign rolandic epilepsy. J Child Neurol 19 : 53-58, 2004.
 
9) Fonseca LC, et al : School performance in children with benign childhood epilepsy with centrotemporal spikes. Arq Neuropsiquiatr 62 : 459-462, 2004.
PubMed
10) Kanemura H, et al : Serial changes of prefrontal lobe growth in the patients with benign childhood epilepsy with centrotemporal spikes presenting with cognitive impairments/behavioral problems. Brain Dev 33 : 106-113, 2011.
 
11) Tassinari CA, et al : Electrical status epilepticus during slow sleep (ESES or CSWS) including acquired epileptic aphasia (Landau-Kleffner syndrome). In : Epileptic Syndrome in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 295-314, John Libbey, London, 2005.
 
12) Engler F, et al : Treatment with Sulthiame (Ospolot) in benign partial epilepsy of childhood and related syndromes : an open clinical and EEG study. Neuropediatrics 34 : 105-109, 2003.
PubMed
13) Bello-Espinosa LE, Roberts SL : Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases. Seizure 12 : 157-159, 2003.
PubMed
14) Kanemura H, et al : Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy. Brain Dev 35 : 386-391, 2013.
PubMed
P.379 掲載の参考文献
1) Yasuda T : Benign adult familial myoclonus epilepsy (BAFME). Kawasaki Med J 17 : 1-13, 1991.
 
2) 稲月原ほか : ミオクローヌスてんかんとてんかんを合併する家族性疾患について-Familial essential myoclonus and epilepsy (FEME) の疾病分類的位置づけ. 精神神経学雑誌 92 : 1-21, 1990.
 
3) Okuma Y, et al : Familial cortical tremor with epilepsy. Parkinsonism Relat Disord 3 : 83-87, 1997.
PubMed
4) Okino S : Familial benign myoclonus epilepsy of adult onset : a previously unrecognized myoclonic disorder. J Neurol Sci 145 : 113-118, 1997 (Published erratum appears in J Neurol Sci 152 : 233, 1997).
 
5) 大沼悌一 : 進行性ミオクローヌスてんかんとその近縁疾患-病態と診断 : 遺伝子診断ならびに神経生理学的最近の進歩を中心として-. てんかん研究 17 : 153-172, 1999.
 
6) Mikami M, et al : Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1. Am J Hum Genet 65 : 745-751, 1999.
PubMed
7) Plaster NM, et al : Genetic localization of the familial adult myoclonic epilepsy (FAME) gene to chromosome 8q24. Neurology 53 : 1180-1183, 1999.
PubMed
8) Guerrini R, et al : Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures : a newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2. Brain 124 : 2459-2475, 2001.
PubMed
9) Depienne C, et al : Familial cortical myoclonic tremor with epilepsy : the third locus (FCMTE3) maps to 5p. Neurology 74 : 2000-2003, 2010.
PubMed
10) Yeetong P, et al : A newly identified locus for benign adult familial myoclonic epilepsy on chromosome 3q26.32-3q28. Eur J Hum Genet 21 : 225-228, 2013.
PubMed
11) Stogmann E, et al : Autosomal recessive cortical myoclonic tremor and epilepsy : association with a mutation in the potassium channel associated gene CNTN2. Brain 136 : 1155-1160, 2013.
PubMed
12) Mori S, et al : Remapping and mutation analysis of benign adult familial myoclonic epilepsy in a Japanese pedigree. J Hum Genet 56 : 742-747, 2011.
 
13) Kato T, et al : UBR5 Gene Mutation Is Associated with Familial Adult Myoclonic Epilepsy in a Japanese Family. ISRN Neurol 2012 : 508308, 2012.
 
14) Hitomi T, et al : Increased cortical hyperexcitability and exaggerated myoclonus with aging in benign adult familial myoclonus epilepsy. Mov Disord 26 : 1509-1514, 2011.
PubMed
15) Hitomi T, et al : Increased clinical anticipation with maternal transmission in benign adult familial myoclonus epilepsy in Japan. Epileptic Disord 15 : 428-432, 2013.
PubMed
P.385 掲載の参考文献
1) 千葉茂ほか : 睡眠関連てんかん. 日本臨牀 66 (増刊号2) : 448-451, 2008.
Medical*Online
2) 千葉茂 : 睡眠時随伴症をめぐって. 日本医事新報 4521 : 54-59, 2010.
Medical*Online
3) 吉澤門土, 千葉茂 : 明日からの精神科臨床に活かせる「脳波とてんかん」 . てんかんにみられる睡眠障害. 日本総合病院精神医学会雑誌, 2014. (印刷中)
 
4) Janz D : Epilepsy and the sleep-waking cycle. In : The Epilepsies : Handbook of Clinical Neurology (ed by Vinken PJ, Bruyn GW), p 457-490, North Holland Publishing, Amsterdam, 1974.
 
5) American Academy of Sleep Medicine : Sleep related epilepsy. In : American Academy of Sleep Medicine International Classification of Sleep Disorders, 3rd editioned (by Darien IL), American Academy of Sleep Medicine, Westchester, 2014.
 
6) 阪本一剛, 千葉茂 : 睡眠関連てんかん. 睡眠医療 5 : 141-146, 2011.
Medical*Online
7) 阪本一剛, 千葉茂 : さまざまな睡眠障害, 特論-睡眠に関連する特殊な病態, 睡眠関連てんかん. 脳とこころのプライマリケア 5. 意識と睡眠 (千葉茂編, 日野原重明, 宮岡等監), p 795-799, シナジー, 2012.
 
8) Foldvary-Schaefer N, Grigg-Damberger M : Sleep and epilepsy : what we know, don't know, and need to know. J Clin Neurophysiol 23 : 4-20, 2006.
 
9) 千葉茂ほか : 睡眠関連てんかん. 精神科治療学 24 : 187-194, 2009.
 
10) Herman ST, et al : Effects of sleep on seizures. In : Sleep and Epilepsy : the Clinical Spectrum (ed by Bazil CW, et al), p 165-180, Elsevier, Amsterdam, 2002.
 
11) 藤村洋太, 千葉茂 : 睡眠・覚醒がてんかんに及ぼす影響. 睡眠医療 7 : 161-166, 2013.
Medical*Online
12) 千葉茂 : 偽発作. 別冊日本臨牀 神経症候群 VI-てんかん症候群-, p 385-389, 日本臨牀社, 2002.
 
13) 千葉茂 : 「眠れない」を解決する. 睡眠障害にまつわる身近な疑問から各症候まで徹底解説! 身につけたい最低限の鑑別診断 睡眠中に寝ぼけて行動してしまう. 治療 93 : 228-232, 2011.
 
14) 白田朱香ほか : 睡眠検査のピットフォール-実施上の注意点・問題点-. 最終回 睡眠関連てんかんのVideo-Polysomnography. 記録と判定のピットフォール. 睡眠医療 8 : 105-111, 2014.
 
15) Tinuper P, et al : Familial frontal lobe epilepsy and its relationship with other nocturnal paroxysmal events. Epilepsia 51 (Suppl 1) : 51-53, 2010.
 
P.388 掲載の参考文献
1) Scheffer IE, Berkovic SF : Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120 (Pt 3) : 479-490, 1997.
 
2) Wallace RH, et al : Febrile seizures and generalized epilepsy associated with a mutation in the Na+ -channel beta1 subunit gene SCN1B. Nat Genet 19 : 366-370, 1998.
 
3) Escayg A, et al : Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2 . Nat Genet 24 : 343-345, 2000.
PubMed
4) Sugawara T, et al : A missense mutation of the Na+ channel alpha II subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA 98 : 6384-6389, 2001.
 
5) Baulac S, et al : First genetic evidence of GABAA receptor dysfunction in epilepsy : a mutation in the gamma2-subunit gene. Nat Genet 28 : 46-48, 2001.
PubMed
6) Wallace RH, et al : Mutant GABAA receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28 : 49-52, 2001.
PubMed
7) Meadows LS, et al : Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J Neurosci 22 : 10699-10709, 2002.
PubMed
8) Escayg A, Goldin AL : Sodium channel SCN1A and epilepsy : mutations and mechanisms. Epilepsia 51 : 1650-1658, 2010.
PubMed
9) Sugiura Y, et al : Different degrees of loss of function between GEFS+ and SMEI Nav 1.1 missense mutants at the same residue induced by rescuable folding defects. Epilepsia 53 : e111-114, 2012.
PubMed
10) Dravet C, et al : Severe myoclonic epilepsy in infancy : Dravet syndrome. Adv Neurol 95 : 71-102, 2005.
PubMed
11) Claes L, et al : De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68 : 1327-1332, 2001.
PubMed
12) 杉浦嘉泰 : てんかんとチャネル-生理学的解析. アクチュアル脳・神経疾患の臨床 てんかんテキストNew Version (辻省次, 宇川義一編), p 10-18, 中山書店, 2012.
 
13) Jacob TC, et al : GABA A receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci 9 : 331-343, 2008.
PubMed
P.394 掲載の参考文献
1) Striano S, et al : Eyelid myoclonia with absences (Jeavons syndrome) : a well-defined idiopathic generalized epilepsy syndrome or a spectrum of photosensitive conditions? Epilepsia 50 : 15-19, 2009.
PubMed
2) Jeavons PM : Nosological problems of myoclonic epilepsies in childhood and adolescence. Dev Med Child Neurol 19 : 3-8, 1977.
 
3) Duncan JS, Panayiotopoulos CP : Eyelid Myoclonia with Absences, John Libbey and Company, London, 1996.
 
4) Scuderi C, et al : Eyelid myoclonia with absences in three subjects with mental retardation. Neurol Sci 21 : 247-250, 2000.
PubMed
5) Engel J Jr : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of the ILAE Task Force on Classification and Terminology. Epilepsia 42 : 796-803, 2001.
PubMed
6) Giannakodimos S, Panayiotopoulos CP : Eyelid myoclonia with absences in adults : a clinical and video-EEG study. Epilepsia 37 : 36-44, 1996.
PubMed
7) Panayiotopoulos CP : Jeavons syndrome. In : Clinical Guide to Epileptic Syndromes and Their Treatment, p 453-456, Springer, London, 2007.
 
8) Ogura K, et al : EEG evaluation of fixation-off sensitivity in eyelid myoclonia with absences. Pediatr Neurol 33 : 142-145, 2005.
PubMed
9) Striano S, et al : Eyelid myoclonia with absences : an overlooked epileptic syndrome? Neurophysiol Clin 32 : 287-296, 2002.
PubMed
10) Caraballo RH, et al : A study of 63 cases with eyelid myoclonia with or without absences : type of seizure or an epileptic syndrome? Seizure 18 : 440-445, 2009.
 
11) Panayiotopoulos CP : Absence epilepsies. In : Epilepsy : A Comprehensive Textbooked (by Engel JJ, Pedley TA), p 2327-2346, Lippincott-Raven Publishers, Philadelphia, 1997.
 
12) Alfradique I, Vasconcelos MM : Juvenile myoclonic epilepsy. Arq Neuropsiquiatr 65 : 1266-1271, 2007.
PubMed
P.399 掲載の参考文献
1) Coppola G, et al : Migrating partial seizures in infancy : a malignant disorder with developmental arrest. Epilepsia 36 : 1017-1024, 1995.
PubMed
2) Dulac O : Malignant migrating partial seizures in infancy. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 73-76, John Libbey Eurotext, Montrouge, 2005.
 
3) McTague A, et al : Migrating partial seizures of infancy : expansion of the electroclinical, radiological and pathological disease spectrum. Brain 136 : 1578-1591, 2013.
PubMed
4) Barcia G, et al : De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 44 : 1255-1259, 2012.
PubMed
5) Carranza Rojo D, et al : De novo SCN1A mutations in migrating partial seizures in infancy. Neurology 77 : 380-383, 2011.
PubMed
6) Poduri A, et al : Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia 53 : e146-e150, 2012.
PubMed
7) Ohba C, et al : Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia 55 (7) : 994-1000, 2014.
PubMed
8) Milh M, et al : Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat 34 : 869-872, 2013.
PubMed
9) Poduri A, et al : SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol 74 : 873-882, 2013.
PubMed
10) 須貝研司 : 遊走性焦点を伴う乳児てんかん (MPSI). 厚生労働科学研究費補助金 (難治性疾患等克服研究事業) 稀少難治性てんかんに関する調査研究平成25年度総括・分担研究報告書 (研究代表者 大槻泰介), p 15-17, 2014.
 
11) Cilio MR, et al : Migrating partial seizures in infancy. In : Epilepsy. A Comprehensive Textbook, 2nd ed (ed by Engel J Jr, Pedley TA), p 2323-2328, Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, 2008.
 
12) Okuda K, et al : Successful control with bromide of two patients with migrating partial seizures in infancy. Brain Dev 22 : 56-59, 2000.
PubMed
13) Caraballo R, et al : Epilepsy of infancy with migrating focal seizures : Six patients treated with bromide. Seizure. 2014 Jul 5. pii : S1059-131 (114) 00197-6. doi : 10.1016/j.seizure.2014.06.016. [Epub ahead of print]
 
14) Bearden D, et al : Targeted treatment of migrating partial seizures of infancy with quinidine. Ann Neurol 76 (3) : 457-461, 2014.
PubMed
15) Marsh E, et al : Migrating partial seizures in infancy : expanding the phenotype of a rare seizure syndrome. Epilepsia 46 : 568-572, 2005.
PubMed
P.403 掲載の参考文献
1) Kazemi NJ, Cascino GD : The double lesion : dual pathology and pathological correlation. In : The Epilepsies : Etiologies and Preventioned (by Kotagal P, Luders HO), p 349-356, Academic Press, London, 1999.
 
2) Levesque MF, et al : Surgical treatment of limbic epilepsy associated with extrahippocampal lesions : the problem of dual pathology. J Neurosurg 75 : 364-370, 1991.
PubMed
3) D'Aegenzio L, Cross JH : Hippocampal sclerosis and dual pathology. In : Wyllie's Treatment of Epilepsy. Principles and Practice, 5th ed (ed by Wyllie E), p 332-338, Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, 2011.
 
4) Li LM, et al : Surgical outcome in patients with epilepsy and dual pathology. Brain 122 : 799-805, 1999.
PubMed
5) Salanova V, et al : Temporal lobe epilepsy : analysis of patients with dual pathology. Acta Neurol Scand 109 : 126-131, 2004.
PubMed
6) Spencer S, Huh L : Outcomes of epilepsy surgery in adults and children. Lancet Neurol 7 : 525-537, 2008.
PubMed
7) Babb TL, Brown JW : Pathological findings in epilepsy. In : Surgical Treatment of the Epilepsies (ed by Engel J Jr), p 511-540, Raven Press, New York, 1987.
 
8) Fried I, et al : Hippocampal pathology in patients with intractable seizures and temporal lobe masses. J Neurosurg 76 : 735-740, 1992.
PubMed
9) Cendes F, et al : Frequency and characteristics of the double lesion in patients with lesional epilepsy. Neurology 45 : 2058-2064, 1995.
 
10) Kim DW, et al : Epilepsy with dual pathology : surgical treatment of cortical dysplasia accompanied by hippocampal sclerosis. Epilepsia 51 : 1429-1435, 2010.
PubMed
11) Li LM, et al : Surgical treatment of patients with single and dual pathology : relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology 48 : 437-444, 1997.
PubMed
12) Usui N, et al : Intracranial EEG findings in patients with lesional lateral temporal lobe epilepsy. Epilepsy Res 78 : 82-91, 2008.
PubMed
13) Iida K, et al : MEG and magnetic source imaging in MRI-negative refractory partial epilepsy. In : MRI-negative Epilepsy : Evaluation and Surgical Management (ed by So EL, Ryvlin P), Cambridge University Press, 2014. (in press)
 
14) Iwasaki M, et al : Surgical implications of neuromagnetic spike localization in temporal lobe epilepsy. Epilepsia 43 : 415-424, 2002.
PubMed
15) Lombardi D, et al : Low grade glioma in intractable epilepsy : lesionectomy versus epilepsy surgery. Acta Neurochir Suppl 68 : 70-74, 1997.
PubMed
P.406 掲載の参考文献
1) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
2) 亀山茂樹 : 疾患の特徴と診断のポイント 21. 視床下部過誤腫. 稀少難治てんかん診療マニュアル (大槻泰介ほか編), p 68-69, 診断と治療社, 2013.
 
3) Munari C, et al : Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol 95 : 154-160, 1995.
PubMed
4) 亀山茂樹 : 視床下部過誤腫による笑い発作に対する定位温熱凝固術. てんかん治療Update研究と臨床の最前線. 最新・外科治療動向. 医学のあゆみ 232 : 991-997, 2010.
 
5) Kameyama S, et al : Minimally invasive magnetic resonance imaging-guided stereotactic radiofrequency thermocoagulation for epileptogenic hypothalamic hamartomas. Neurosurgery 65 : 438-449, 2009.
PubMed
6) 亀山茂樹 : 視床下部過誤腫. ビジュアル脳神経外科4, 脳室・松果体 (冨永悌二編), p 60-71, メジカルビュー社, 2011.
 
7) 亀山茂樹 : 視床下部過誤腫に対する治療法の選択. ビジュアル脳神経外科6, 間脳・下垂体・傍鞍部 (斎藤延人編), p 208-221, メジカルビュー社, 2013.
 
8) Fukuda M, et al : Stereotaxy for hypothalamic hamartoma with intractable gelastic seizures : technical case report. Neurosurgery 44 : 1347-1350, 1999.
PubMed
9) Homma J, et al : Stereotactic radiofrequency thermocoagulation for hypothalamic hamartoma with intractable gelastic seizures. Epilepsy Res 76 : 15-21, 2007.
PubMed
10) Kameyama S, et al : Ictogenesis and symptomatogenesis of gelastic seizures in hypothalamic hamartomas : an ictal SPECT study. Epilepsia 51 : 2270-2279, 2010.
PubMed
11) Nurbhai MA, et al : Infantile hypothalamic hamartoma with multiple congenital abnormalities. Neuropathol A Neurobiol 11 : 61-70, 1985.
PubMed
12) Brandberg G, et al : Hypothalamic hamartoma with gelastic seizures in Swedish children and adolescents. Eur J Paediatr Neurol 8 : 35-44, 2004.
PubMed
13) 亀山茂樹 : 視床下部過誤腫. Annual Review神経2014 (鈴木則宏ほか編), p 167-172, 中外医学社, 2014.
 
14) 亀山茂樹 : 笑い発作. てんかん研究 31 : 86-73, 2013.
 
15) Delande O, et al : Successful surgical relief of seizures associated with hamartoma of the floor of the fourth ventricle in children : report of two cases. Neurosurgery 49 : 726-730, 2001.
PubMed
P.412 掲載の参考文献
1) Daumas-Duport C, et al : Dysembryoplastic neuroepithelial tumor : a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 23 : 545-556, 1988.
PubMed
2) 杉山一彦, 栗栖薫 : 神経細胞系および神経膠混合系腫瘍. 脳神経外科大系 脳腫瘍 I (山浦晶編), p 373-398, 中山書店, 2004.
 
3) Daumas-Duport C, et al : Dysembryoplastic neuroepithelial tumour. In : WHO Classification of Tumours of the Central Nervous System, 4th ed (ed by Louis DN, et al), p 99-102, IARC Press, Lyon, 2007.
 
4) Chassoux F, Daumas-Duport C : Dysembryoplastic neuroepithelial tumors : Where are we now? Epilepsia 54 (Suppl 9) : 129-134, 2013.
 
5) Chassoux F, et al : Dysembryoplastic neuroepithelial tumors : an MRI-based schema for epilepsy surgery. Neurology 79 : 1699-1707, 2012.
 
6) Luyken C, et al : The spectrum of long-term epilepsy-associated tumors : Long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44 : 822-830, 2003.
PubMed
7) Sharma MC, et al : Dysembryoplastic neuroepithelial tumor : a clinicopathological study of 32 cases. Neurosurg Rev 32 : 161-169, 2009.
PubMed
8) Giulioni M, et al : Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications. J Neurosurg 119 : 37-47, 2013.
PubMed
9) Degen R, et al : Various findings in surgically treated epilepsy patients with dysembryoplastic neuroepithelial tumors in comparison with those of patients with other low-grade brain tumors and other neuronal migration disorders. Epilepsia 43 : 1379-1384, 2002.
PubMed
10) Nolan MA, et al : Dysembryoplastic neuroepithelial tumors in childhood. Neurology 62 : 2270-2276, 2004.
PubMed
11) Campos AR, et al : Simple and complex dysembryoplastic neuroepithelial tumors (DNT) variants : clinical profile, MRI, and histopathology. Neuroradiology 51 : 433-443, 2009.
PubMed
12) Chang EF, et al : Seizure control outcome after resection of dysembryoplastic neuroepithelial tumor in 50 patients. J Neurosurg Pediatr 5 : 123-130, 2010.
PubMed
13) Kagawa K, et al : Electrocorticographic-histopathologic correlations implying epileptogenicity of dysembryoplastic neuroepithelial tumor. Neurol Med Chir 53 : 676-687, 2013.
PubMed
14) Bulakbasi N, et al : Dysembryoplastic neuroepithelial tumors : proton MR spectroscopy, diffusion and perfusion characteristics. Neuroradiology 49 : 805-812, 2007.
PubMed
15) Rheims S, et al : Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [11C] methionine PET. Neuro Oncol 16 : 1417-1426, 2014.
PubMed
P.416 掲載の参考文献
1) 近藤孝之, 池田昭夫 : てんかんの遺伝子と病態生理. Mebio 29 (11) : 18-23, 2012.
Medical*Online
2) Ottmann R : Autosomal dominant partial epilepsy with auditory features. In : Gene Reviews (ed by Pagon RA, et al), University of Washington, Washington, 1993-2014.
 
3) Michelucci R, et al : Lateral temporal lobe epilepsies : clinical and genetic features. Epilepsia 50 (Suppl 5) : 52-54, 2009.
 
4) Kawamata J, et al : Mutations in LGI1 gene in Japanese families with autosomal dominant lateral temporal lobe epilepsy : the first report from Asian families. Epilepsia 51 : 690-693, 2009.
PubMed
5) Ottoman R, et al : LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 62 : 1120-1126, 2004.
 
6) Michelucchi R, et al : Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. Epilepsia 54 : 1288-1297, 2013.
 
7) Kalachikov S, et al : Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30 : 335-341, 2002.
PubMed
8) Lancaster E, et al : Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77 : 179-189, 2011.
PubMed
9) Striano P, et al : Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 76 : 1173-1176, 2011.
PubMed
10) Fukata Y, et al : Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA 107 : 3799-3804, 2010.
PubMed
11) Baulac S, et al : A rat model for LGI1-related epilepsies. Hum Mol Genet 21 : 3546-3557, 2012.
PubMed
12) Michelucci R, et al : Autosomal dominant lateral temporal epilepsy : clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia 44 : 1289-1297, 2003.
PubMed
13) Poza JJ, et al : Autosomal dominant lateral temporal epilepsy : clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann Neurol 45 : 182-188, 1999.
PubMed
14) Crompton D, et al : Familial mesial temporal lobe epilepsy : a benign epilepsy syndrome showing complex inheritance. Brain 133 : 3221-3231, 2010.
PubMed
15) Morita ME, et al : MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy. Neurology 79 : 2349-2354, 2012.
PubMed
P.422 掲載の参考文献
1) Scheffer IE, et al : Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder. Lancet 343 : 515-517, 1994.
PubMed
2) Steinlein OK, et al : Mutations in familial nocturnal frontal lobe epilepsy might be associated with distinct neurological phenotypes. Seizure 21 : 118-123, 2012.
PubMed
3) Steinlein OK, et al : A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11 : 201-203, 1995.
PubMed
4) Hirose S, et al : A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 53 : 1749-1753, 1999.
PubMed
5) Phillips HA, et al : CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 68 : 225-231, 2001.
PubMed
6) Aridon P, et al : Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 79 : 342-350, 2006.
PubMed
7) Kurahashi H, et al : Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology 73 : 1214-1217, 2009.
PubMed
8) Heron SE, et al : Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 44 : 1188-1190, 2012.
PubMed
9) Dibbens LM, et al : Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 45 : 546-551, 2013.
PubMed
10) Ishida S, et al : Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 45 : 552-555, 2013.
PubMed
11) Picard F, et al : DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology 82 : 2101-2106, 2014.
PubMed
12) Bertrand D, et al : The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol Dis 20 : 799-804, 2005.
PubMed
13) Barcia G, et al : De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet 44 : 1255-1259, 2012.
PubMed
14) Provini F, et al : Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases. Brain 122 : 1017-1031, 1999.
PubMed
15) Milligan CJ, et al : KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Ann Neurol 75 : 581-590, 2014.
PubMed
P.425 掲載の参考文献
1) Scheffer IE, et al : Familial partial epilepsy with variable foc : i a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol 44 : 890-899, 1998.
 
2) Xiong L, et al : Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 65 : 1698-1710, 1999.
PubMed
3) Callenbach PM, et al : Familial partial epilepsy with variable foci in a Dutch family : clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia 44 : 1298-1305, 2003.
 
4) Berkovic SF, et al : Familial partial epilepsy with variable foc : i clinical features and linkage to chromosome 22q12. Epilepsia 45 : 1054-1060, 2004.
 
5) Baulac S, Baulac M : Advances on the genetics of Mendelian idiopathic epilepsies. Clin Lab Med 30 : 911-929, 2010.
PubMed
6) Heron SE, et al : Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 44 : 1188-1190, 2012.
PubMed
7) Kalachikov S, et al : Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30 : 335-341, 2002.
PubMed
8) Klein KM, et al : Familial focal epilepsy with variable foci mapped to chromosome 22q12 : expansion of the phenotypic spectrum. Epilepsia 53 : e151-155, 2012.
PubMed
9) Dibbens LM, et al : Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 45 : 546-551, 2013.
PubMed
10) Ishida S, et al : Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 45 : 552-555, 2013.
PubMed
11) Lal D, et al : DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol 75 (5) : 788-792, 2014.
PubMed
12) Scheffer IE, et al : Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 75 (5) : 782-787, 2014.
PubMed
13) Bar-Peled L, et al : A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340 : 1100-1106, 2013.
PubMed
14) Martin C, et al : A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population. Clin Genet 2013 Nov 1. doi : 10.1111/cge.12311. [Epub ahead of print]
 
P.429 掲載の参考文献
1) Gastaut H, et al : H.H.E. syndrome : hemiconvulsions, hemiplegia, epilepsy. Epilepsia 1-5 : 418-447, 1959.
 
2) 浜野晋一郎 : 片側けいれん・片麻痺・てんかん (HHE) 症候群. 稀少難治てんかん診療マニュアル (大槻泰介ほか編), p 47-50, 診断と治療社, 2013.
 
3) Berg AT, et al : Revised terminology and concepts for organization of seizures and epilepsies : report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 51 : 676-685, 2010.
PubMed
4) Chauvel P, Dravet C : The HHE syndrome. In : Epileptic Syndromes in Infancy, Childhood and Adolescence, 4th ed (ed by Roger J, et al), p 277-293, John Libbey Eurotext, Montrouge, 2005.
 
5) Auvin S, et al : Hemiconvulsion-hemiplegia-epilepsy syndrome : current understandings. Eur J Paediatr Neurol 16 : 413-421, 2012.
PubMed
6) Aicardi J, Chevrie JJ : Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia 11 : 187-197, 1970.
PubMed
7) Kataoka K, et al : Cranial computed tomographic and electroencephalographic abnormalities in children with post-hemiconvulsive hemiplegia. Eur Neurol 28 : 279-284, 1988.
PubMed
8) 田中佳子ほか : 急性小児片麻痺における脳血流シンチグラフィーの経時的変化について. 脳と発達 26 : 68-67, 1994.
 
P.432 掲載の参考文献
1) Battaglia A : 1p36 deletion syndrome. In : GeneReviews (ed by Pagon RA, et al), University of Washington, Seattle, 1993-2014.
 
2) 佐藤康仁 : 1p36欠失症候群の疫学. 厚生労働省科学研究費補助金 難治性疾患克服研究事業1p36欠失症候群の実態把握と合併症診療ガイドライン作成 平成24年度研究報告書, p 27-29, 2013.
 
3) 島田姿野 : 表現型と遺伝子型の関連 (genotype-phenotype). 1p36欠失症候群ハンドブック (山本俊至編), p 60-67, 診断と治療社, 2012.
 
4) Shimada S, et al : Mild developmental delay and obesity in two patients with mosaic 1p36 deletion syndrome. Am J Med Genet A 164A : 415-420, 2014.
PubMed
5) Saito Y, et al : Polymicrogyria and infantile spasms in a patient with 1p36 deletion syndrome. Brain Dev 33 : 437-441, 2011.
 
6) Saito S, et al : Bilateral perisylvian polymicrogyria, periventricular nodular heterotopia, and left ventricular noncompaction in a girl with 10.5-11.1 Mb terminal deletion of 1p36. Am J Med Genet A 146A : 2891-2897, 2008.
 
7) Shiba N, et al : Neuropathology of brain and spinal malformations in a case of monosomy 1p36. Acta Neuropathol Commun 1 (1) : 45, 2013.
 
8) Heilstedt HA, et al : Loss of the potassium channel β-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome. Epilepsia 42 : 1103-1111, 2001.
 
9) 松尾真理 : 合併症と検査. 1p36欠失症候群ハンドブック (山本俊至編), p 51-59, 診断と治療社, 2012.
 
10) Battaglia A, et al : Further delineation of deletion 1p36 syndrome in 60 patients : a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 121 : 404-410, 2008.
PubMed
11) 前垣義弘 : てんかんの特徴と治療. 1p36欠失症候群ハンドブック (山本俊至編), p 68-72, 診断と治療社, 2012.
 
12) Bahi-Buisson N, et al : Spectrum of epilepsy in terminal 1p36 deletion syndrome. Epilepsia 49 : 509-515, 2008.
PubMed
13) Kurosawa K, et al : Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome. Brain Dev 27 : 378-382, 2005.
PubMed
P.435 掲載の参考文献
1) Battaglia A, et al : Wolf-Hirschhorn (4p-) syndrome. Adv Pediatr 48 : 75-113, 2001.
PubMed
2) Battaglia A, Carey JC : Seizure and EEG patterns in Wolf-Hirschhorn (4p-) syndrome. Brain Dev 27 (5) : 362-364, 2005.
PubMed
3) Battaglia A, et al : Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome : experience with 87 patients and recommendations for routine health supervision. Am J Med Genet C Semin Med Genet 148C (4) : 246-251, 2008.
PubMed
4) Fisch GS, et al : Cognitive-behavioral features of Wolf-Hirschhorn syndrome and other subtelomeric microdeletions. Am J Med Genet C Semin Med Genet 154 C (4) : 417-426, 2010.
 
5) Sifakis S, et al : Prenatal diagnosis of Wolf-Hirschhorn syndrome confirmed by comparative genomic hybridization array : report of two cases and review of the literature. Mol Cytogene 5 : 12, 2012.
 
6) Andrew D, et al : The etiology of Wolf-Hirschhorn syndrome. Trends Genet 21 (3) : 188-195, 2005.
 
P.439 掲載の参考文献
1) Williams CA, et al : Angelman syndrome : consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet 56 : 237-238, 1995.
PubMed
2) Clayton-Smith J, Pembrey ME : Angelman syndrome. J Med Genet 29 : 412-415, 1992
PubMed
3) Horsthemke B, Wagstaff J : Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet A 146A : 2041-2052, 2008.
PubMed
4) Lossie AC, et al : Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38 : 834-845, 2001.
PubMed
5) Kishino T, et al : UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 15 : 70-73, 1997.
PubMed
6) Brown WM, Consedine NS : Just how happy is the happy puppet? An emotion signaling and kinship theory perspective on the behavioral phenotype of children with Angelman syndrome. Med Hypotheses 63 : 377-385, 2004.
PubMed
7) Tan WH, et al : If not Angelman, what is it? A review of Angelman-like syndromes. Am J Med Genet A 164A : 975-992, 2014.
 
8) Dan B : Angelman syndrome : current understanding and research prospects. Epilepsia 50 : 2331-2339, 2009.
 
9) Riday TT, et al : Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest 122 : 4544-4554, 2012.
 
10) Egawa K, et al : Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med 4 : 157-163, 2012.
 
11) Huang HS, et al : Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481 : 185-189, 2011.
PubMed
P.443 掲載の参考文献
1) Rethore MO, et al : Ring chromosome 14. II. A case report of r (14) mosaicism. The r (14) : phenotype. Ann Genet 27 : 91-95, 1984.
 
2) De Blois MC, et al : r14 syndrome without major dysmorphism. Ann Genet 33 : 155-158, 1990.
PubMed
3) Schiade BK, et al : FISH mapping of telomeric 14q32 deletions : search for the cause of seizures. Am J Med Genet 138A : 218-224, 2005.
 
4) Frenny JS, Nilang S : Ring chromosome 14 with epilepsy and developmental delay. Indian Pedi atr 43 : 744-745, 2006.
 
5) Morimoto M, et al : Ring chromosome 14 with localization-related epilepsy : three cases. Epilepsia 44 : 1245-1249, 2003.
PubMed
6) Ville D, et al : Ring 14 chromosome presenting as early-onset isolated partial epilepsy. Dev Med Child Neurol 51 : 917-922, 2009.
PubMed
7) Imataka G, et al : Partial epilepsy and developmental delay in infant with ring chromosome 14. Genet Couns 24 : 81-83, 2013.
PubMed
8) Riley SB, et al : Inheritance of ring 14 chromosome. J Med Genet 18 : 209-213, 1981.
PubMed
9) Matalon R, et al : Transmission of ring 14 chromosome from mother to two sons. Am J Med Genet 36 : 381-385, 1990.
PubMed
10) 松尾真理ほか : 染色体異常とてんかん. 日小児会誌 110 : 1183-1192, 2006.
 
11) Ottman R, et al : Genetic testing in the epilepsies-report of the ILAE Genetics Commission. Epilepsia 51 : 655-670 , 2010.
PubMed
P.448 掲載の参考文献
1) Borgaonkar DS, et al : Usefulness of chromosome catalog in delineating new syndromes. Birth Defects Orig Artic Ser 12 : 87-95, 1976.
PubMed
2) Inoue Y, et al : Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 120 : 939-953, 1997.
PubMed
3) 井上有史 : 環状20番染色体. 専門医のための精神科臨床リュミエール14 精神科領域におけるけいれん・けいれん様運動, p 89-92, 中山書店, 2009.
 
4) Takahashi Y, et al : Non photosensitive video game induced partial seizures. Epilepsia 36 : 837-841, 1995.
 
5) Augustijn PB, et al : Ring chromosome 20 epilepsy syndrome in children : electroclinical features. Neurology 57 : 1108-1111, 2001.
PubMed
6) Zou YS, et al : Mosaic ring 20 with no detectable deletion by FISH analysis : Characteristic seizure disorder and literature review. Am J Med Genet A 140 : 1696-1706, 2006.
PubMed
7) Ville D, et al : Early pattern of epilepsy in the ring chromosome 20 syndrome. Acta Neurol Scand 111 : 205-208, 2005.
 
8) Conlin LK, et al : Molecular analysis of chromosome ring 20 syndrome. Molecular analysis of ring chromosome 20 syndrome reveals two distinct groups of patients. J Med Genet 48 : 1-9, 2011.
PubMed
9) Biraben A, et al : PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. Neurology 63 : 73-77, 2004.
PubMed
10) Del Sole A, et al : Exploring dopaminergic activity in ring chromosome 20 syndrome : a SPECT study. Q J Nucl Med Mol Imaging 54 : 564-569, 2010.
PubMed
11) Chawla J, et al : Intractable epilepsy with ring chromosome 20 syndrome treated with vagal nerve stimulation : case report and review of the literature. J Child Neurol 17 : 778-780, 2002.
PubMed
12) Parr JR, et al : Epilepsy responds to vagus nerve stimulation in ring chromosome 20 syndrome. Dev Med Child Neurol 48 : 80 ; author reply 80, 2006.
PubMed
13) Hirano Y, et al : Refractory and severe status epilepticus in a patient with ring chromosome 20 syndrome. 29th International Epilepsy Congress, p 401, 2011.
 
14) Jacobs J, et al : Refractory and lethal status epilepticus in a patient with ring chromosome 20 syndrome. Epileptic Disord 10 : 254-259, 2008.
 
P.452 掲載の参考文献
1) Summar K, Lee B : Down syndrome and other abnormalities of chromosome number. In : Nelson Textbook of Pediatrics, 19th ed (ed by Kliegman RM, et al), p 399-404, Elsevier Saunders, Philadelphia, 2011.
 
2) 大橋博文 : Down症候群. 小児内科 44 (増刊号 : 小児疾患の診断治療基準第4版) : 124-125, 2012.
 
3) Huether C, et al : Maternal age specific risk rate estimates for Down syndrome among live births in whites and other races from Ohio and metropolitan Atlanta, 1970-1989. J Med Genet 35 : 482-490, 1998.
PubMed
4) 梶井正 : わが国の高齢出産とDown症候群増加傾向の分析. 日小児会誌 111 : 1426-1482, 2007.
 
5) Park J, et al : Two key genes closely implicated with the neuropathological characteristics in Down syndrome : DYRK1A and RCAN1. BMB Rep 42 : 6-15, 2009.
PubMed
6) Bull MJ : Health supervision for children with Down syndrome. Pediatrics 128 : 393-406, 2011.
PubMed
7) 清水健司 : Down症候群の健康管理とフォローアップ, 集団外来の役割. 小児科診療 76 : 1105-1110, 2013.
Medical*Online
8) Roizen NJ, et al : A community cross-sectional survey of medical problems in 440 children with Down syndrome. J Pediatr 164 : 871-875, 2014.
PubMed
9) Goldberg-Stern H, et al : Seizure frequency and characteristics in children with Down syndrome. Brain Dev 23 : 375-378, 2001.
PubMed
10) Pueschel SM, et al : Seizure disorders in Down syndrome. Arch Neurol 48 : 318-320, 1991.
PubMed
11) Verrotti A, et al : Electroclinical features and long-term outcome of cryptogenic epilepsy in children with Down syndrome. J Pediatr 163 : 1754-1758, 2013.
PubMed
12) Lott IT, et al : Down syndrome and dementia : seizures and cognitive decline. J Alzheimers Dis 29 : 177-185, 2012.
PubMed
13) Silva ML, et al : Early clinical and EEG features of infantile spasms in Down syndrome. Epilepsia 37 : 977-982, 1996.
PubMed
14) Eisermann MM, et al : Infantile spasms in Down syndrome-effects of delayed anticonvulsive treatment. Epilepsy Res 55 : 21-27, 2003.
PubMed
15) Ferlazzo E, et al : Lennox-Gastaut syndrome with late-onset and prominent reflex seizures in trisomy 21 patients. Epilepsia 50 : 1587-1595, 2009.
PubMed
P.457 掲載の参考文献
1) Rett A : On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116 : 723-726, 196 [6PubMed : 5300597].
 
2) Hagberg B, et al : A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls : Rett's syndrome : report of 35 cases. Ann Neurol 14 : 471-479, 1983.
 
3) Nuel JF, et al : Rett syndrome : Revised diagnostic criteria and nomenclature. Ann Neurol 68 : 944-950, 2010.
 
4) 松石豊次郎 : レット症候群研究の現況と展望. 日本臨牀 71 (11) : 2043-2053, 2013.
Medical*Online
5) Jian L, et al : Predictors of seizure onset in Rett syndrome. J Pediatr 149 : 542-547, 2006.
PubMed
6) Pintaudi M, et al : Epilepsy in Rett syndrome : Clinical and genetic features. Epilepsy Behav 19 : 296-300, 2010.
 
7) Cardoza B, et al : Epilepsy in Rett syndrome : association between phenotype and genotype, and implications for practice. Seizure 20 : 646-649, 2011.
PubMed
8) Guerrini R, Parrini E : Epilepsy in Rett syndrome, and CDKL5-and FOXG1-gene-related encephalopathies. Epilepsia 53 : 2067-2078, 2012.
PubMed
9) Dolce A, et al : Rett syndrome and epilepsy : an update for child neurologists. Pediatr Neurol 48 : 337-345, 2013.
PubMed
10) d'Orsi G, et al : Epileptic seizures, movement disorders, and breathing disturbances in Rett syndrome : Diagnostic relevance of video-polygraphy. Epilepsy Behav 25 : 401-407, 2012.
PubMed
11) 伊藤雅之ほか : レット症候群の全国疫学調査, p 13-14, 厚生労働科学研究費補助金 難治性疾患克服研究事業 レット症候群の診断と予防・治療法確立のための臨床および生物科学の集学的研究 (H22-難治-一般-133) 平成22総括・分担研究報告書, p 5-20, 2012.
 
12) Amir RE, et al : Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23 : 185-188, 1999.
 
13) Nomura Y, Segawa M : 8 The monoamine hypothesis in Rett syndrome. In : Rett Disorder and the Developing Brained (by Kerr A, Engerstrom W), p 205-225, Oxford University Press, Oxford, 2005.
 
14) Samaco RC, et al : Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci USA 106 : 21966-21971, 2009.
PubMed
15) Specchio N, et al : Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome. Epilepsy Res 88 : 112-117, 2010.
PubMed
P.463 掲載の参考文献
1) 難波栄二 : 脆弱X症候群. 小児内科 44 (増刊号) : 136-137, 2012.
 
2) Hagerman R, Hagerman P : Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 12 : 786-798, 2013.
PubMed
3) Hunter J, et al : Epidemiology of fragile X syndrome : A systematic review and meta-analysis. Am J Med Genet A 164 : 1648-1658, 2014.
 
4) 難波栄二 (研究代表者) : 日本人脆弱X症候群の実態調査 平成21年度総括・分担研究報告書, 2010.
 
5) 難波栄二 (研究代表者) : 日本人脆弱X症候群および関連疾患の診断・治療推進の研究 平成22～23年度総合研究報告書, 2012.
 
6) Nolin SL, et al : Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 161A : 771-778, 2013.
PubMed
7) Gerhardt J, et al : The DNA replication program is altered at the FMR1 locus in fragile X embryonic stem cells. Mol Cell 9 : 19-31, 2014.
 
8) 難波栄二 : 脆弱X症候群の分子機構と治療. 医学のあゆみ 239 : 633-638, 2011.
Medical*Online
9) Udagawa T, et al : Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat Med 19 : 1473-1477, 2012.
 
10) Bagni C, et al : Fragile X syndrome : causes, diagnosis, mechanisms, and therapeutics. J Clin Invest 122 : 4314-4322, 2012.
PubMed
11) Osterweil EK, et al : Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. Neuron 77 : 243-250, 2013.
 
12) Xu D, et al : Top3β is an RNA topoisomerase that works with fragile X syndrome protein to promote synapse formation. Nat Neurosci 16 : 1238-1247, 2013.
 
P.467 掲載の参考文献
1) Klepper J : GLUT1 deficiency syndrome in clinical practice. Epilepsy Res 100 : 272-277, 2012.
PubMed
2) Klepper J, Leiendecker B : GLUT1 deficiency syndrome-2007 update. Dev Med Child Neurol 49 : 707-716, 2007.
PubMed
3) Leen WG, et al : Glucose transporter 1 deficiency syndrome : the expanding clinical and genetic spectrum of a treatable disorder. Brain 133 : 655-670, 2010.
PubMed
4) 小国弘量 : グルコーストランスポーター1欠損症症候群の実態と診断治療指針に関する研究. 厚生労働科学研究費補助金 (難治性疾患克服研究事業) グルコーストランスポーター1欠損症症候群の実態と診断治療指針に関する研究. 平成23年度総括・分担研究報告書, p 1-7, 2012.
 
5) Klepper J, Leiendecker B : Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol 28 : 1045-1048, 2013.
PubMed
6) Ito Y, et al : A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 53 : 658-663, 2011.
 
7) Hildebrand MS, et al : Glucose metabolism transporters and epilepsy : only GLUT1 has an established role. Epilepsia 55 : e18-21, 2014.
PubMed
8) 伊藤康ほか : 家族性グルコーストランスポーター 1欠損症症候群. 女医大誌 83 (臨増) : 9-13, 2013.
 
9) Wang D, et al : Glut-1 deficiency syndrome : clinical, genetic, and therapeutic aspects. Ann Neurol 57 : 111-118, 2005.
PubMed
10) 伊藤康, 小国弘量 : ここまで治せるようになった先天代謝異常症. グルコーストランスポーター1欠損症症候群. 小児内科 44 : 1682-1686, 2012.
 
11) Leen WG, et al : GLUT1 deficiency syndrome into adulthood : a follow-up study. J Neurol 261 : 589-599, 2014.
PubMed
12) Tzadok M, et al : The many faces of glut1 deficiency syndrome. J Child Neurol 29 : 349-359, 2014.
PubMed
P.471 掲載の参考文献
1) Juberg RC, Hellman CD : A new familial form of convulsive disorder and mental retardation limited to females. J Pediatr 79 : 726-732, 1971.
PubMed
2) Scheffer IE, et al : Epilepsy and mental retardation limited to females : an under-recognized disorder. Brain 131 : 918-927, 2008.
PubMed
3) Dibbens LM, et al : X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 40 : 776-781, 2008.
 
4) Depienne C, et al : Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet 5 : e1000381, 2009.
PubMed
5) Higurashi N, et al : PCDH19 mutation in Japanese females with epilepsy. Epilepsy Res 99 : 28-37, 2012.
PubMed
6) Marini C, et al : Protocadherin 19 mutations in girls with infantile-onset epilepsy. Neurology 75 : 646-653, 2010.
 
7) 日暮憲道, 廣瀬伸一 : 総説 女性に限定されるてんかんと精神遅滞-本邦患者の特徴とPCDH19遺伝子解析を考慮するポイント. 日小児会誌 115 : 1513-1523, 2011.
 
8) Higurashi N, et al : PCDH19-related female-limited epilepsy : further details regarding early clinical features and therapeutic efficacy. Epilepsy Res 106 : 191-199, 2013.
PubMed
9) Depienne C, et al : Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Hum Mutat 32 : E1959-1975, 2011.
PubMed
10) Marini C, et al : Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy. Epilepsia 53 : 2111-2119, 2012.
 
11) Specchio N, et al : Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations. Epilepsia 52 : 1251-1257, 2011.
 
12) Carvill GL, et al : Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 45 : 825-830, 2013.
PubMed
13) Redies C, et al : Delta-Protocadherins : unique structures and functions. Cell Mol Life Sci 62 : 2840-2852, 2005.
PubMed
14) Gaitan Y, Bouchard M : Expression of the delta-protocadherin gene Pcdh19 in the developing mouse embryo. Gene Expr Patterns 6 : 893-899, 2006.
PubMed
15) 日暮憲道ほか : Dravet症候群. 子どものけいれん・てんかん-見つけ方・見分け方から治療戦略へ (奥村彰久, 浜野晋一郎編), p 171-175, 中山書店, 2013.
 
P.474 掲載の参考文献
1) Gloyn AL, et al : Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350 : 1838-1849, 2004.
PubMed
2) Hattersley AT, Ashcroft FM : Activating mutations in Kir6.2 and neonatal diabetes : new clinical syndromes, new scientific insights, and new therapy. Diabetes 54 : 2503-2513, 2005.
PubMed
3) 鈴木滋ほか : 【小児疾患診療のための病態生理】 代謝栄養性疾患 新生児糖尿病. 小児内科 41 : 522-527, 2009.
 
4) Proks P, et al : A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet 15 : 1793-1800, 2006.
PubMed
5) Ashcroft FM : ATP-sensitive potassium channelopathies : focus on insulin secretion. J Clin Invest 115 : 2047-2058, 2005.
PubMed
6) Proks P, et al : A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 6 : 470-475, 2005.
PubMed
7) Proks P, et al : Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 101 : 17539-17544, 2004.
PubMed
8) Sellick GS, et al : Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 36 : 1301-1305, 2004.
PubMed
9) Senee V, et al : Wolcott-Rallison syndrome : clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 53 : 1876-1883, 2004.
PubMed
10) Pearson ER, et al : Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355 : 467-477, 2006.
PubMed
11) Rafiq M, et al : Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31 : 204-209, 2008.
PubMed
12) Koster JC, et al : The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy. J Clin Endocrinol Metab 93 : 1054-1061, 2008.
PubMed
13) Shimomura K, et al : A novel mutation causing DEND syndrome : a treatable channelopathy of pancreas and brain. Neurology 69 : 1342-1349, 2007.
PubMed
14) Mlynarski W, et al : Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat Clin Pract Neurol 3 : 640-645, 2007.
 
15) Bahi-Buisson N, et al : Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2. J Child Neurol 22 : 1147-1150, 2007.
PubMed
P.478 掲載の参考文献
1) Childhood absence epilepsy (Pyknolepsy). てんかん学用語事典 (日本てんかん学会用語事典編集委員会編), p 29-30, 日本てんかん学会, 2006.
 
2) Engel J : A proposed diagnostic scheme for people with epileptic seizures and with epilepsy : report of ILAE task force on classification and terminology. Epilepsia 42 : 796-803, 2001.
 
3) Titomanlio L, et al : Familial occurrence of early-onset childhood absence epilepsy. Eur J Paediatr Neurol 11 : 178-180, 2007.
PubMed
4) Audenaert D, et al : A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology 61 : 854-856, 2003.
PubMed
5) Shahar E, et al : Typical absence epilepsy presenting prior to age of 3 years : an uncommon form of idiopathic generalized epilepsy. Eur J Paediatr Neurol 11 : 346-352, 2007.
PubMed
6) Farooque P, et al : Early-onset childhood absence epilepsy : is it a distinct entity? Epileptic Disord 13 (4) : 411-416, 2011.
PubMed
7) Caraballo RH, et al : Absence seizures in the first 3 years of life : an electroclinical study of 46 cases. Epilepsia 52 : 393-400, 2011.
PubMed
8) Chaix I, et al : Absence epilepsy with onset before age three years : a heterogeneous and often severe condition. Epilepsia 44 : 944-949, 2003.
 
9) Verrotti A, et al : Early-onset pure absence epilepsy : a distinct epileptic syndrome. Acta Paediatr 100 (5) : 647-650, 2011.
PubMed
10) Verrotti A, et al : Early-onset versus typical childhood absence epilepsy : Are they all the same thing? Seizure 21 : 409, 2012.
PubMed
11) Suls A, et al : Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 66 : 415-419, 2009.
PubMed
12) Agostinelli S, et al : Clinical dissection of early onset absence epilepsy in children and prognostic implications. Epilepsia 54 (10) : 1761-1770, 2013.
PubMed
13) Panayiotopoulos CP : Typical absence seizures and related epileptic syndromes : assessment of current state and directions for future research. Epilepsia 49 : 2131-2139, 2008.
PubMed
14) Pavone P, et al : Neuropsychological assessment in children with absence epilepsy. Neurology 56 : 1047-1051, 2001.
PubMed
15) Fernandez-Torre JL, et al : Early onset absence epilepsy : clinical features in three children. Brain Dev 28 : 311-314, 2006.
PubMed
P.482 掲載の参考文献
1) Sweney MT, et al : Alternating hemiplegia of childhood : early characteristics and evolution of a neurodevelopmental syndrome. Pediatrics 123 : e534-e541, 2009.
PubMed
2) Sasaki M, et al : Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology 82 : 482-490, 2014.
PubMed
3) Saito Y, et al : A case of alternating hemiplegia of childhood with cerebellar atrophy. Pediatr Neurol 19 : 65-68, 1998.
 
4) Saito Y, et al : Evolution of hemiplegic attacks and epileptic seizures in alternating hemiplegia of childhood. Epilepsy Res 90 : 248-258, 2010.
PubMed
5) Bassi MT, et al : A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood. J Med Genet 41 : 621-628, 2004.
PubMed
6) Heinzen EL, et al : De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 44 : 1030-1034, 2012.
PubMed
7) Rosewich H, et al : Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood : a whole-exome sequencing gene-identification study. Lancet Neurol 11 : 764-773, 2012.
PubMed
8) Ishii A, et al : Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients. PLoS One 8 : e56120, 2013.
PubMed
9) van den Maagdenberg AM, et al : A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41 : 701-710, 2004.
PubMed
10) Demos MK, et al : A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis 9 : 15, 2014.
PubMed
11) Kirshenbaum GS, et al : Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+, K+ -ATPaseα3 missense mutant mice. PLoS One 8 : e60141, 2013.
 
12) Sasaki M, et al : Intermediate form between alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism. Mov Disord 29 : 153-154, 2014.
PubMed
13) Kon K, et al : Otoacoustic emission in patients with neurological disorders who have auditory brainstem response abnormality. Brain Dev 22 : 327-335, 2000.
PubMed
14) Inui T, et al : Profiles of blood biomarkers in alternating hemiplegia of childhood-increased MMP-9 and decreased substance P indicates its pathophysiology. Brain Dev 34 : 196-200, 2012.
PubMed
15) Rotstein M, et al : Glut1 deficiency and alternating hemiplegia of childhood. Neurology 73 : 2042-2044, 2009.
PubMed
P.487 掲載の参考文献
1) 花井敏男 : てんかんの子どもと学校生活. 教育と医学 58 : 768-775, 2010.
 
2) 花井敏男 : こどものてんかん 発作時の対応や生活指導. 月刊「波」 30 : 278-280, 2006.
 
3) 木村育美, 小寺久仁子 : てんかんへの社会的支援. 小児てんかんの最新医療 (岡明編), p 262-265, 中山書店, 2008.
 
P.491 掲載の参考文献
1) Gilliam F, et al : Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38 : 233-236, 1997.
PubMed
2) Taylor DC, et al : Patients' aim for epilepsy surgery : desires beyond seizure freedom. Epilepsia 42 : 629-633, 2001.
PubMed
3) ジョージJ. ゴルディンほか : てんかんの心理社会的側面. てんかんリハビリテーション (ジョージN. ライト (編), 国立武蔵療養所てんかん研究会 (訳), 秋元波留夫 (監修)), p 79-96, 創造出版, 1980.
 
4) 青柳智夫 : この調査を活動の力に! 会員実状調査報告- (5). 月刊波 27 : 62-63, 2003.
 
5) 総務省統計局 : 6-2職業別就業者数. 政府統計の窓口 > 労働力調査 > 基本集計 > 長期時系列データ. [http://www.e-stat.go.jp/SG1/estat/List.do?bid=000000110009&cycode=0]
 
6) Majkowska-Zwolin'ska B, et al : Employment in people with epilepsy from the perspectives of patients, neurologists, and the general population. Epilepsy Behav 25 : 489-494, 2012.
 
7) Jacoby A, et al : Uptake and costs of care for epilepsy : findings from a U.K. regional study. Epilepsia 39 : 776-786, 1998.
 
8) Collings JA : International differences in psychosocial well-being : a comparative study of adults with epilepsy in three countries. Seizure 3 : 183-190, 1994.
PubMed
9) 第3部地域で生活するために. てんかんとともに働き暮らすために (「てんかんのある障害者の生活支援体制を構築するための事業」企画委員会編), p 65-93, 日本てんかん協会, 2008.
 
10) Jacoby A : Impact of epilepsy on employment status : findings from a UK study of people with well-controlled epilepsy. Epilepsy Res 21 : 125-132, 1995.
PubMed
11) Jacoby A, et al : The clinical course of epilepsy and its psychosocial correlates : findings from a U.K. community study. Epilepsia 37 : 148-161, 1996.
 
12) Hicks RA, Hicks MJ : Attitudes of major employers toward the employment of people with epilepsy : a 30-year study. Epilepsia 32 : 86-88, 1991.
PubMed
13) 第1部自立していくためにどんな援助が求められているか. てんかんとともに働き暮らすために (「てんかんのある障害者の生活支援体制を構築するための事業」企画委員会編), p 7-44, 日本てんかん協会, 2008.
 
14) 相沢欽一ほか : 第2章 ハローワークにおける精神障害者に対する新規求職登録及び紹介就職等の実態調査 : 精神障害者の雇用促進のための就業状況等に関する調査研究, p 21-78, 高齢・障害・求職者雇用支援機構障害者職業総合センター, 2010. [http://www.nivr.jeed.or.jp/research/report/houkoku/houkoku95.html]
 
15) Smeets VM, et al : Epilepsy and employment : literature review. Epilepsy Behav 10 : 354-362, 2007.
PubMed
P.495 掲載の参考文献
1) Wada K, et al : Marital status of patients with epilepsy with special reference to the influence of epileptic seizures on the patient's married life. Epilepsia 45 (Suppl 8) : 33-36, 2004.
 
2) Otani K : Risk factors for the increased seizure frequency during pregnancy and puerperium. Folia Psychiat Neurol Jpn 39 : 33-41, 1985.
PubMed
3) Kaneko S : Pregnancy and quality of life in women with epilepsy. Clin Ther 20 (Suppl A) : 30-47, 1998.
 
4) Meador K, et al : Pregnancy outcomes in women with epilepsy : a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 81 : 1-13, 2008.
PubMed
5) Kaneko S, et al : Congenital malformations due to antiepileptic drugs. Epilepsy Res 33 : 145-158, 1999.
PubMed
6) Vajda FJ, et al : Foetal malformations and seizure control : 52 months data of the Australian Pregnancy Registry. Eur J Neurol 13 : 645-654, 2006.
PubMed
7) Vajda FJ, et al : The Australian Register of antiepileptic drugs in pregnancy : the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 47 : 468-474, 2007.
PubMed
8) EURAP Study Group : Seizure control and treatment in pregnancy : observations from the EURAP epilepsy pregnancy registry. Neurology 66 : 354-360, 2006.
 
9) Tomson T, et al : Dose-dependent risk of malformations with antiepileptic drugs : an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 10 : 609-617, 2011.
PubMed
10) Battino D, et al : Seizure control and treatment changes in pregnancy : observations from the EURAP epilepsy pregnancy registry. Epilepsia 54 : 1621-1627, 2013.
PubMed
11) 兼子直ほか : てんかんをもつ妊娠可能年齢の女性に対する治療ガイドライン. てんかん研究 25 : 27-31, 2007.
 
P.501 掲載の参考文献
1) 警察庁 : 一定の病気に係る免許の可否等の運用基準. 第1回一定の病気等に係る運転免許制度の在り方に関する有識者検討会参考資料, 2012. [http://www.npa.go.jp/koutsuu/menkyo4/siryo.pdf]
 
2) 田熊清継ほか : 内因性疾患による交通外傷の検討. 日救急医会誌 17 : 177-182, 2006.
 
3) 篠原一彰, 松本昭憲 : 運転中の急病発症. Prog Med 32 : 1601-1604, 2012.
Medical*Online
4) Takeda A, et al : Driving and epilepsy : a prospective questionnaire survey in Japan. Jpn J Psychiatry Neurol 45 : 19-32, 1991.
 
5) Advisory Board to the Driving Licence Committee of the European Union : Epilepsy and driving in Europe. Final Report, 2005.
 
6) 馬塲美年子ほか : てんかん発作による意識障害に起因した自動車事故例の検討-本邦判例からみた運転者の刑事責任と現行法上の問題点について. てんかん研究 31 : 8-18, 2013.
 
7) 日本てんかん学会法的問題検討委員会 : てんかんのある人における運転免許の現状と問題点. てんかん研究 30 : 60-67, 2012.
 
8) 日本てんかん学会の提言 (平成24年10月11日). [http://square.umin.ac.jp/jes/images/jes-image/driveteigen2.pdf]
 
9) Drazkowski JF, et al : Frequency of physician counseling and attitudes toward driving motor vehicles in people with epilepsy : comparing a mandatory-reporting with a voluntary-reporting state. Epilepsy Behav 19 : 52-54, 2010.
 
10) McLachlan RS, et al : Impact of mandatory physician reporting on accident risk in epilepsy. Epilepsia 48 (8) : 1500-1505, 2007.
PubMed
P.506 掲載の参考文献
1) Blumer D : Evidence supporting the temporal lobe epilepsy personality syndrome. Neurology 53 : S9-S12, 1999.
PubMed
2) Bear DM : Temporal lobe epilepsy-a syndrome of sensory-limbic hyperconnection. Cortex 15 : 357-384, 1979.
PubMed
3) Waxman SG, Geschwind N : The interictal behavior syndrome of temporal lobe epilepsy. Arc Gen Psychiatry 32 : 1580-1586, 1975.
 
4) Garyfallow G, et al : Psychopathology and personality characteristics of epileptic patients : epilepsy, psychopathology and personality. Acta Psychiatr Scand 78 : 87-95, 1988.
 
5) Dodrill CB, Batzel Lawrence W : Interictal behavioral features of patients with epilepsy. Epilepsia 27 : S64-S76, 1986.
 
6) Devinsky O, Najjar S : Evidence against the existence of a temporal lobe epilepsy personality syndrome. Neurology 53 : S13-S25, 1999.
PubMed
7) Tebartz van Elst L, et al : Affective aggression in patients with temporal lobe epilepsy. Brain 123 : 234-243, 2000.
 
8) Mula M, et al : Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 49 : 650-656, 2008.
PubMed
9) Foran A, et al : Specificity of psychopathology in temporal lobe epilepsy. Epilepsy Behav 27 : 193-199, 2013.
PubMed
10) Trimble M : Treatment issues for personality disorders in epilepsy. Epilepsia 54 (Suppl 1) : 41-45, 2013.
 
11) Filho GMA, et al : Personality traits in juvenile myoclonic epilepsy : evidence of cortical abnor malities from a surface morphometry study. Epilepsy Behav 27 : 385-392, 2013.
 
12) Wieser HG, et al : Unilateral limbic epileptic status activity, stereo EEG, behavioral, and cognitive data. Epilepsia 26 : 19-29, 1985.
 
13) Bear DM, Fedio P : Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arc Neurol 34 : 454-467, 1977.
 
14) 岩佐博人 : てんかんに併存する幻覚妄想状態. 精神科治療学 29 : 337-344, 2014.
 
15) Tebartz van Elst L : Aggression and epilepsy. In : The Neuropsychiatry of Epilepsy (ed by Trimble MR, Schmitz B), p 81-106, Cambridge University Press, Cambridge, 2002.
 
P.511 掲載の参考文献
1) Amiet C, et al : Epilepsy in autism is associated with intellectual disability and gender : evidence from a meta-analysis. Biol Psychiatry 64 : 577-582, 2008.
PubMed
2) Clarke DF, et al : The prevalence of autistic spectrum disorder in children surveyed in a tertiary care epilepsy clinic. Epilepsia 46 : 1970-1977, 2005.
 
3) Matsuo M, et al : Frequent association of autism spectrum disorder in patients with childhood onset epilepsy. Brain Dev 32 : 759-763, 2010.
PubMed
4) Hirtz D, et al : How common are the "common" neurologic disorders? Neurology 68 : 326-337, 2007.
PubMed
5) Brooks-Kayal A : Epilepsy and autism spectrum disorders : Are there common developmental mechanisms? Brain Dev 32 : 731-738, 2010.
PubMed
6) Chez MG, et al : Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 8 : 267-271, 2006.
 
7) Kawasaki Y, et al : Paroxysmal EEG abnormalities and epilepsy in pervasive developmental disorders : Follow-up study until adolescence and beyond. Brain Dev 32 : 769-775, 2010.
PubMed
8) Kleijer KTE, et al : Neurobiology of autism gene products : towards pathogenesis and drug targets. Psychopharmacology (Berl) 231 : 1037-1062, 2014.
PubMed
9) Zuberi SM, et al : Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 76 : 594-600, 2011.
PubMed
10) Saemundsen E, et al : Risk of autism spectrum disorders after infantile spasms : a population-based study nested in a cohort with seizures in a first year of life. Epilepsia 49 : 1865-1870, 2008.
 
11) Paciorkowski AR, et al : Copy number variants and infantile spasms : evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur J Hum Genet 19 : 1238-1245, 2011.
 
12) Hrdlicka M, et al : Not EEG abnormalities but epilepsy is associated with autistic regression and mental functioning in childhood autism. Eur Child Adolesc Psychiatry 13 : 209-213, 2004.
PubMed
13) Tuchman R, Rapin I : Regression in pervasive developmental disorders : seizures and epileptiform electroencephalogram correlates. Pediatrics 99 : 560-566, 1997.
PubMed
14) Tuchman RF : Autistic and dysphasic children. II : epilepsy. Pediatrics 88 : 1219-1225, 1991.
PubMed
15) Shinnar S, et al : Language regression in childhood. Pediatr Neurol 24 : 183-189, 2001.
PubMed
P.517 掲載の参考文献
1) 松浦雅人 : てんかんと認知機能障害. 臨床精神医学 42 : 1535-1541, 2013.
Medical*Online
2) Overvliet GM, et al : Nocturnal epileptiform EEG discharges, nocturnal epileptic seizures, and language impairments in children : review of the literature. Epilepsy Behav 19 : 550-558, 2010.
 
3) Holmes MD, et al : Is partial epilepsy progressive? Ten-year follow-up of EEG and neuropsychological changes in adults with partial seizures. Epilepsia 39 : 1189-1193, 1998.
PubMed
4) Arif H, et al : Patient-reported cognitive side effects of antiepileptic drugs : predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav 14 : 202-209, 2009.
PubMed
5) 松浦雅人 : てんかんとdefault-mode network. Epilepsy 8 : 15-21, 2014.
Medical*Online
P.521 掲載の参考文献
1) Muhammed L : A retrospective diagnosis of epilepsy in three historical figures : St Paul, Joan of Arc and Socrates. J Med Biogr 21 : 208-211, 2013.
 
2) てんかんとはなにか. てんかん治療ガイドライン2010 (日本神経学会監), p 1, 医学書院, 2010.
 
3) Kaplan PW : Nonconvulsive status epilepticus. Semin Neurol 16 : 33-40, 1996.
PubMed
4) Walker M, et al : Nonconvulsive status epilepticus : Epilepsy Research Foundation workshop reports. Epileptic Disord 7 : 253-296, 2005.
PubMed
5) 永山正雄 : 非痙攣性てんかん重積とは何ですか? 高次脳機能障害を呈するのですか? 高次脳機能障害Q&A基礎編 (河村満編), p 190-192, 新興医学出版社, 2011.
 
6) 石垣征一郎ほか : 高齢発症てんかんと認知症. Epilepsy 27 : 119-125, 2013.
 
7) 石垣征一郎ほか : てんかんと認知症. 日本臨牀 72 : 926-930, 2014.
Medical*Online
8) Butler CR, Zeman AZ : Recent insights into the impairment of memory in epilepsy : transient epileptic amnesia, accelerated long-term forgetting and remote memory impairment. Brain 131 : 2243-2263, 2008.
PubMed
9) 杉本あずさほか : てんかん性高次脳機能障害の検討. Brain Nerve 65 : 195-202, 2013.
 
10) Sugimoto A, et al : Successful use of anti-epileptic drugs in three cases of epilepsy with higher brain dysfunction. Neurol Clin Neurosci 1 : 18-23, 2013.
 
11) Rosenbaum DH, et al : Epileptic aphasia. Neurology 36 : 822-825, 1986.
PubMed
12) Benatar M : Ictal aphasia. Epilepsy Behav 3 : 413-419, 2002.
PubMed
13) Herskovitz M, Schiller Y : Prolonged ictal aphasia : a diagnosis to consider. J Clin Neurosci 19 : 1605-1606, 2012.
 
14) Chung PW, et al : Nonconvulsive status epilepticus presenting as a subacute progressive aphasia. Seizure 11 : 449-454, 2002.
PubMed
15) Luders H, et al : Basal temporal language area demonstrated by electrical stimulation. Neurology 36 : 505-510, 1986.
PubMed
P.524 掲載の参考文献
1) 兼本浩祐, 大島智弘 : てんかんと精神症状. 医学のあゆみ 232 (10) : 1086-1091, 2010.
Medical*Online
2) 松浦雅人 : 慢性てんかん性精神病. 精神科治療学 18 (2) : 135-139, 2003.
 
3) 兼本浩祐ほか : てんかんに関連する精神障害の治療法. Modern Physician 32 (3) : 337-340, 2012.
 
4) Logsdail SJ, Toone BK : Post-ictal psychoses. A clinical and phenomenological description. Br J Psychiatry 152 : 246-252, 1988.
PubMed
5) Wieser HG, et al : Unilateral limbic epileptic status activity : stereo-EEG, behavioural, and cognitive data. Epilepsia 26 : 19-29, 1985.
 
6) Cockerell OC, et al : Acute psychological disorders in patients with epilepsy : a nation-wide study. Epilepsy Res 25 : 119-131, 1996.
PubMed
7) Kanemoto K, et al : Postictal psychosis : a comparison with acute interictal and chronic psychoses. Epilepsia 37 : 551-556, 1996.
PubMed
8) 山田了士 : てんかんに随伴する精神症状. 総合病院精神医学 23 (1) : 27-34, 2011.
 
9) Landolt H : Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attack. In : Lectures on Epilepsy (ed by Lorenz de Haas AM), p 91-133, Elsevier, Amsterdam, 1958.
 
10) Tellenbach H : Epilepsie als Anfallsleiden und als Psychose : alternative Psychosen paranoider Pragung bei forcierter Normalizierung (Landolt) des Elektoencephalogramms. Epileptischer Nervenarzt 36 : 190-202, 1965.
 
11) Wolf P : Acute behavioral symptomatology at disappearance of epileptiform EEG abnormality ; Paradoxical or forced normalization. In : Neurobehavioral Problems in Epilepsy (ed by Smith DB, Treiman DM), p 127-142, Raven Press, New York, 1991.
PubMed
P.528 掲載の参考文献
1) Barbieri V, et al : One-year postsurgical follow up of 12 subjects with epilepsy and interictal psychosis. Epilepsy Behav 22 : 385-387, 2011.
PubMed
2) Inoue Y, Mihara T : Psychiatric disorders before and after surgery for epilepsy. Epilepsia 42 (Suppl 6) : 13-18, 2001.
 
3) Kanemoto K, et al : Presurgical postictal and acute interictal psychoses are differentially associated with postoperative mood and psychotic disorders. J Neuropsychiatry Clin Neurosci 13 : 243-247, 2001.
PubMed
4) Mace CJ, Trimble MR : Psychosis following temporal lobe surgery : a report of six cases. J Neurol Neurosurg Psychiatry 54 : 639-644, 1991.
 
5) Andermann LF, et al : Psychosis after resection of ganglioglioma or DNET : evidence for an association. Epilepsia 40 (1) : 83-87, 1999.
PubMed
6) Manchanda R, et al : Post-ictal psychosis after right temporal lobectomy. J Neurol Neurosurg Psychiatry 56 : 277-279, 1993.
PubMed
7) Christodoulou C, et al : Postictal psychosis after temporal lobectomy. Neurology 59 : 1432-1435, 2002.
PubMed
8) Matsuura M : Psychosis of epilepsy, with special reference to anterior temporal lobectomy. Epilepsia 38 (Suppl 6) : 32-34, 1997.
 
9) Stevens JR : Psychiatric consequences of temporal lobectomy for intractable seizures : a 20-30-year follow-up of 14 cases. Psychol Med 20 : 529-545, 1990.
PubMed
10) Leinonen E, et al : Postoperative psychoses in epileptic patients after temporal lobectomy. Acta Neurol Scand 90 : 394-399, 1994.
PubMed
11) Trimble MR : The Psychosis of Epilepsy, Raven Press, New York, 1991.
 
12) Glosser G, et al : Psychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomy. J Neurol Neurosurg Psychiatry 68 : 53-58, 2000.
PubMed
13) Shaw P, et al : Schizophrenia-like psychosis arising de novo following a temporal lobectomy : timing and risk factors. J Neurol Neurosurg Psychiatry 75 : 1003-1008, 2004.
PubMed
14) Roberts GW, et al : A "mock up" of schizophrenia : temporal lobe epilepsy and schizophrenia-like psychosis. Biol Psychiatry 28 : 127-143, 1990.
PubMed
15) Wolf P : Acute behavioral symptomatology at disappearance of epileptiform EEG abnormality. Paradoxical or "forced" normalization. Adv Neurol 55 : 127-142, 1991.
PubMed
P.532 掲載の参考文献
1) 兼子直 : てんかん教室, p 217-225, 新興医学出版, 2012.
 
2) Kaneko S, et al : Development of individualized medicine for epilepsy based on genetic information. Expert Rev Clin Pharmacol 1 : 661-681, 2008.
PubMed
3) Morimoto M, et al : SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia 47 : 1732-1736, 2006.
 
4) Mullen SA, Scheffer IE : Translational research in epilepsy genetics : sodium channels in man to interneuronopathy in mouse. Arch Neurol 66 : 21-26, 2009.
 
5) Singh NA, et al : A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18 : 25-29, 1998.
 
6) Hirose S, et al : A novel mutation of KCNQ3 (c.925T→C) in a Japanese family with benign familial neonatal convulsions. Ann Neurol 47 : 822-826, 2000.
 
7) Singh NA, et al : KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions : expansion of the functional and mutation spectrum. Brain 126 : 2726-2737, 2003.
PubMed
8) Aridon P, et al : Increased sensitivity of the neuronal nicotinic receptorα2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 79 : 342-359, 2006.
 
9) Steinlein OK, et al : A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11 : 201-203, 1995.
PubMed
10) Singh S, et al : Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population. J Hum Genet 50 : 347-352, 2005.
PubMed
11) Medina MT, et al : Novel mutations in Myoclonin1/E FHC1 in sporadic and familial juvenile myoclonic epilepsy. Neurology 70 : 2137-2144, 2008.
 
12) Parihar R, et al : Association of the GRM4 gene variants with juvenile myoclonic epilepsy in an Indian population. J Genet 93 : 193-197, 2014.
 
13) Sugawara T, et al : Detection of SCN1A mutations in patients with severe myoclonic epilepsy in infancy by custom resequence array. J Epileptology 21 : 5-13, 2013.
 
14) Blumenfeld H, et al : Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 49 : 400-409, 2008.
 
15) Yamada J, et al : A novel prophylactic effect of furosemide treatment on autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Epilepsy Res 107 : 127-137, 2013.
 
P.536 掲載の参考文献
1) Gates JR, et al : Imitators of Epilepsy, 2nd ed (ed by Kaplan PW, Fisher RS) [てんかん鑑別診断学 (吉野相英, 立澤賢孝訳)], p 75-77, p 276-299, 医学書院, 2010.
 
2) 山口成良 : 臨床精神医学講座 9てんかん (松下正明ほか編), p 72-81, 中山書店, 1998.
 
3) Trimble MR, Schmitz B : Neuropsychiatry of Epilepsy, 2nd ed [臨床てんかんnext step-知的障害・自閉症・認知症から併発精神障害まで (吉野相英ほか訳)], p 133-141, 新興医学出版社, 2013.
 
4) 「てんかん治療ガイドライン」作成委員会 : てんかん治療ガイドライン2010, p 126-130, 医学書院, 2010.
 
5) 兼本浩祐, 日本てんかん学会ガイドライン作成委員会 : 心因性非てんかん性発作 (いわゆる偽発作) に関する診断・治療ガイドライン. てんかん研究 26 (3) : 478-482, 2009.
 
P.541 掲載の参考文献
1) 循環器病の診断と治療に関するガイドライン2011年度合同研究班 (班長井上博) : 失神の診断・治療ガイドライン (2012年改訂版). [www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf] (cited 2014 Aug 7)
 
2) 住吉正孝 : 新しい「失神の診断・治療ガイドライン (2012年改訂版) 」に基づいた失神の診断と治療へのアプローチ. Therapeutic Research 34 : 1067-1072, 2013.
 
3) 千葉茂 : 失神. 別冊日本臨牀 神経症候群 VI, p 390-393, 日本臨牀社, 2002.
 
4) Steriades ES, et al : Incidence and prognosis of syncope. N Engl J Med 347 : 878-885, 2002.
 
5) 佐々木青磁ほか : 脱力様発作が頻発した脳循環障害の1例. 精神医学 31 : 1221-1224, 1989.
 
6) Ayd FJ, Jr : Lexicon of Psychiatry, Neurology, and the Neurosciences, Lippincott Williams & Wilkins, Philadelphia, 2000.
 
7) 千葉茂 : てんかん. 標準精神医学 (第5版) (野村総一郎ほか編), p 431-449, 医学書院, 2012.
 
8) Bassetti C : Transient loss of consciousness and syncope. In : Handbook of Clinical Neurology, Vol 119 (3rd series). Neurologic Aspects of Systemic Disease, Part 1 (ed by Biller J, Ferro J), p 169-191, Elsevier, 2014.
 
9) 千葉茂ほか : cough syncopeの一例. 臨床脳波 32 : 204-207, 1990.
 
10) 小林洋一 : 反射性失神の診断-ヘッドアップチルト試験 (HUT) と埋め込み型ループレコーダー (ILR) の役割-. 心臓 45 : 1355-1363, 2013.
 
11) 千葉茂, 藤村洋太 : 意識と脳波. 脳とこころのプライマリケア 5 意識と睡眠 (日野原重明, 宮岡等監, 千葉茂編), p 29-36, シナジー, 2012.
 
12) 千葉茂 : 睡眠時随伴症をめぐって. 医事新報 4521 : 54-59, 2011.
 
13) 藤村洋太ほか : てんかん. 日本臨牀 71 (増刊号5) : 691-697, 2013.
Medical*Online
14) 松田美夏ほか : てんかんにみられる睡眠構造の異常. 睡眠医療 7 : 179-183, 2013.
Medical*Online
15) 白田朱香ほか : 睡眠検査のピットフォール. 実施上の注意点・問題点 (最終回). 睡眠関連てんかんのVideo-Polysomnography記録と判定のピットフォール. 睡眠医療 8 : 105-111, 2014.
 
P.546 掲載の参考文献
1) DiMario FJ Jr : Prospective study of children with cyanotic and pallid breath-holding spells. Pediatrics 107 : 265-269, 2001.
PubMed
2) Breningstall GN : Breath-holding spells. Pediatr Neurol 14 : 91-97, 1996.
PubMed
3) Lombroso CT, Lerman P : Breathholding spells (cyanotic and pallid infantile syncope). Pediatrics 39 : 563-581, 1967.
PubMed
4) Yilmaz U, et al : The value of neurologic and cardiologic assessment in breath holding spells. Pak J Med Sci 30 : 59-64, 2014.
PubMed
5) Kolkiran A, et al : Autonomic nervous system functions in children with breath-holding spells and effects of iron deficiency. Acta Paediatr 94 : 1227-1231, 2005.
PubMed
6) Holowach J, Thurston DL : Breath-holding spells and anemia. N Engl J Med 268 : 21-23, 1963.
PubMed
7) Mocan H, et al : Breath holding spells in 91 children and response to treatment with iron. Arch Dis Child 81 : 261-262, 1999.
PubMed
8) 伊藤康ほか : 鉄欠乏性貧血を合併した頻回憤怒けいれんの1例. 小児科臨床 58 : 1821-1824, 2005.
Medical*Online
9) McWilliam RC, Stephenson JB : Atropine treatment of reflex anoxic seizures. Arch Dis Child 59 : 473-475, 1984.
PubMed
10) Abbaskhanian A, et al : Effects of piracetam on pediatric breath holding spells : a randomized double blind controlled trial. Iran J Child Neurol 6 (4) : 9-15, 2012.
PubMed
11) Lukkarinen H, et al : Recurrent sinus arrest and asystole due to breath-holding spell in a toddler ; recovery with levetiracetam-therapy. Circulation 122 : e637, 2010.
 
12) 阪上智俊ほか : 心静止を伴う重症息止め発作にlevetiracetamが著効した1例. 脳と発達 44 : 496-498, 2012.
Medical*Online
P.550 掲載の参考文献
1) Easton JD, et al : Definition and evaluation of transient ischemic attack : a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council ; Council on Cardiovascular Surgery and Anesthesia ; Council on Cardiovascular Radiology and Intervention ; Council on Cardiovascular Nursing ; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40 : 2276-2293, 2009.
PubMed
2) Asayama K, et al : Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population : participant-level meta-analysis. Hypertension 63 : 1189-1197, 2014.
PubMed
3) Kimura K, et al : Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc Dis 18 : 47-56, 2004.
PubMed
4) Ninomiya T, et al : Impact of kidney disease and blood pressure on the development of cardiovascular disease : an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 118 : 2694-2701, 2008.
PubMed
5) Yaggi HK, et al : Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 : 2034-2041, 2005.
PubMed
6) Gage BF, et al : Validation of clinical classification schemes for predicting stroke : results from the National Registry of Atrial Fibrillation. JAMA 285 : 2864-2870, 2001.
 
7) Coppens M, et al : The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J 34 : 170-176, 2013.
 
8) Schurks M, et al : Migraine and cardiovascular disease : systematic review and meta-analysis. BMJ 339 : b3914, 2009.
PubMed
9) 青木志郎ほか : 病型別にみた初発神経症状の頻度. 脳卒中データバンク2009 (小林祥泰編), p 32-33, 中山書店, 2009.
 
10) Fiebach JB, et al : CT and diffusion-weighted MR imaging in randomized order : Diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 33 : 2206-2210, 2002.
PubMed
11) Theodore WH : The postictal state : effects of age and underlying brain dysfunction. Epilepsy Behav 19 : 118-120, 2010.
 
12) Mangla A, et al : Transient global amnesia and the risk of ischemic stroke. Stroke 45 : 389-393, 2014.
PubMed
13) Mazya M, et al : Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase : safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 43 : 1524-1531, 2012.
PubMed
14) Johnston SC, et al : Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369 : 283-292, 2007.
PubMed
15) Rothwell PM, et al : Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study) : a prospective population-based sequential comparison. Lancet 370 : 1432-1442, 2007.
PubMed
P.554 掲載の参考文献
1) Caplan LR : Transient global amnesia. In : Handbook of Clinical Neurology, Vol 45 (ed by Vinken PJ, Bruyn GW), p 205-218, Elsevier, Amsterdam, 1985.
 
2) Bartsch T, Deuschl G : Transient global amnesia : functional anatomy and clinical implications. Lancet Neurol 9 : 205-214, 2010.
PubMed
3) Hunter G : Transient global amnesia. Neurol Clin 29 : 1045-1054, 2011.
PubMed
4) Bartsch T, Butler C : Transient amnesic syndromes. Nat Rev Neurol 9 : 86-97, 2013.
PubMed
5) 大里敦子 : 一過性全健忘. 脳血管障害と神経心理学, 第二版 (平山惠造, 田川皓一編), p 83-88, 医学書院, 2013.
 
6) Sedlaczek O, et al : Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology 62 : 2165-2170, 2004.
PubMed
7) Ryoo I, et al : Lesion detectability on diffusion-weighted imaging in transient global amnesia : the influence of imaging timing and magnetic field strength. Neuroradiology 54 : 329-334, 2012.
PubMed
8) Fisher CM, Adams RD : Transient global amnesia. Trans Am Neurol Assoc 83 : 143-146, 1958.
 
9) Miller JW, et al : Transient global amnesia : clinical characteristics and prognosis. Neurology 37 : 733-737, 1987.
PubMed
10) Hodges JR, Warlow CP : The aetiology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain 113 : 639-657, 1990.
PubMed
11) Quinette P, et al : What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 129 : 1640-1658, 2006.
PubMed
12) Zeman A, et al : Transient epileptic amnesia : a description of the clinical and neuropsychological features in 10 cases and a review of the literature. J Neurol Neurosurg Psychiatry 64 : 435-443, 1998.
 
13) Butler CR, Zeman AZ : Recent insights into the impairment of memory in epilepsy : transient epileptic amnesia, accelerated long-term forgetting and remote memory impairment. Brain 131 : 2243-2263, 2008.
PubMed
14) 井上有史ほか : 側頭葉てんかんにおける健忘発作と発作後健忘状態-2症例の健忘症状・発作時頭蓋内脳波の分析. てんかん研究 11 : 110-120, 1993.
 
15) Zeman A, Butler C : Transient epileptic amnesia. Curr Opin Neurol 23 : 610-616, 2010.
PubMed
P.559 掲載の参考文献
1) Bianchin MM, et al : Migraine and epilepsy : a focus on overlapping clinical, pathophysiological, molecular, and therapeutic aspects. Curr Pain Headache Res 14 : 276-283, 2010.
 
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
3) Yankovsky AE, et al : Characteristics of headache associated with intractable partial epilepsy. Epilepsia 46 : 1241-1245, 2005.
PubMed
4) Haut SR, et al : Chronic disorders with episodic manifestations : focus on epilepsy and migraine. Lancet Neurol 5 : 148-157, 2006.
PubMed
5) 柴田興一 : 片頭痛とてんかん. ペインクリニック 34 : 919-927, 2013.
Medical*Online
6) Russell MB, Ducros A : Sporadic and familial hemiplegic migraine : pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10 : 457-470, 2011.
PubMed
7) Rogawski MA : Migraine and epilepsy-Shared mechanisms within the family of episodic disorders. In : Jasper's Basic Mechanisms of the Epilepsies [Internet], 4th ed (ed by Noebels JL, et al), p 1-17, National Center for Biotechnology Information, Bethesda, 2012.
 
8) 柴田興一 : 片頭痛視覚前兆の神経生理学. Brain and Nerve 59 : 961-970, 2007.
 
9) Tian GF, et al : An astrocytic basis of epilepsy. Nat Med 11 : 973-981, 2005.
PubMed
10) Taylor I, et al : Benign occipital epilepsies of childhood : clinical features and genetics. Brain 131 : 2287-2294, 2008.
PubMed
11) Caraballo R, et al : Idiopathic childhood occipital epilepsy of Gastaut : a review and differentiation from migraine and other epilepsies. J Child Neurol 24 : 1536-1542, 2009.
 
12) Clarke T, et al : Evidence of shared genetic risk factors for migraine and rolandic epilepsy. Epilepsia 50 : 2428-2433, 2009.
PubMed
13) Panayiotopoulos CP : Elementary visual hallucinations, blindness, and headache in idiopathic occipital epilepsy : differentiation from migraine. J Neurol Neurosurg Psychiatry 66 : 536-540, 1999.
 
14) 慢性頭痛の診療ガイドライン作成委員会 : II 片頭痛 3. 予防療法. 慢性頭痛の診療ガイドライン2013 (日本神経学会, 日本頭痛学会編), p 145-187, 医学書院, 2013.
 
P.564 掲載の参考文献
1) Bakker MJ, et al : Startle syndromes. Lancet Neurol 5 : 513-524, 2006.
PubMed
2) Dreissen YE, et al : Exaggerated startle reactions. Clin Neurophysiol 123 : 34-44, 2012.
PubMed
3) Kimura M, et al : Two Japanese families with hyperekplexia who have a Arg271Gln mutation in the glycine receptor alpha 1 subunit gene. Brain Dev 28 : 228-231, 2006.
PubMed
4) Mine J, et al : A 14-year-old girl with hyperekplexia having GLRB mutations. Brain Dev 35 : 660-663, 2013.
 
5) Harvey RJ, et al : The genetics of hyperekplexia : more than startle! Trends Genet 24 : 439-447, 2008.
PubMed
6) Schaefer N, et al : Glycine receptor mouse mutants : model systems for human hyperekplexia. Br J Pharmacol 170 : 933-952, 2013.
PubMed
7) Thomas RH, et al : Genotype-phenotype correlations in hyperekplexia : apnoeas, learning difficulties and speech delay. Brain 136 : 3085-3095, 2013.
PubMed
8) Carta E, et al : Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem 287 : 28975-28985, 2012.
PubMed
9) Chung SK, et al : GLRB is the third major gene of effect in hyperekplexia. Hum Mol Genet 22 : 927-940, 2012.
PubMed
10) Harvey RJ, et al : A critical role for glycine transporters in hyperexcitability disorders. Front Mol Neurosci 1 : 1, 2008.
PubMed
11) Bode A, Lynch JW : The impact of human hyperekplexia mutations on glycine receptor structure and function. Mol Brain 7 : 2, 2014.
PubMed
12) Dreissen YE, Tijssen MA : The startle syndromes : physiology and treatment. Epilepsia 53 (Suppl 7) : 3-11, 2012.
 
13) Mineyko A, et al : Hyperekplexia : treatment of a severe phenotype and review of the literature. Can J Neurol Sci 38 : 411-416, 2011.
PubMed
P.569 掲載の参考文献
1) American Academy of Sleep Medicine : The International Classification of Sleep Disorder, 3rd ed, American Academy of Sleep Medicine, Westchester, 2014.
 
2) 米国睡眠医学会 (日本睡眠学会診断分類委員会訳) : 睡眠障害国際分類 第2版 診断とコードの手引き, 医学書院, 2010.
 
3) 神山潤 : 睡眠の生理と臨床, 改訂第2版, 診断と治療社, 2008.
 
4) Jain SV, Glauser TA : Effects of epilepsy treatments on sleep architecture and daytime sleepiness : an evidence-based review of objective sleep metrics. Epilepsia 55 : 26-37, 2014.
PubMed
5) Derry CP, et al : Distinguishing sleep disorders from seizures : diagnosing bumps in the night. Arch Neurol 63 : 705-709, 2006.
PubMed
6) Bisulli F, et al : Diagnostic accuracy of a structured interview for nocturnal frontal lobe epilepsy (SINFLE) : a proposal for developing diagnostic criteria. Sleep Med 13 : 81-87, 2012.
PubMed
7) Manni R, et al : The FLEP scale in diagnosing nocturnal frontal lobe epilepsy, NREM and REM parasomnias : data from a tertiary sleep and epilepsy unit. Epilepsia 49 : 1581-1585, 2008.
PubMed
8) Vignatelli L, et al : Interobserver reliability of ICSD-R minimal diagnostic criteria for the parasomnias. J Neurol 252 : 712-717, 2005.
PubMed
9) Tinuper P, et al : The parasomnias : mechanisms and treatment. Epilepsia 53 (Suppl 7) : 12-19, 2012.
 
10) 木村清次 : Benign neonatal sleep myoclonusの2例. 小児科臨床 52 : 1537-1539, 1999.
Medical*Online
P.572 掲載の参考文献
1) 諸岡啓一 : 軽症下痢とけいれん. 小児科 23 : 131-137, 1982.
 
2) Centers for Disease Control and Prevention (CDC) : Reduction in rotavirus after vaccine introduction -United States, 2000-2009. MMWR Morb Mortal Wkly Rep 58 : 1146-1149, 2009.
PubMed
3) Lynch M, et al : Rotavirus and central nervous system symptoms : cause or contaminant? Case reports and review. Clin Infect Dis 33 : 932-938, 2001.
PubMed
4) Le Saux N, et al : Substantial morbidity for hospitalized children with community-acquired rotavirus infections : 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J 29 : 879-882, 2010.
PubMed
5) Abe T, et al : Infantile convulsions with mild gastroenteritis. Brain Dev 22 : 301-306, 2000.
PubMed
6) Schumacher RF, Forster J : The CNS symptoms of rotavirus infections under the age of two. Klin Padiatr 211 : 61-64, 1999.
PubMed
7) 東田好広ほか : 当院の小児救急外来における痙攣性疾患の現状. Tokushima Red Cross Hospital Medical Journal 1 : 31-34, 2007.
 
8) Chan CM, et al : Norovirus as cause of benign convulsion associated with gastro-enteritis. J Paediatr Child Health 47 : 373-377, 2011.
PubMed
9) Chen SY, et al : Norovirus infection as a cause of diarrhea-associated benign infantile seizures. Clin Infect Dis 48 : 849-855, 2009.
PubMed
10) Sugata K, et al : Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics 122 : 392-397, 2008.
PubMed
11) Ushijima H, et al : Detection and sequencing of rotavirus VP 7 gene from human materials (stools, sera, cerebrospinal fluids, and throat swabs) by reverse transcription and PCR. J Clin Microbiol 32 : 2893-2897, 1994.
 
12) de Villiers FP, et al : Central nervous system involvement in neonatal rotavirus infection. Ann Trop Paediatr 23 : 309-312, 2003.
PubMed
13) Weclewicz K, et al : Microtubule-associated protein 2 appears in axons of cultured dorsal root ganglia and spinal cord neurons after rotavirus infection. J Neurosci Res 36 : 173-182, 1993.
PubMed
14) Goto T, et al : A case of meningoencephalitis associated with G1P [8] rotavirus infection in a Japanese child. Scand J Infect Dis 39 : 1067-1070, 2007.
 
15) Maruyama K, et al : Ictal EEG in patients with convulsions with mild gastroenteritis. Brain Dev 29 : 43-46, 2007.
PubMed
16) Verrotti A, et al : Benign convulsions associated with mild gastroenteritis : a multicenter clinical study. Epilepsy Res 93 : 107-114, 2011.
PubMed
17) Natsume J, et al : Transient splenial lesions in children with "benign convulsions with gastroenteritis". Brain Dev 29 : 519-521, 2007.
PubMed
18) 福山幸夫 : 小児のてんかん境界領域-とくに熱性けいれんおよびいわゆる乳児けいれんについて. 精神医学 5 : 211-222, 1963.
 
19) Watanabe K, et al : Benign complex partial epilepsies in infancy. Pediatr Neurol 3 : 208-211, 1987.
PubMed
20) Watanabe K, et al : Benign partial epilepsy with secondarily generalized seizures in infancy. Epilepsia 34 : 635-638, 1993.
PubMed
21) Ishii A, et al : Genetic analysis of PRRT2 for benign infantile epilepsy, infantile convulsions with choreoathetosis syndrome, and benign convulsions with mild gastroenteritis. Brain Dev 35 : 524-530, 2013.
PubMed
22) Salmi TT, et al : Central nervous system involvement in patients with rotavirus gastroenteritis. Scand J Infect Dis 10 : 29-31, 1978.
PubMed
23) Hoshino A, et al : Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 34 : 337-343, 2012.
PubMed
24) Takanashi J, et al : Clinical and radiological features of rotavirus cerebellitis. AJNR Am J Neuroradiol 31 : 1591-1595, 2010.
PubMed
25) Kawamura Y, et al : Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan. Brain Dev 36 : 601-607, 2014.
PubMed
26) Nakano I, et al : Sudden death from systemic rotavirus infection and detection of nonstructural rotavirus proteins. J Clin Microbiol 49 : 4382-4385, 2011.
PubMed
27) 市山高志ほか : 軽症胃腸炎関連けいれんに対する少量carbamazepine療法. 脳と発達 37 : 493-497, 2005.
Medical*Online
28) Payne DC, et al : Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis 58 : 173-177, 2014.
PubMed
29) 国立感染症研究センター. [http://www.nih.go.jp/niid/ja/kansennohanashi/3377-rota-intro.html]
 
P.577 掲載の参考文献
1) 宇川義一 : ヒトの神経生理からみた「てんかん」 . Brain Nerve 65 : 521-530, 2013.
 
2) 宇川義一 : てんかんと鑑別すべき不随意運動. てんかん研究 31 : 304, 2013.
 
3) Smith PE : Epilepsy : mimics, borderland and chameleons. Pract Neurol 12 : 299-307, 2012.
PubMed
4) 宇川義一 : 不随意運動あれこれ. 日内誌 100 : 2653-2661, 2011.
 
5) 宇川義一 : ビデオでみる不随意運動の基礎. 臨床神経学 52 : 827-831, 2012.
 
6) 水澤英洋, 宇川義一 : 神経診察 : 実際とその意義Neurological Examination A to Z, 中外医学社, 2011.
 
7) 松本英之, 宇川義一 : 不随意運動. Medicina 49 : 618-621, 2012.
 
8) Matsumoto H, et al : Psychogenic unilateral ptosis with ipsilateral muscle spasm of orbicular oculi. Acta Med Indones 44 : 243-245, 2012.
PubMed
9) Ugawa Y, et al : Myoclonus in Alzheimer's disease. J Neurol 235 : 90-94, 1987.
PubMed
10) Ugawa Y, et al : Neurophysiology of cortical positive myoclonus. Adv Neurol 89 : 89-97, 2002.
PubMed
11) Ugawa Y, et al : Physiological analysis of asterixis : silent period locked averaging. J Neurol Neurosurg Psychiatry 52 : 89-93, 1989.
PubMed
12) Matsumoto H, Ugawa Y : Neurophysiological analyses of asterixis utilizing innovative approaches. Clin Neurophysiol 123 : 1695-1696, 2012.
PubMed
13) Matsumoto H, et al : Unilateral asterixis caused by an internal capsule lesion. Intern Med 53 : 341-342, 2014.
PubMed
14) Crompton DE, Berkovic SF : The borderland of epilepsy : clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol 8 : 370-381, 2009.
PubMed
15) 松本英之 : 抗てんかん薬の選択. Modern Physician 33 : 1054, 2013.
 

XV 頭痛

P.584 掲載の参考文献
1) Lashley KS : Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 46 : 331-339, 1941.
 
2) Leao AAP : Spreading depression of activity in cerebral cortex. J Neurophysiol 7 : 359-390, 1944.
 
3) Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 179 : 717-718, 1962.
 
4) Wolff HG : Headache and Other Head Pain, 1st ed, Oxford University Press, New York, 1948.
 
5) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache 8 (Suppl 7) : 1-96, 1988.
 
6) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders : 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
7) Moskowitz MA, et al : Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13 : 1167-1177, 1993.
PubMed
8) Sanchez-Del-Rio M, et al : New insights into migraine pathophysiology. Curr Opin Neurol 19 : 294-298, 2006.
 
P.591 掲載の参考文献
1) Headache Classification of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 8 (Suppl 7) : 1-96, 1988.
 
2) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders : 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
3) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
4) WHO : Neurological Disorders : Public Health Challenges. Chapter 3. [http://www.who.int/mental_health/neurology/neurodiso/en/]
 
5) 濱田潤一 : 頭痛の疫学. 医学のあゆみ 243 : 1024-1030, 2012.
Medical*Online
6) Robbins MS, Lipton RB : The epidemiology of primary headache. Semin Neurol 30 : 107-119, 2010.
PubMed
7) Sakai F, Igarashi H : Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 17 : 15-22, 1997.
PubMed
8) Takeshima T, et al : Population-based door-to-door survey of migraine in Japan : the Daisen study. Headache 44 : 8-19, 2004.
PubMed
9) 五十嵐久佳ほか : 群発頭痛の予後. 頭痛研究会会誌 23 : 24-26, 1996.
 
10) Imai N, et al : Clinical profile of cluster headaches in Japan : low prevalence of chronic cluster headache, and uncoupling of sense and behavior of restlessness. Cephalalgia 31 : 628-633, 2010.
 
11) Manzoni GC : Gender ratio of cluster headache over the years : a possible role of changes in lifestyle. Cephalalgia 18 : 138-142, 1998.
 
P.595 掲載の参考文献
1) Abu-Arafeh I, et al : Prevalence of headache and migraine in children and adolescents : a systematic review of population-based studies. Dev Med Child Neurol 52 : 1088-1097, 2010.
PubMed
2) 日本頭痛学会 : 慢性頭痛の診療ガイドライン, p 1-213, 医学書院, 2006.
 
3) 慢性頭痛の診療ガイドライン作成委員会 : 慢性頭痛の診療ガイドライン 2013, p 2-343, 医学書院, 2013.
 
4) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7) : 1-96, 1988.
 
5) 鈴木紫布ほか : 高校生における一次性頭痛の特徴. 臨床神経学 45 : 717-723, 2005.
 
6) Headache Classification Subcommittee of the International Headache Society : The international classification of headache disorders. 2nd edition. Cephalalgia 24 (Suppl 1) : 1-160, 2004.
 
7) Ando N, et al : Prevalence and features of migraine in Japanese junior high school students aged 12-15 yr. Brain Dev 29 : 482-485, 2007.
PubMed
8) Stovner LJ, Andree C : Prevalence of headache in Europe : a review for the Eurolight project. J Headache Pain 11 : 289-299, 2010.
PubMed
9) 安藤直樹ほか : 当院頭痛外来を受診した小児頭痛の分類と特徴. 日本頭痛学会誌 37 : 6-8, 2010.
 
10) 藤田光江ほか : 小児慢性反復性頭痛の研究 第4編 : 一般小児科から他科へ依頼する頭痛. 日児誌 105 : 576-583, 2001.
 
11) 藤田光江 : 小児頭痛の疫学. 頭痛のすべて (辻省次, 鈴木則宏編), p 224-227, 中山書店, 2011.
 
P.601 掲載の参考文献
1) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7) : 1-96, 1988.
 
2) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl 1) : 1-160, 2004.
 
3) 工藤雅子, 寺山靖夫 : 頭痛の分類. 識る診る治す 頭痛のすべて アクチュアル脳・神経疾患の臨床 (鈴木則宏編, 辻省次総編), p 8-14, 中山書店, 2011.
 
4) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
5) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
6) Olessen J, Lipton RB : Migraine classification and diagnosis. International Headache Society Criteria. Neurology 44 (6 Suppl 4) : 6-10, 1994.
 
7) 五十嵐久佳 : 頭痛の疫学. Clinical Neuroscience 25 (5) : 516-518, 2007.
 
8) 清水利彦 : 片頭痛. Clinical Neuroscience 32 (5) : 493-495, 2014.
 
9) Ducros A, et al : The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345 : 17-24, 2001.
 
10) Bigal ME, et al : Chronic daily headache in a tertiary care population : correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 22 : 432-438, 2002.
 
11) Cohen AS, et al : Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA). A prospective clinical study of SUNCT and SUNA. Brain 129 : 2746-2760, 2006.
 
12) Raeder GJ, et al : Paratrigeminal paralysis of oculopupillary sympathic. Brain 47 : 149-158, 1924.
 
P.606 掲載の参考文献
1) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 (第2版 新訂増補日本語版), p 1-173, 医学書院, 2007.
 
2) 慢性頭痛の診療ガイドライン作成委員会 : 慢性頭痛の診療ガイドライン 2013, p 1-349, 医学書院, 2013.
 
3) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
4) 間中信也 : 頭痛の問診と診察. Modern Physician 31 : 933-936, 2011.
 
5) 土井光 : 治療に難渋する頭痛 慢性連日性頭痛. 医学のあゆみ 243 : 1192-1196, 2012.
 
6) Basugi A, et al : Usefulness of three simple questions to detect red flag headaches in outpatient settings. 日頭痛会誌 33 : 30-33, 2006.
 
7) 工藤雅子 : 一次性雷鳴頭痛はどのように診断し治療するか. 日頭痛会誌 40 : 52-53, 2013.
 
8) 山本文夫ほか : 雷鳴頭痛とRCVS. 治療 93 : 1601-1608, 2011.
Medical*Online
9) 水谷徹 : 解離性脳動脈瘤の発生, 治癒機転からみた治療の考え方. 脳神経外科ジャーナル 19 : 104-111, 2010.
 
10) 郭泰植ほか : 頭痛のみで発症した椎骨動脈解離の診断における3D black blood MRI (VISTA) 法の有用性. 日頭痛会誌 40 : 421-428, 2014.
 
11) Naganuma M, et al : Clinical characteristics of subarachnoid hemorrhage with or without headache. J Stroke Cerebrovasc Dis 17 : 334-339, 2008.
PubMed
12) 問診票, スクリーナーをどう利用したらよいでしょうか. Mindsガイドライン. [http://minds.jcqhc.or.jp/stc/0025/3/0025_g0000155_0008.html]
 
13) Lance JW : Diagnosis based on the history. In : Mechanism and Management of Headache, 6th ed (ed by Goadsby PJ), p 26, Butterworth-Heinemann Medical Published, Oxford, 2000.
 
14) 五十嵐久佳 : 女性特有の頭痛. 日頭痛会誌 38 : 70-74, 2011.
 
15) 藤田光江 : 生涯教育セミナー (上級) 子供の頭痛の診かた. 日頭痛会誌 37 : 76-81, 2010.
 
P.612 掲載の参考文献
1) 慢性頭痛の診療ガイドライン作成委員会 (編) : 慢性頭痛の診療ガイドライン2013, 医学書院, 2013.
 
2) 濱田潤一 : 頭痛診療と診療アルゴリズム. 頭痛診療ハンドブック (鈴木則宏編), p 23-30, 中外医学社, 2009.
 
3) 濱田潤一 : 内科コモンプロブレム 頭痛. medicina 41 : 592-596, 2004.
 
4) Dowson AJ, et al : Establishing principles for migraine management in primary care. Int J Clin Pract 57 : 493-507, 2003.
PubMed
5) Detsky ME, et al : Does this patient with headache have a migraine or need neuroimaging? JAMA 196 : 1274-1283, 2006.
PubMed
6) Dodick DW : Clinical clues (primary/secondary). The 14th Migraine Trust International Symposium, London, 2002.
 
7) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders : 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
8) Pryse-Phillips W, et al : A headache diagnosis project. Headache 42 (Suppl 1) : 728-737, 2002.
 
P.617 掲載の参考文献
1) 国際頭痛分類 第2版 新訂増補日本語版 (日本頭痛学会・国際頭痛分類普及委員会訳), p 1-172, 医学書院, 2007.
 
2) I-8 アルゴリズムをどう使用するか. 慢性頭痛の診療ガイドライン (日本頭痛学会編), p 17-19, 医学書院, 2006.
 
3) CQ I-8 アルゴリズムをどう使用するか. 慢性頭痛の診療ガイドライン2013 (慢性頭痛の診療ガイドライン作成委員会編), p 281-283, 医学書院, 2013.
 
4) CQ VII-3 小児の二次性頭痛にはどのようなものが多いか. 慢性頭痛の診療ガイドライン 2013 (慢性頭痛の診療ガイドライン作成委員会編), p 281-283, 医学書院, 2013.
 
5) Lareef TM, et al : Headache in young children in the emergency department : use of computed tomography. Pediatrics 124 (1) : e12-17, 2009.
 
6) 藤田光江 : 頭痛を認める患児の検査は何を行いますか? 小児内科 43 (増刊号) : 306-308, 2011.
 
7) Detsky ME, et al : Does this patient with headache have a migraine or need neuroimaging? JAMA 296 (10) : 1274-1283, 2006.
PubMed
8) Medina LS, et al : Children with headache : Clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology 202 : 819-824, 1997.
PubMed
9) 桑原健太郎 : 大学病院小児科頭痛外来における患者の臨床的検討. 日頭痛会誌 37 (2) : 232, 2010.
 
10) 間中信也 : 慢性連日性頭痛. 小児科臨床ピクシス (12) 小児の頭痛. 診かた治しかた (五十嵐隆総編集, 椎原弘章専門編集), p 128-130, 中山書店, 2009.
 
11) 桑原健太郎 : 頭痛. 特集 : 症状・症候から診断を導くコツ. 小児科 53 (11) : 1389-1394, 2012.
 
12) 小児起立性調節障害診断・治療ガイドライン (日本小児心身医学会編), p 1-54, 南江堂, 2009.
 
13) くり返す子どもの痛みの理解と対応ガイドライン (日本小児心身医学会編), p 121-178, 南江堂, 2009.
 
14) 小児科医のための不登校診療ガイドライン (日本小児心身医学会編), p 55-84, 南江堂, 2009.
 
P.622 掲載の参考文献
1) Russell MB, Olesen J : Increased familial risk and evidence of genetic factor in migraine. Br Med J 311 : 541-544, 1995.
 
2) Ulrich V, et al : Evidence of a genetic factor in migraine with aura : a population-based Danish twin study. Ann Neurol 45 : 242-246, 1999.
PubMed
3) Russell MB, et al : Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 42 : 332-336, 2002.
PubMed
4) Ophoff RA, et al : Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87 : 543-552, 1996.
PubMed
5) 古和久典, 中島健二 : 頭痛に関与している遺伝子-ゲノム解析の現状. 医学のあゆみ 243 : 1044-1050, 2012.
Medical*Online
6) Nyholt DR, et al : A high-density association screen of 155 ion transport genes for involvement with common migraine. Hum Mol Genet 17 : 3318-3331, 2008.
PubMed
7) Cuenca-Leon E, et al : Familial hemiplegic migraine : linkage to chromosome 14q32 in a Spanish kindred. Neurogenetics 10 : 191-198, 2009.
 
8) Suzuki M, et al : Defective membrane expression of the Na+ -HCO3-cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci USA 107 : 15963-15968, 2010.
PubMed
9) Freilinger T, et al : A novel mutation in SLC1A3 associated with pure hemiplegic migraine. J Headache Pain 11 : S90, 2010.
 
10) Riant F, et al : PRRT2 mutations cause hemiplegic migraine. Neurology 79 (21) : 2122-2124, 2012.
PubMed
11) Menon S, et al : Association of a Notch 3 gene polymorphism with migraine susceptibility. Cephalalgia 31 : 264-270, 2011.
PubMed
12) Richards A, et al : C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39 : 1068-1070, 2007.
 
13) Montagna P : Molecular genetics of migraine headaches : a review. Cephalalgia 20 : 3-14, 2000.
PubMed
14) Takeshima T, et al : Leukoyte mitochondrial DNA A to G polymorphism at 11084 is not a risk factor for Japanese migraineurs. Cephalalgia 21 : 987-989, 2001.
 
15) Lafreniere RG, et al : A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16 : 1157-1160, 2010.
PubMed
16) de Vries B, et al : Molecular genetics of migraine. Hum Genet 126 : 115-132, 2009.
PubMed
17) Anttila V, et al : Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42 : 869-873, 2010.
PubMed
18) Chasman DI, et al : Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43 : 695-698, 2011.
PubMed
19) Freilinger T, et al : Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44 : 777-782, 2012.
PubMed
20) Anttila V, et al : Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 45 : 912-917, 2013.
PubMed
21) 古和久典, 高橋祐二 : 慢性頭痛の診療ガイドライン2013 遺伝子. Clinical Neuroscience 32 : 581-584, 2014.
 
22) Wessman M, et al : Migraine : a complex genetic disorder. Lancet Neurol 6 : 521-532, 2007.
 
23) Di Lorenzo C, et al : Migraine headache : a review of the molecular genetics of a common disorder. J Headache Pain 13 : 571-580, 2012.
PubMed
24) Ulrich V, et al : The relative influence of environment and genes in episodic tension-type headache. Neurology 62 : 2065-2069, 2004.
PubMed
25) Russell MB, et al : Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of 11 199 twin pairs. J Headache Pain 7 : 119-126, 2006.
PubMed
26) Russell MB : Epidemiology and genetics of cluster headache. Lancet Neurol 3 : 279-283, 2004.
PubMed
27) Schurks M, et al : Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 66 : 1917-1919, 2006.
PubMed
28) Rainero I, et al : Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache : a meta-analysis. J Headache Pain 8 : 152-156, 2007.
PubMed
29) Gentile G, et al : Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain 11 : 431-435, 2010.
 
30) Di Lorenzo C, et al : The wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett 424 : 179-184, 2007.
PubMed
31) Di Lorenzo C, et al : Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 10 : 349-355, 2009.
PubMed
32) Maher B, Griffiths L : Identification of molecular genetic factors that influence migraine. Mol Genet Genomics 285 : 433-446, 2011.
PubMed
33) Nyholt DR, et al : Genomewide significant linkage to migrainous headache on chromosome 5q21. Am J Hum Genet 77 : 500-512, 2005.
PubMed
34) Anttila V, et al : Consistently replicating locus linked to migraine on 10q22-q23. Am J Hum Genet 82 : 1051-1063, 2008.
PubMed
35) Anttila V, et al : Trait components provide tools to dissect the genetic susceptibility of migraine. Am J Hum Genet 79 : 85-99, 2006.
PubMed
P.628 掲載の参考文献
1) Graham JR, Wolff HG : Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39 : 737-763, 1938.
 
2) Olesen J, et al : Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 28 : 791-798, 1990.
PubMed
3) Lauritzen M : Cerebral blood flow in migraine and cortical spreading depression. Acta Neurol Scand Suppl 113 : 1-40, 1987.
PubMed
4) Olesen J, et al : Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9 : 344-352, 1981.
PubMed
5) Leao AAP : Spreading depression of activity in the cerebral cortex. J Neurophysiol 7 : 359-390, 1944.
 
6) Hadjikhani N, et al : Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98 : 4687-4692, 2001.
PubMed
7) Moskowitz MA : The neurobiology of vascular head pain. Ann Neurol 16 : 157-168, 1984.
PubMed
8) Burstein R, et al : An association between migraine and cutaneous allodynia. Ann Neurol 47 : 614-624, 2000.
PubMed
9) Goadsby PJ, Hoskin KL : Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor : a central action in migraine? Ann Neurol 43 : 711-718, 1998.
PubMed
10) Asghar MS, et al : Evidence for a vascular factor in migraine. Ann Neurol 69 : 635-645, 2011.
PubMed
11) Bolay H, et al : Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 : 136-142, 2002.
 
12) Raskin NH, et al : Headache may arise from perturbation of brain. Headache 27 : 416-420, 1987.
PubMed
13) Weiller C, et al : Brain stem activation in spontaneous human migraine attacks. Nat Med 1 : 658-660, 1995.
PubMed
14) Moskowitz MA, et al : Deciphering migraine mechanisms : clues from familial hemiplegic migraine genotypes. Ann Neurol 55 : 276-280, 2004.
PubMed
P.634 掲載の参考文献
1) 神経学会・日本頭痛学会 (監), 慢性頭痛の診療ガイドライン作成委員会 (編) : 慢性頭痛の診療ガイドライン 2013, 医学書院, 2013.
 
2) 濱田潤一 : 頭痛の疫学. 医学のあゆみ 243 (13) : 1024-1030, 2012.
Medical*Online
3) Sakai F, Igarashi H : Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 17 (1) : 15-22, 1997.
PubMed
4) Takeshima T, et al : Population-based door-to-door survey of migraine in Japan : the Daisen study. Headache 44 (1) : 8-19, 2004.
PubMed
5) 濱田潤一 : 片頭痛の前兆と疼痛のメカニズムはどのように考えられているか. Modern Physician 33 (10) : 1201-1204, 2013.
 
6) 濱田潤一 : 片頭痛における神経原性炎症. 日頭痛会誌 38 : 46-49, 2011.
 
7) Pietrobon D, Moskowitz M : Pathophysiology of migraine. Annu Rev Physiol 75 : 365-391, 2013.
PubMed
8) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
PubMed
9) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
10) Angus-Leppan H : Migraine : mimics, borderlands and chameleons. Pract Neurol 13 (5) : 308-318, 2013.
PubMed
P.637 掲載の参考文献
1) Sakai F, Igarashi H : Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 17 : 15-22, 1997.
PubMed
2) Russell MB, et al : A nosographic analysis of the migraine aura in a general population. Brain 119 (Pt 2) : 355-361, 1996.
 
3) Rasmussen BK, et al : Migraine with aura and migraine without aura : an epidemiological study. Cephalalgia 12 : 221-228, 1992.
PubMed
4) Leao AAP : Spreading depression of activity in the cerebral cortex. J Neurophysiol 7 : 359-390, 1944.
 
5) Olesen J, et al : Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9 (4) : 344-352, 1981.
PubMed
6) Lauritzen M : Pathophysiology of the migraine aura : the spreading depression theory. Brain 117 : 199-210, 1994.
PubMed
7) Hadjikhani N, et al : Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98 : 4687-4692, 2001.
PubMed
8) Headache Classification Committee of the International Headache Society (HIS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
9) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
10) Ferrari MD : Migraine. Lancet 351 : 1043-1051, 1998.
PubMed
11) Olesen J, et al : No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol 11 : 671-677, 2004.
PubMed
12) II 片頭痛 2. 急性期治療. 慢性頭痛の診療ガイドライン 2013 (慢性頭痛の診療ガイドライン作成委員会編), p 118-119, 医学書院, 2013.
 
P.643 掲載の参考文献
1) Bickerstaff ER : Basilar artery migraine. Lancet 1 : 15-17, 1961.
 
2) Sturzenegger MH, Meienberg O : Basilar artery migraine : a follow-up study of 82 cases. Headache 25 : 408-415, 1985.
PubMed
3) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facical pain. Cephalalgia 8 (Suppl 7) : 1-96, 1988.
 
4) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders ; 2nd edition. Cephalalgia 24 (Suppl 1) : 1-160, 2004.
 
5) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
6) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
7) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
8) 加藤昌弘, 高井一美 : 脳底動脈型片頭痛. 脳と発達 14 : 451-455, 1982.
 
9) Kirchman M, et al : Basilar-type migraine ; Clinical, epidemiologic and genetic features. Neurology 66 : 880-886, 2006.
 
10) Ying G, et al : Clinical characteristic of basilar-type migraine in the neurological clinic of a university hospital. Pain Med 15 : 1230-1235, 2014.
PubMed
11) Bickerstaff ER : Impairment of consciousness in migraine. Lancet 2 : 1057-1059, 1961.
PubMed
12) 山根清美ほか : Basilar artery migraineに関連したTGA (Transient global amnesia). 脳神経 41 : 1103-1107, 1989.
 
13) Olsen J, Jorgensen MB : Leao's spreading depression in the hippocampus explains transient global amnesia. Acta Neurol Scand 73 : 219-220, 1986.
 
14) Lewis SL : Aetiology of transient global amnesia. Lancet 352 : 397-399, 1998.
PubMed
15) Caplan L, et al : Transient global amnesia and migraine. Neurology 28 : 387, 1978 (Abstract).
 
16) 山根清美ほか : 一過性全健忘 (TGA) の原因に関する検討-特にbasilar migraineを原因にするTGAについて. 日頭痛会誌 26 : 31-33, 1999.
 
17) Dennis M, Warlow C : Migraine aura without headache : transient ischaemic attack or not? J Neurol Neurosurg Psychiatry 55 : 437-440, 1992.
PubMed
18) 山根清美ほか : 椎骨脳底動脈領域の脳血管障害と鑑別を要するbasilar migraine. 頭痛研会誌 24 : 64-65, 1997.
 
19) 山根清美, 白田明子 : Basilar migraineに合併した脳梗塞の2症例. 日頭痛会誌 27 : 128-131, 2000.
 
20) 山根清美ほか : 不思議の国のアリス症候群を呈した片頭痛 (basilar migraine) の2症例. 日頭痛会誌 28 : 22-24, 2001.
 
P.649 掲載の参考文献
1) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) Lykke TL, et al : An epidemiological survey of hemiplegic migraine. Cephalalgia 22 : 361-375, 2002.
 
4) Moskowitz MA, Macfarlane R : Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc Brain Metab Rev 5 : 159-177, 1993.
PubMed
5) Hadjikhani N, et al : Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98 : 4687-4692, 2001.
PubMed
6) Di Lorenzo C, et al : Migraine headache : a review of the molecular genetics of a common disorder. J Headache Pain 13 : 571-580, 2012.
PubMed
7) Weller CM, et al : A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood. Cephalalgia 2014 May 13. pii : 0333102414532379. [Epub ahead of print]
 
8) Bottger P, et al : Migraine-and dystonia-related disease-mutations of Na+ / K+ -ATPases : relevance of behavioral studies in mice to disease symptoms and neurological manifestations in humans. Neurosci Biobehav Rev 36 : 855-871, 2012.
 
9) Ducros A, et al : The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345 : 17-24, 2001.
 
10) 竹島多賀夫ほか : 頭痛発症に関与する遺伝子 片麻痺性片頭痛. 神経内科 66 : 244-251, 2007.
 
11) Takahashi T, et al : Japanese cases of familial hemiplegic migraine with cerebellar ataxia carrying a T666M mutation in the CACNA1A gene. J Neurol Neurosurg Psychiatry 72 : 676-677, 2002.
 
12) Suzuki M, et al : Defective membrane expression of the Na+ -HCO3-cotransporter NBCe1 is associated with familial migraine. Proc Natl Acad Sci USA 107 : 15963-15968, 2010.
PubMed
13) Uchino M, et al : Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and CADASIL-like disorders in Japan. Ann N Y Acad Sci 977 : 273-278, 2002.
PubMed
14) Richards A, et al : C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39 : 1068-1070, 2007.
 
15) Pelzer N, et al : Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia 34 : 708-711, 2014.
PubMed
16) Sanchez-Albisua I, et al : Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine. Pediatr Neurol 49 : 286-288, 2013.
PubMed
P.654 掲載の参考文献
1) Russell MB, Ducros A : Sporadic and familial hemiplegic migraine : pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10 : 457-470, 2011.
PubMed
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
4) Thomsen LL, et al : Evidence for a separate type of migraine with aura : sporadic hemiplegic migraine. Neurology 60 : 595-601, 2003.
PubMed
5) Thomsen LL, et al : An epidemiological survey of hemiplegic migraine. Cephalalgia 22 : 361-375, 2002.
 
6) Takahashi T, et al : Japanese cases of familial hemiplegic migraine with cerebellar ataxia carrying a T666M mutation in the CACNA1A gene. J Neurol Neurosurg Psychiatry 72 : 676-677, 2002.
 
7) Iizuka T, et al : Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiatry 83 : 205-212, 2012.
PubMed
8) Riant F, et al : De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology 75 : 967-972, 2010.
PubMed
9) Moskowitz MA, et al : Deciphering migraine mechanisms : clues from familial hemiplegic migraine genotypes. Ann Neurol 55 : 276-280, 2004.
PubMed
10) Leo L, et al : Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 7 : e1002129, 2011.
PubMed
11) Eikermann-Haerter K, et al : Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci 31 : 5755-5763, 2011.
PubMed
12) Zhang X, et al : Activation of meningeal nociceptors by cortical spreading depression : implications for migraine with aura. J Neurosci 30 : 8807-8814, 2010.
PubMed
13) Zhang X, et al : Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 69 : 855-865, 2011.
PubMed
14) Iizuka T, et al : Biphasic neurovascular changes in prolonged migraine aura in familial hemiplegic migraine type 2. J Neurol Neurosurg Psychiatry. doi : 10.1136/jnnp-2014-307731
 
15) Pelzer N, et al : Familial and sporadic hemiplegic migraine : diagnosis and treatment. Curr Treat Options Neurol 15 : 13-27, 2013.
PubMed
16) Schwedt TJ, et al : Sporadic hemiplegic migraine with permanent neurological deficits. Headache 54 : 163-166, 2014.
PubMed
P.660 掲載の参考文献
1) Hill DL, et al : Most cases labeled as "retinal migraine" are not migraine. J Neuroophthalmol 27 : 3-8, 2007.
PubMed
2) Galezowski X : Ophthalmic megrim : an affection of the vaso-motor nerves of the retina and retinal centre which may end in a thrombosis. Lancet 119 : 176-177, 1882.
 
3) Carroll D : Retinal migraine. Headache 10 : 9-13, 1970.
PubMed
4) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl 1) : 1-160, 2004.
 
5) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
6) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
7) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
8) Martins-Ferreira H, et al : Perspectives on spreading depression. Brain Res Brain Res Rev 32 : 215-234, 2000.
PubMed
9) Winterkorn JMS, Burde RM : Vasospasm-not migraine-in the anterior visual pathway. Ophthalmol Clin NA 9 : 393-405, 1996.
 
10) Flammer J, et al : Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 20 : 319-349, 2001.
 
11) Winterkorn JMS, et al : Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 329 : 396-398, 1993.
 
12) Gan KD : Transient monocular visual loss and retinal migraine. CMAJ 73 : 1441-1442, 2005.
 
13) Grosberg BM, et al : Retinal migraine reappraised. Cephalalgia 26 : 1275-1286, 2006.
PubMed
14) Winterkorn JMS : "Retinal migraine" is an oxymoron. J Neuroophthalmol 27 : 1-2, 2007.
PubMed
15) Ota I, et al : Fundus video of retinal migraine. JAMA Ophthalmol 131 : 1481-1482, 2013.
PubMed
16) Kline LB, Kelly CL : Ocular migraine in a patient with cluster headaches. Headache 20 : 253-257, 1980.
 
P.665 掲載の参考文献
1) The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
2) Silberstein SD, et al : Classification of daily and near-daily headaches : field trial of revised IHS criteria. Neurology 47 : 871-875, 1996.
PubMed
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
4) Lyngberg AC, et al : Prognosis of migraine and tension-type headache : a population-based follow-up study. Neurology 65 : 580-585, 2005.
PubMed
5) Bigal ME, et al : Acute migraine medications and evolution from episodic to chronic migraine : a longitudinal population-based study. Headache 48 : 1157-1168, 2008.
 
6) Scher AI, et al : Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106 : 81-89, 2003.
 
7) Bigal ME, Lipton RB : Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67 : 252-257, 2006.
 
8) Bigal ME, Lipton RB : Migraine chronification. Curr Neurol Neurosci Rep 11 : 139-148, 2011.
PubMed
9) Louter MA, et al : Cutaneous allodynia as a predictor of migraine chronification. Brain 136 : 3489-3496, 2013.
PubMed
10) Moulton EA, et al : Interictal dysfunction of a brainstem descending modulatory center in migraine patients. PLoS One 3 : e3799, 2008.
PubMed
11) de Tommaso M, et al : Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain 101 : 25-32, 2003.
PubMed
12) de Tommaso M, et al : Changes in cortical processing of pain in chronic migraine. Headache 45 : 1208-1218, 2005.
PubMed
13) May A : A review of diagnostic and functional imaging in headache. J Headache Pain 7 : 174-184, 2006.
 
14) Mainero C, et al : Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine. Ann Neurol 70 : 838-845, 2011.
PubMed
15) Chen WT, et al : Persistent ictal-like visual cortical excitability in chronic migraine. Pain 152 : 254-258, 2011.
PubMed
16) Welch KM, et al : Periaqueductal gray matter dysfunction in migraine : cause or the burden of illness? Headache 41 : 629-637, 2001.
 
17) Rocca MA, et al : Brain gray matter changes in migraine patients with T2-visible lesions : a 3-T MRI study. Stroke 37 : 1765-1770, 2006.
PubMed
18) Schmidt-Wilcke T, et al : Subtle grey matter changes between migraine patients and healthy controls. Cephalalgia 28 : 1-4, 2008.
PubMed
19) Valfre W, et al : Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 48 : 109-117, 2008.
PubMed
20) Kim JH, et al : Regional grey matter changes in patients with migraine : a voxel-based morphometry study. Cephalalgia 28 : 598-604, 2008.
 
21) Schmitz N, et al : Attack frequency and disease duration as indicators for brain damage in migraine. Headache 48 : 1044-1055, 2008.
PubMed
22) Leong ML, et al : Neuronal loss in the rostral ventromedial medulla in a rat model of neuropathic pain. J Neurosci 31 : 17028-17039, 2011.
 
23) Maleki N, et al : Concurrent functional and structural cortical alterations in migraine. Cephalalgia 32 : 607-620, 2012.
PubMed
24) Aurora SK, et al : OnabotulinumtoxinA for treatment of chronic migraine : results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30 : 793-803, 2010.
PubMed
25) Diener HC, et al : OnabotulinumtoxinA for treatment of chronic migraine : results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30 : 804-814, 2010.
PubMed
26) Serra G, Marchioretto F : Occipital nerve stimulation for chronic migraine : a randomized trial. Pain Physician 15 : 245-253, 2012.
 
P.669 掲載の参考文献
1) 片頭痛発作重積. 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, p 11, 医学書院, 2014. (Status migrainosus. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 651, 2013. )
 
2) 救命救急室 (ER) での頭痛診療の手順はいかにあるべきか. 慢性頭痛のガイドライン2013 (日本神経学会・日本頭痛学会監修, 慢性頭痛の診療ガイドライン作成委員会編), p 12-15, 医学書院, 2013.
 
3) Jauslin P, et al : The hospital management of severe migrainous headache. Headache 31 : 658-660, 1991.
PubMed
4) Beltramone M, Donnet A : Status migrainosus and migraine aura status in a French tertiary-care center : An 11-year retrospective analysis. Cephalalgia 34 : 633-637, 2014.
 
5) Couch JR, Diamond S : Status migrainosus : Causative and therapeutic aspects. Headache 23 : 94-101, 1983.
PubMed
6) Tfelt-Hansen C, Koehler P : One Hundred Years of Migraine Research : Major Clinical And Scientific Observations From 1910 to 2010. Headache 51 : 752-778, 2011.
 
7) 稲福徹也 : 頭痛. 新・総合診療医学 病院総合診療医学編 (徳田安春編), p 66-68, カイ書林, 2012.
 
8) 秋山久尚 : 44歳, 女性 片頭痛と診断されたが, 実はくも膜下出血であった頭痛. 症例から学ぶ 戦略的片頭痛診断・治療 (平田幸一ほか編), p 123-129, 南山堂, 2010.
 
9) Simona S, et al : CADASIL presenting as status migrainosus and persisting aura without infarction. J Headache Pain 10 : 51-53, 2009.
 
10) Italiano D, et al : Recurrent occipital seizures misdiagnosed as status migrainosus. Epileptic Disord 13 : 179-201, 2011.
 
11) 小網博之ほか : 分娩後片頭痛発作の重積により, 脳血管vasospasmによるTIAを生じた1例. 沖縄県医学会雑誌 43 : 13-16, 2005.
 
12) Cure J, Rothrock J : Prolonged status migrainosus complicated by cerebellar infarction. Headache 47 : 1091-1092, 2007.
PubMed
13) 片頭痛重症発作, 発作重積の急性期治療はどのように行うか. 慢性頭痛のガイドライン 2013 (日本神経学会・日本頭痛学会監修, 慢性頭痛の診療ガイドライン作成委員会編), p 136-138, 医学書院, 2013.
 
P.674 掲載の参考文献
1) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) Haas DC : Prolonged migraine aura status. Ann Neurol 11 : 197-199, 1982.
PubMed
4) Luda E, et al : Sustained visual aura : a totally new variation of migraine. Headache 31 : 582-583, 1991.
PubMed
5) Liu GT, et al : Persistent positive visual phenomena in migraine. Neurology 45 : 664-668, 1995.
PubMed
6) Leao APP : Spreading depression of the activity of cerebral cortex. Arch Neurol Psychiatry 46 : 333-339, 1941.
 
7) Cutrer FM, et al : Functional neuroimaging : enhanced understanding of migraine pathophysiology. Neurology 55 (Suppl 2) : S36-S45, 2000.
 
8) Chen WT, et al : Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain 134 : 2387-2395, 2011.
PubMed
9) Chen WT, et al : Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 41 : 823-825, 2001.
PubMed
10) Relja G, et al : Persistent aura without infarction : description of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia 25 : 56-59, 2004.
 
11) Jager HR, et al : Diffusion-and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 25 : 323-332, 2004.
 
12) Evans RW : A persistent migraine aura. Headache 40 : 696-698, 2000.
PubMed
13) Rozen TD : Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology 55 : 732-733, 2000.
PubMed
14) Wang YF, et al : The visual aura rating scale as an outcome predictor for persistent visual aura without infarction. Cephalalgia 28 : 1298-1304, 2008.
PubMed
15) Haan J, et al : Acetazolamide treatment for migraine aura status. Neurology 55 : 1588-1589, 2000.
PubMed
16) Rothrock JF : Successful treatment of persistent migraine aura with divalproex sodium. Neurology 48 : 261-262, 1997.
PubMed
17) San-Juan OD, Zermeno PF : Migraine with persistent aura in a Mexican patient : case report and review of the literature. Cephalalgia 27 : 456-460, 2007.
 
P.679 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 651-652, 2013.
 
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) Donaghy M, et al : Duration, frequency, recency, and type of migraine and risk of ischemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 73 : 747-750, 2002.
 
4) Kurth T : Migraine and ischaemic vascular events. Cephalalgia 27 : 965-975, 2007.
PubMed
5) Schurks M, et al : Migraine and cardiovascular disease : systemic review and meta-analysis. BMJ 339 : b3914, 2009.
 
6) Sher AI, et al : Cardiovascular risk factors and migraine : the GEM population-based study. Neurology 64 : 614-620, 2005.
 
7) Hadjikhani N, et al : Mechanism of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98 : 4687-4692, 2001.
PubMed
8) Laurell K, et al : Migrainous infarction : a Nordic multicenter study. Eur J Neurol 18 : 1220-1226, 2011.
PubMed
9) Moskowitz MA : Pathophysiology of headache-past and present. Headache 47 (Suppl 1) : S58-63, 2007.
 
10) Tietjen GE : Migraine as a systemic vasculopathy. Cephalalgia 29 : 987-996, 2009.
PubMed
11) Wolf ME, et al : Clinical and MRI characteristics of acute migrainous infarction. Neurology 31 : 1911-1917, 2011.
 
12) Arai S, et al : Migrainous infarction in an adult : evaluation with serial diffusion-weighted images and cerebral blood flow studies. Radiat Med 26 : 313-317, 2008.
 
13) Arboix A, et al : Cortical laminar necrosis related to migrainous cerebral infarction. World J Clin Cases 16 : 256-259, 2013.
 
14) Liag Y, Scott TF : Migrainous infarction with appearance of laminar necrosis on MRI. Clin Neurol Neurosurg 109 : 592-596, 2007.
 
15) Goldstein LB, et al : Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42 : 517-584, 2011.
PubMed
16) Laurell K, Lundstrom E : Migrainous infarction : aspects on risk factors and therapy. Curr Pain Headache Rep 16 : 255-260, 2012.
PubMed
P.684 掲載の参考文献
1) Lennox W, Lennox M : Epilepsy and Related Disorders, Vol 1, p 449-459, Little Brown & Company, Boston, 1960.
 
2) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders ; 2nd edition. Cephalalgia 24 : 1-160, 2004.
 
3) Andermann F : Clinical features of migraine-epilepsy syndromes. In : Migraine and Epilepsy (ed by Andermann F, Lugaresi E), p 3-30, Butterworths, Boston, 1987.
 
4) Sances G, et al : Migralepsy : a call for a revision of the definition. Epilepsia 50 : 2487-2496, 2009.
 
5) Verrotti A, et al : Should "migralepsy" be considered an obsolete concept? A multicenter retrospective clinical/EEG study and review of the literature. Epilepsy Behav 21 : 52-59, 2011.
PubMed
6) Verrotti A, et al : Migralepsy and related conditions : advances in pathophysiology and classification. Seizure 20 : 271-275, 2011.
PubMed
7) Belcastro V, et al : Migralepsy, hemicrania epileptica, post-ictal headache and "ictal epileptic headache" : a proposal for terminology and classification revision. J Headache Pain 12 : 289-294, 2011.
PubMed
8) Shibata Y, et al : Our clinical experience with migraine-triggered seizure. Japanese Journal of Headache 35 : 76-78, 2009.
 
9) 柴田靖 : Migralepsy : migraine triggered seizure. 日頭痛会誌 40 : 120-122, 2013.
 
10) Rogawski MA : Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol 65 : 709-714, 2008.
PubMed
11) Bramwell E : Discussion on migraine. Br Med J 2 : 765-769, 1926.
 
12) Marks DA, Ehrenberg BL : Migraine-related seizures in adults with epilepsy, with EEG correlation. Neurology 43 : 2476-2483, 1993.
PubMed
13) Slatter KH : Some clinical and EEG findings in patients with migraine. Brain 91 : 85-98, 1968.
PubMed
14) Mateo I, et al : Migraine-associated seizures with recurrent and reversible magnetic resonance imaging abnormalities. Headache 44 : 265-270, 2004.
PubMed
P.687 掲載の参考文献
1) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl) : 1-160, 2004.
 
2) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, p 1-160, 医学書院, 2007.
 
3) 疋田敏之 : 小児の頭痛update 小児周期性症候群. 脳と発達 44 : 125-128, 2012.
 
4) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
5) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
6) Li BU, Misiewicz L : Cyclic vomiting syndrome : a brain-gut disorder. Gastroenterol Clin North Am 32 : 997-1019, 2003.
PubMed
7) Stickler GB : Relationship between cyclic vomiting syndrome and migraine. Clin Pediatr (Phila) 44 : 505-508, 2005.
PubMed
8) Li BU : Cyclic vomiting syndrome : age-old syndrome and new insights. Semin Pediatr Neurol 8 : 13-21, 2001.
PubMed
9) Benson JM, et al : Sumatriptan in the treatment of cyclic vomiting. Ann Pharmacother 29 : 997-999, 1995.
PubMed
10) Hikita T, et al : Sumatriptan as a treatment for cyclic vomiting syndrome : a clinical trial. Cephalalgia 31 : 504-507, 2011.
PubMed
11) Hikita T, et al : Effective prophylactic therapy for cyclic vomiting syndrome in children using valproate. Brain Dev 31 : 411-413, 2009.
PubMed
12) 児玉浩子, 疋田敏之 : 周期性嘔吐症候群の最近の知見と治療. 小児科 48 : 1309-1315, 2007.
 
13) Gokhale R, et al : Use of barbiturates in the treatment of cyclic vomiting during childhood. J Pediatr Gastroenterol Nutr 25 : 64-67, 1997.
PubMed
14) Andersen JM, et al : Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 100 : 977-981, 1997.
PubMed
15) 疋田敏之ほか : Valproate sodiumとphenobarbitalの併用が予防に有効であった周期性嘔吐症候群の2例. 脳と発達 40 : 393-396, 2008.
Medical*Online
P.691 掲載の参考文献
1) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl) : 1-160, 2004.
 
2) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, p 1-160, 医学書院, 2007.
 
3) 疋田敏之 : 小児の頭痛update 小児周期性症候群. 脳と発達 44 : 125-128, 2012.
 
4) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
5) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
6) Abu-Arafeh I, Russell G : Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Arch Dis Child 72 : 413-417, 1995.
PubMed
7) Mortimer MJ, et al : Clinical epidemiology of childhood abdominal migraine in an urban general practice. Dev Med Child Neurol 35 : 243-248, 1993.
 
8) Worawattanakul M, et al : Abdominal migraine : prophylactic treatment and follow-up. J Pediatr Gastroenterol Nutr 28 : 37-40, 1999.
PubMed
9) 大日方薫 : ちょっと気になる症状のみかた, 考えかた くり返す腹痛. 小児内科 28 : 1433-1436, 1996.
 
10) Moran JA : Adult abdominal migraine and sumatriptan : a case report. Ir Med J 91 : 215-216, 1998.
PubMed
11) Kakisaka Y, et al : Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders : does the mechanism overlap that of migraine? J Child Neurol 25 : 234-237, 2010.
 
12) Raina M, et al : Intravenous dihydroergotamine therapy for pediatric abdominal migraines. Clin Pediatr (Phila) 52 : 918-921, 2013.
PubMed
13) Tan V, et al : Abdominal migraine and treatment with intravenous valproic acid. Psychosomatics 47 : 353-355, 2006.
PubMed
14) Dignan F, et al : The prognosis of childhood abdominal migraine. Arch Dis Child 84 : 415-418, 2001.
PubMed
P.696 掲載の参考文献
1) Basser LS : Benign paroxysmal vertigo of childhood. Brain 87 : 141-152, 1964.
PubMed
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
PubMed
3) Russell G, Abu-Arafeh I : Paroxysmal vertigo in children-an epidemiologic study. Int J Pediatr Otorhinolaryngol 49 (Suppl 1) : 105-107, 1999.
 
4) Erbek SH, et al : Vertigo in childhood : a clinical experience. Int J Pediatr Otorhinolaryngol 70 : 1547-1554, 2006.
PubMed
5) 上田直子ほか : 小児めまい症例の疾患分類と平衡機能検査. Equilibrium Res 69 : 39-46, 2010.
 
6) Dunn DW, Snyder CH : Benign paroxysmal vertigo of childhood. Am J Dis Child 130 : 1099-1100, 1976.
PubMed
7) Cass SP, et al : Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 106 : 182-189, 1997.
PubMed
8) Drigo P, et al : Benign paroxysmal vertigo of childhood. Brain Dev (Netherlands) 23 : 38-41, 2001.
 
9) Batuecas-Caletrio A, et al : Is benign paroxysmal vertigo of childhood a migraine precursor? Eur J Paediatr Neurol 17 : 397-400, 2013.
PubMed
10) Lanzi G, et al : Benign paroxysmal vertigo in childhood : a longitudinal study. Headache 26 : 494-497, 1986.
PubMed
11) Zhang D, et al : Benign paroxysmal vertigo of childhood : diagnostic value of vestibular test and high stimulus rate auditory brainstem response test. Int J Pediatr Otorhinolaryngol 76 : 107-110, 2012.
PubMed
12) Eeg-Olofsson O, et al : Benign paroxysmal vertigo in childhood. Acta Otolaryngol 93 : 283-289, 1982.
PubMed
13) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
14) Inoue Y, Yabe T : Lomerizine therapy for the treatment of benign paroxysmal vertigo of childhood transitioning into atypical basilar migraine : A case report. Exp Ther Med 5 : 1573-1575, 2013.
PubMed
15) Kabbouche MA : Childhood periodic syndromes. In : Pediatric Headache in Clinical Practice (ed by Hershey AD, et al), p 101-114, Wiley-Blackwell, Hoboken, 2009.
 
16) Krams B, et al : Benign paroxysmal vertigo of childhood : long-term outcome. Cephalalgia 31 : 439-443, 2011.
PubMed
P.700 掲載の参考文献
1) Snyder CH : Paroxysmal torticollis in infancy : A possible form of labyrinthitis. Am J Dis Child 117 : 458-460 , 1969.
PubMed
2) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, p 1-160, 医学書院, 2007.
 
3) Headache Classification Committee of the International Headache Society, The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
 
4) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
5) Sanner G, Bergstrom B : Benign paroxysmal torticollis in infancy. Acta Paediatr Scand 68 : 219-223, 1979.
PubMed
6) Deonna T, Martin D : Benign paroxysmal torticollis in infancy. Arch Dis Child 56 : 956-959, 1981.
PubMed
7) Hanukoglu A, et al : Benign paroxysmal torticollis in infancy. Clin Pediatr (Phila) 23 : 272-274, 1984.
PubMed
8) Guerrero Vazquez J, et al : Benign paroxysmal torticollis. Apropos of 3 cases. An Esp Pediatr 29 : 149-152, 1988.
PubMed
9) Angelini L, et al : Transient paroxysmal dystonia in infancy. Neuropediatrics 19 : 171-174, 1988.
 
10) Ishida T, et al : Benign paroxysmal torticollis in infancy : case report. No To Hattatsu 22 : 274-278, 1990. (Japanese)
PubMed
11) Bratt HD, Menelaus MB : Benign paroxysmal torticollis of infancy. J Bone Joint Surg Br 74B : 449-451, 1992.
 
12) Cohen HA, et al : Benign paroxysmal torticollis in infancy. Pediatr Neurol 9 : 488-490, 1993.
PubMed
13) Cataltepe SU, Barron TF : Benign paroxysmal torticollis presenting as "seizures" in infancy. Clin Pediatr (Phila) 32 : 564-565, 1993.
PubMed
14) Gupta AK, et al : Torticollis secondary to posterior fossa tumors. J Pediatr Orthop 16 : 505-507, 1996.
PubMed
15) Kimura S, Nezu A : Electromyographic study in an infant with benign paroxysmal torticollis. Pediatr Neurol 19 : 236-238, 1998.
 
16) Balslev T, et al : Benign paroxysmal torticollis. Recurrent involuntary twisting of the head in infants and young children. Ugeskr Laeger 160 : 5365-5367, 1998.
PubMed
17) Drigo P, et al : Benign paroxysmal torticollis of infancy. Brain Dev 22 : 169-172, 2000.
PubMed
18) Giffin NJ, et al : Benign paroxysmal torticollis of infancy : four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol 44 : 490-493, 2002.
PubMed
19) Dimitrijevic L, et al : Benign paroxysmal torticollis in infancy. Vojnosanit Pregl 63 : 69-71, 2006. (Serbian)
PubMed
20) Scagni P, et al : Benign paroxysmal torticollis of infancy. A case report. Minerva Pediatr 58 : 499-501, 2006.
PubMed
21) Casella LB, et al : Benign paroxysmal torticollis of infancy : diagnosis and clinical evolution of six patients. Arq Neuropsiquiatr 64 : 845-848, 2006. (Portuguese)
PubMed
22) Roubertie A, et al : Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. J Neurol 255 : 1600-1602, 2008.
 
23) Rosman NP, et al : The neurology of benign paroxysmal torticollis of infancy : report of 10 new cases and review of the literature. J Child Neurol 24 : 155-160, 2009.
PubMed
24) Vila-Pueyo M, et al : A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy. Eur J Paediatr Neurol 18 : 430-433, 2014.
PubMed
P.705 掲載の参考文献
1) Bendtsen L, et al : Tension-type headache : mechanisms. Handb Clin Neurol 97 : 359-366, 2010.
PubMed
2) Stovner LJ, et al : The global burden of headache : a documentation of headache prevalence and disability world wide. Cephalalgia 27 : 193-210, 2007.
 
3) 北川泰久 : 緊張型頭痛のメカニズム-末梢性から中枢性因子へ. 日頭痛会誌 35 : 1-7, 2008.
 
4) Ristic D, et al : Acetylsalicylic acid inhibits α,β-meATP-induced facilitation of neck muscle nociception in mice-implications for acute treatment of tension-type headache. Eur J Pharmacol 673 : 13-19, 2011.
 
5) Tornoe B, et al : Reduced neck-shoulder muscle strength and aerobic power together with increased pericranial tenderness are associated with tension-type headache in girls : A case-control study. Cephalalgia 34 : 540-547, 2013.
PubMed
6) Arendt-Nielsen L, et al : Experimental muscle pain impairs descending inhibition. Pain 140 : 465-471, 2008.
PubMed
7) Bezov D, et al : Pain perception studies in tension-type headache. Headache 51 : 262-271, 2011.
PubMed
8) Fumal A, Schoenen J : Tension-type headache : current research and clinical management. Lancet Neurol 7 : 70-83, 2008.
PubMed
9) Buchgreitz L, et al : Abnormal pain processing in chronic tension-type headache : a high-density EEG brain mapping study. Brain 131 : 3232-3238, 2008.
PubMed
10) Rossi P, et al : The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms. Clin Neurophysiol 122 : 1075-1085, 2011.
 
11) Olesen J : The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120 : 157-171, 2008.
PubMed
12) Yildirim G, et al : Randomised controlled blink reflex in patients with migraine and tension type headache. J Pak Med Assoc 61 : 978-982, 2011.
PubMed
13) Della VC, et al : Peripheral interleukin-1β levels are elevated in chronic tension-type headache patients. Pain Res Manag 18 : 301-306, 2013.
 
14) Blaauw BA, et al : Anxiety, depression and behavioral problems among adplescents with recurrent headache : the Young-HUNT study. J Headache Pain 15 : 38, 2014.
 
15) 山口智 : 鍼治療がヒトの瞳孔反応に及ぼす影響. 自律神経 40 : 157-161, 2003.
 
P.710 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
PubMed
2) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders : 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
3) Takeshima T, et al : Population-based door to door survey of migraine in Japan : the Daisen study. Headache 44 (1) : 8-19, 2004.
PubMed
4) Crystal SC, et al : Tension-type headache in the elderly. Curr Pain Headache Rep 13 : 474-478, 2009.
PubMed
5) Fumal A, et al : Tension-type headache : current research and clinical management. Lancet Neurol 7 : 70-83, 2008.
PubMed
6) Buchgreitz L, et al : Increased prevalence of tension-type headache over a 12-year period is related to increased pain sensitivity. A population study. Cephalalgia 27 : 145-152, 2007.
 
7) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
8) Diamond S, et al : Ibuprofen plus caffeine in the treatment of tension-type headache. Clin Pharmacol Ther 68 : 312-319, 2008.
 
9) Diener HC, et al : The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache : a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25 : 776-787, 2005.
 
10) Scher AI, et al : Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106 : 81-89, 2003.
 
11) Bendtsen L, et al : EFNS guideline on the treatment of tension-type headache-report of an EFNS task force. Eur J Neurol 17 : 1318-1325, 2010.
PubMed
12) Fumal A, et al : Tension-type headache : current research and clinical management. Lancet Neurol 7 (1) : 70-83, 2008.
PubMed
13) Lyngberg AC, et al : Prognosis of migraine and tension-type headache : a population-based follow-up study. Neurology 65 (4) : 580-585, 2005.
PubMed
P.714 掲載の参考文献
1) Headache Classification Committee of the International Headache Society : 2. Tension-type headache (TTH). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 672-682, 2013.
 
2) Sahler K : Epidemiology and cultural differences in tension-type headache. Curr Pain Headache Rep 16 : 525-532, 2012.
PubMed
3) Sakai F, Igarashi H : Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 17 : 15-22, 1997.
PubMed
4) Takeshima T, et al : Population-based door-to-door survey of migraine in Japan : the Daisen study. Headache 44 : 8-19, 2004.
PubMed
5) 五十嵐久佳 : 慢性頭痛, 分類と疫学. 日内会誌 90 : 567-573, 2001.
 
6) 慢性頭痛の診療ガイドライン作成委員会 : III 緊張型頭痛. 慢性頭痛の診療ガイドライン2013, p 189-213, 医学書院, 2013.
 
7) Jensen R : Peripheral and central mechanisms in tension-type headache : an update. Cephalalgia 23 (Suppl 1) : 49-52, 2003.
 
8) 大熊壮尚 : 緊張型頭痛の病態と治療. 医学のあゆみ 243 (13) : 1161-1166, 2012.
Medical*Online
9) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
10) 日本頭痛学会・国際頭痛分類普及委員会 : 4. その他の一次性頭痛. 国際頭痛分類 第2版 新訂増補日本語版, p 32-38, 医学書院, 2007.
 
11) Mathew NT : Transformed migraine. Cephalalgia 13 (Suppl 12) : 78-83, 1993.
 
12) Nauman M, et al : Assessment : Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 : 1707-1714, 2008.
 
13) Nestoriuc Y, et al : Meta-analysis of biofeedback for tension-type headache : efficacy, spasticity, and treatment moderators. J Consult Clin Psychol 76 : 379-396, 2008.
 
14) Davis MA, et al : Acupuncture for tension-type headache : a meta-analysis of randomized, controlled trials. J Pain 9 : 667-677, 2008.
PubMed
15) Lyngberg AC, et al : Prognosis of migraine and tension-type headache : a population-based follow -up study. Neurology 65 : 580-585, 2005.
PubMed
16) Crystal SC, et al : Tension-type headache in the elderly. Curr Pain Headache Rep 13 : 474-478, 2009.
PubMed
P.718 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) Leone M, Bussone G : Pathophysiology of trigeminal autonomic cephalalgias. Lancet 8 : 755-764, 2009.
PubMed
3) May A : Cluster headache : pathogenesis, diagnosis, and management. Lancet 366 : 843-855, 2005.
PubMed
4) Goadsby PJ, Edvinsson L : Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117 : 427-434, 1994.
 
5) 今井昇 : 群発頭痛の中枢神経の機能異常. Clin Neurosci 25 : 586-587, 2007.
 
6) May A, et al : Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 5 : 836-838, 1999.
 
7) May A, et al : Hypothalamic activation in cluster headache attacks. Lancet 352 : 275-278, 1998.
PubMed
8) Wang SJ, et al : Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache. J Neurol Neurosurg Psychiatry 77 : 622-625, 2006.
PubMed
9) Lodi R, et al : Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy. Neurology 66 : 1264-1266, 2006.
PubMed
10) de Lecea L, et al : The hypocretins : hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95 : 322-327, 1998.
PubMed
11) Leone M, et al : Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 15 : 224-229, 1995.
PubMed
12) Bartsch T, et al : Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 109 : 367-378, 2004.
 
13) Hardebo JE : How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibers. Headache 34 : 125-131, 1994.
PubMed
14) Lieba-Samal D, Wober C : Sexhormones and primary headaches other than migraine. Curr Pain Headache Rep 5 : 407-414, 2011.
 
15) Schurks M : Genetics of cluster headache. Curr Pain Headache Rep 14 : 132-139, 2010.
PubMed
P.722 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 665-671, 2013.
 
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) 慢性頭痛の診療ガイドライン作成委員会 (編) : 群発頭痛およびその他の三叉神経・自律神経性頭痛. 慢性頭痛の診療ガイドライン 2013, p 215-238, 医学書院, 2013.
 
4) Fischera M, et al : The incidence and prevalence of cluster headache : a meta-analysis of population-based studies. Cephalalgia 28 : 614-618, 2008.
PubMed
5) Imai N, et al : Clinical profile of cluster headaches in Japan : low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness. Cephalalgia 31 : 628-633, 2011.
PubMed
6) Russell MB, et al : Familial occurrence of cluster headache. J Neurol Neurosurg Psychiatry 58 : 341-343, 1995.
PubMed
7) Leone M, et al : Increased familial risk of cluster headache. Neurology 56 : 1233-1236, 2001.
PubMed
8) 今井昇 : 本邦における群発頭痛の実態. 臨床神経 53 : 1128-1130, 2013.
 
9) Torelli P, et al : Possible predictive factors in the evolution of episodic to chronic cluster headache. Headache 40 : 798-808, 2000.
PubMed
10) Rozen TD : Cluster headache as the result of secondhand cigarette smoke exposure during childhood. Headache 50 : 130-132, 2010.
PubMed
11) Bahra A, et al : Cluster headache : a prospective clinical study with diagnostic implications. Neurology 58 : 354-361, 2002.
PubMed
12) Rozen TD, et al : Cluster headache in the United States of America : demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache 52 : 99-113, 2012.
PubMed
13) Lin KH, et al : Cluster headache in the Taiwanese-a clinic-based study. Cephalalgia 24 : 631-638, 2004.
PubMed
14) Dong Z, et al : Clinical profile of cluster headaches in China-a clinic-based study. J Headache Pain 14 : 27, 2013.
 
15) Torelli P, et al : Pain and behaviour in cluster headache. A prospective study and review of the literature. Funct Neurol 18 : 205-210, 2003.
PubMed
16) Imai N, et al : Websites offer helpful information concerning consultation with headache specialists. Cephalalgia 30 : 496-499, 2010.
PubMed
17) van Vliet JA, et al : Features involved in the diagnostic delay of cluster headache. J Neurol Neurosurg Psychiatry 74 : 1123-1125, 2003.
PubMed
P.727 掲載の参考文献
1) Sjaastad O, Dale I : A new (?) clinical headache entity "chronic paroxysmal hemicrania" 2. Acta Neurol Scand 54 : 140-159, 1976.
PubMed
2) Kudrow L, et al : Episodic paroxysmal hemicrania? Cephalalgia 7 : 197-201, 1987.
PubMed
3) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
4) Boes CJ, Swanson JW : Paroxysmal hemicrania, SUNCT, and hemicrania continua. Semin Neurol 26 : 260-270, 2006.
PubMed
5) Antonaci F, Sjaastad O : Chronic paroxysmal hemicrania (CPH) : a review of the clinical manifestations. Headache 29 : 648-656, 1989.
PubMed
6) Boes CJ, Dodick DW : Refining the clinical spectrum of chronic paroxysmal hemicrania : a review of 74 patients. Headache 42 : 699-708, 2002.
PubMed
7) Goadsby PJ, Lipton RB : A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 120 : 193-209, 1997.
PubMed
8) Matharu MS, et al : Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 63 : 1637-1677, 2003.
PubMed
9) May A, et al : PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 55 : 1328-1335, 2000.
PubMed
10) May A, et al : Functional magnetic resonance imaging in spontaneous attacks of SUNCT : short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 46 : 791-794, 1999.
PubMed
11) Sprenger T, et al : SUNCT : bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 113 : 422-426, 2005.
PubMed
12) Matharu MS, et al : Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 44 : 747-761, 2004.
PubMed
13) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
14) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
15) 日本頭痛学会 (編) : 慢性頭痛の診療ガイドライン, 医学書院, 2013.
 
P.731 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (HIS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
 
2) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
3) Cohen AS : Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia 27 : 824-832, 2007.
PubMed
4) Bouhassira D, et al : SUNCT syndrome, A case of transformation from trigeminal neuralgia? Cephalalgia 14 : 168-170, 1994.
PubMed
5) Leone M, et al : Coexistence of TACS and trigeminal neuralgia : pathophysiological conjectures. Headache 46 : 1565-1570, 2006.
PubMed
6) Cohen AS, et al : Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)-a prospective clinical study of SUNCT and SUNA. Brain 129 : 2746-2760, 2006.
 
7) Leone M, Bussone G : Pathophysiology of trigeminal autonomic cephalagias. Lancet Neurol 8 : 755-764, 2009.
 
8) Favoni V, et al : SUNCT/SUNA and neurovascular compression : new cases and critical literature review. Cephalalgia 33 (16) : 1337-1348, 2013.
PubMed
9) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
10) Graff-Radford SB : SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 20 : 515-517, 2000.
PubMed
11) Etemadifar M, et al : Efficacy of gabapentin in the treatment of SUNCT syndrome. Cephalalgia 28 : 1339-1342, 2008.
PubMed
12) Williams MH, Broadley SA : SUNCT and SUNA : clinical features and medical treatment. J Clin Neurosci 15 : 526-534, 2008.
PubMed
13) Gardella L, et al : A case of a patient with SUNCT syndrome treated with Jannetta procedure. Cephalalgia 21 : 996-999, 2001.
 
14) Leone M, et al : Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol 57 : 924-927, 2005.
PubMed
15) May A, et al : EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 13 : 1066-1077, 2006.
PubMed
16) Goadsby PJ : Trigeminal autonomic cephalalgias. Continuum (Minneap Minn) 18 (4) : 883-895, 2012.
PubMed
P.735 掲載の参考文献
1) Medina JL, Diamond S : Cluster headache variant : spectrum of a new headache syndrome. Arch Neurol 38 : 705-709, 1981.
PubMed
2) Boghen D, Desaulniers N : Background vascular headache : relief with indomethacin. Can J Neurol Sci 10 : 270-271, 1983.
PubMed
3) Sjaastad O, Spierings EL : "Hemicrania continua" : another headache absolutely responsive to indomethacin. Cephalalgia 4 : 65-70, 1984.
PubMed
4) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
5) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
6) Dodick D : Hemicrania continua : diagnostic criteria and nosologic status. Cephalalgia 21 : 869-872, 2001.
PubMed
7) Peres MFP, et al : Hemicrania continua is not that rare. Neurology 57 : 948-951, 2001.
 
8) Goadsby PJ, Lipton RB : A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 120 : 193-209, 1997.
PubMed
9) Boes CJ, Swanson JW : Paroxysmal hemicrania, SUNCT, and hemicrania continua. Semin Neurol 26 : 260-270, 2006.
PubMed
10) Matharu MS, et al : Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs 63 : 1637-1677, 2003.
PubMed
11) May A, et al : PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 55 : 1328-1335, 2000.
PubMed
12) May A, et al : Functional magnetic resonance imaging in spontaneous attacks of SUNCT : short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol 46 : 791-794, 1999.
PubMed
13) Sprenger T, et al : SUNCT : bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression. Pain 113 : 422-426, 2005.
PubMed
14) Matharu MS, et al : Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 44 : 747-761, 2004.
PubMed
15) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
16) 日本頭痛学会 (編) : 慢性頭痛の診療ガイドライン, 医学書院, 2013.
 
P.739 掲載の参考文献
1) Tinnel J : La cephalee a l'effort. Syndrome de distension douloureuse des veines intracraniennes. Medecine 13 : 113-118, 1932.
 
2) Symonds C : Cough headache. Brain 79 : 557-568, 1956.
PubMed
3) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl) : 61-62, 1987.
 
4) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders ; 2nd edition (ICHD-II). (訳 : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007. )
 
5) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
6) 寺本純 : 良性咳嗽性頭痛の臨床的検討. 日頭痛会誌 30 : 124-125, 2003.
 
7) 寺本純 : 臨床頭痛学, p 384-386, 診断と治療社, 2005.
 
8) Williams B : Cerebrospinal fluid pressure changes in response to coughing. Brain 99 : 331-346, 1976.
PubMed
9) Williams B : Cough headache due to craniospinal pressure dissociation. Arch Neurol 37 : 226-230, 1980.
PubMed
10) Smith WS, Messing RO : Cerebral aneurysm presenting as cough headache. Headache 33 : 203-204, 1993.
PubMed
11) Mathew NT : Indomethacin responsive headache syndrome. Headache 21 : 147-150, 1981.
PubMed
12) Meyer JS : Effort (exertional) headache and migraine. In : Wolff's Headache, 6th ed (ed by Dalessio DJ, Silberstein SD), p 228-230, Oxford Univ Press, New York, 1993.
 
P.742 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) Rooke ED : Benign exertional headache. Med Clin North Am 52 : 801-808, 1968.
PubMed
3) Rasmussen BK, Olesen J : Symptomatic and nonsymptomatic headaches in a general population. Neurology 42 : 1225-1231, 1992.
 
4) Williams SJ, Nukada H : Sport and exercise headache : part 2. Diagnosis and classification. Br J Sports Med 28 : 96-100, 1994.
PubMed
5) Sjaastad O, Bakketeig LS : Exertional headache. I. Vaga study of headache epidemiology. Cephalalgia 22 : 784-790, 2002.
PubMed
6) Chen SP, et al : Exertional headache-a survey of 1963 adolescents. Cephalalgia 29 : 401-407, 2009.
PubMed
7) Van der Ende-Kastelijn K, et al : An online survey of exercise-related headaches among cyclists. Headache 52 : 1566-1573, 2012.
PubMed
8) Pascual J, et al : Headaches precipitated by cough, prolonged exercise or sexual activity : a prospective etiological and clinical study. J Headache Pain 9 : 259-266, 2008.
PubMed
9) Doepp F, et al : Incompetence of internal jugular valve in patients with primary exertional headache : a risk factor? Cephalalgia 28 : 182-185, 2007.
PubMed
10) Heckmann JG, et al : Benign exertional headache/benign sexual headache : a disorder of myogenic cerebrovascular autoregulation? Headache 37 : 597-598, 1997.
PubMed
11) Kordi R, et al : Hemodynamic changes after static and dynamic exercises and treadmill stress test ; different patterns in patients with primary benign exertional headache? Acta Med Iran 50 : 399-403, 2012.
PubMed
12) Pascual J, et al : Cough, exertional, and sexual headaches : An analysis of 72 benign and symptomatic cases. Neurology 46 : 1520-1524, 1996.
PubMed
13) 日本頭痛学会 : 慢性頭痛の診療ガイドライン 2013, p 242-244, 医学書院, 2013.
 
14) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
15) Diamond S : Prolonged benign exertional headache : Its clinical characteristics and response to indomethacin. Headache 22 : 96-98, 1982.
PubMed
16) 池田憲ほか : Propranolol hydrochlorideによる一次性労作性頭痛の予防効果 : indometacinとの比較. 神経治療 25 : 605-608, 2008.
Medical*Online
P.746 掲載の参考文献
1) Kriz K : Coitus as a factor in the pathogenesis of neurologic complications. Cesk Neurol 33 : 162-167, 1970.
PubMed
2) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7) : 1-89, 2004.
 
3) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, p 32-38, 医学書院, 2007.
 
4) Rasmussen BK, Olesen J : Symptomatic and nonsymptomatic headaches in a general population. Neurology 42 : 1225-1231, 1992.
 
5) Tugba T, et al : Features of stabbing, cough, exertional and sexual headache in a Turkish population of headache patients. J Clin Neurosci 15 : 774-777, 2008.
 
6) Lance JW : Headaches related to sexual activity. J Neurol Neurosurg Psychiatry 38 : 1226-1230, 1976.
 
7) Silbert PL, et al : Benign vascular sexual headache and exertional headache : interrelationships and long term prognosis. J Neurol Neurosurg Psychiatry 54 : 417-421, 1991.
PubMed
8) Frese A, et al : Headache associated with sexual activity : demography, clinical features, and comorbidity. Neurology 61 : 796-800, 2003.
PubMed
9) Yeh YC, et al : Clinical features, imaging findings and outcomes of headache associated with sexual activity. Cephalalgia 30 : 1329-1335, 2010.
PubMed
10) Turner IM, Harding TM : Headache and sexual activity : A review. Headache 48 : 1254-1256, 2008.
PubMed
11) Pascual J, et al : Cough, exertional, and sexual headaches : an analysis of 72 benign and symptomatic cases. Neurology 46 : 1520-1524, 1996.
PubMed
12) Frese A, et al : Triptans in orgasmic headache. Cephalalgia 26 : 1458-1461, 2006.
PubMed
13) Paulson GW, Klawans HL : Benign orgasmic cephalalgia. Headache 13 : 181-187, 1974.
PubMed
14) Ostergaard JR, Kraft M : Benign coital headache. Cephalalgia 12 : 353-355, 1992.
PubMed
15) Frese A, et al : Headache associated with sexual activity : prognosis and treatment options. Cephalalgia 27 : 1265-1270, 2007.
PubMed
P.749 掲載の参考文献
1) Day JW, Raskin NH : Thunderclap headache : symptom of unruptured cerebral aneurysm. Lancet 2 (8518) : 1247-1248, 1986.
PubMed
2) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
3) Linn FH : Primary thunderclap headache. In : Handbook of Clinical Neurology (ed by Nappi G, Moskowitz MA), Vol 97, p 473-481, Elsevier BV, Netherlands, 2010.
 
4) Linn FH, et al : Follow-up of idiopathic thunderclap headache in general practice. J Neurol 246 (10) : 946-948, 1999.
PubMed
5) Schwedt TJ, et al : Thunderclap headache. Lancet Neurol 5 (7) : 621-631, 2006.
PubMed
6) Headache Classification Committee of the International Headache Society : International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
7) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
8) Schwedt TJ : Thunderclap headaches : a focus on etiology and diagnostic evaluation. Headache 53 (3) : 563-569, 2013.
PubMed
9) Polmear A : Sentinel headaches in aneurysmal subarachnoid haemorrhage : what is the true incidence? A systematic review. Cephalalgia 23 (10) : 935-941, 2003.
PubMed
10) Bosche B, et al : Members of the Cooperative Study of Brain Injury Depolarizations (COSBID) : Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex. Ann Neurol 67 (5) : 607-617, 2010.
PubMed
11) Singhal AB, et al : Reversible cerebral vasoconstriction syndromes : analysis of 139 cases. Arch Neurol 68 (8) : 1005-1012, 2011.
PubMed
12) Ducros A, et al : The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130 : 3091-3101, 2007.
PubMed
13) Ducros A, et al : Hemorrhagic manifestation of reversible cerebral vasoconstriction syndrome. Stroke 41 : 2505-2511, 2010.
PubMed
14) Negoro K, et al : Benign hot bath-related headache. Headache 40 (2) : 173-175, 2000.
PubMed
15) Wang SJ, et al : Bath-related thunderclap headache : a study of 21 consecutive patients. Cephalalgia 28 (5) : 524-530, 2008.
PubMed
16) Lu SR, et al : Nimodipine for treatment of primary thunderclap headache. Neurology 62 (8) : 1414-1416, 2004.
PubMed
P.753 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) Rasmussen BK, Olesen J : Symptomatic and nonsymptomatic headaches in a general population. Neurology 42 : 1225-1231, 1992.
 
4) Fuh JL, et al : Ice-cream headache-a large survey of 8359 adolescents. Cephalalgia 23 : 977-981, 2003.
PubMed
5) 斎須章浩ほか : 本邦における機能性頭痛 (冷たいものの摂取, 咳, 外的圧迫) の頻度. 日頭痛会誌 33 : 94, 2006.
 
6) Raskin NH, Knittle SC : Ice cream headache and orthostatic symptoms in patients with migraine. Headache 16 : 222-225, 1976.
PubMed
7) Selekler HM, et al : Prevalence and clinical characteristics of an experimental model of 'ice-cream headache' in migraine and episodic tension-type headache patients. Cephalalgia 24 : 293-297, 2004.
PubMed
8) Smith RO : ICE CREAM HEADACHE. Va Med Mon 90 : 562-564, 1963.
PubMed
9) Wolff HG (ed) : Headache and Other Head Pain, 2nd ed, Oxford University Press, Oxford, 1963.
 
10) Raskin NH : Headache, 2nd ed, Churchill Livingstone, London, 1998.
 
11) Sleigh JW : Ice cream headache. Cerebral vasoconstriction causing decrease in arterial flow may have role. BMJ 315 : 609, 1997.
PubMed
12) Mattsson P : Headache caused by drinking cold water is common and related to active migraine. Cephalalgia 21 : 230-235, 2001.
PubMed
P.755 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) Pestronk A, Pestronk S : Goggle migraine. N Engl J Med 308 : 226-227, 1983.
PubMed
4) Blau JN : Ponytail headache : a pure extracranial headache. Headache 44 : 411-413, 2004.
PubMed
5) Rasmussen BK, Olesen J : Symptomatic and nonsymptomatic headaches in a general population. Neurology 42 : 1225-1231, 1992.
 
6) 斎須章浩ほか : 本邦における機能性頭痛 (冷たいものの摂取, 咳, 外的圧迫) の頻度. 日頭痛会誌 33 : 94, 2006.
 
7) Lance J, Goadsby PJ : Miscellaneous headaches unassociated with a structural lesion. In : The Headaches, 2nd ed (ed by Olesen J, et al), p 752-753, Lippincott Williams & Wilkins, Philadelphia, 2000.
 
8) Rasmussen BK, Olesen J : Secondary headaches and their interrelations with primary headaches in a general population. In : Headache Classification and Epidemiology (ed by Olesen J), p 149-154, Raven Press, New York, 1994.
 
9) Krymchantowski AV : Headaches due to external compression. Curr Pain Headache Rep 14 : 321-324, 2010.
PubMed
P.759 掲載の参考文献
1) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007. 759
 
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 677, 2013.
 
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
4) Sjaastad O, et al : Chronic paroxysmal hemicrania : Mechanical precipitation of attacks. Headache 19 : 31-36, 1979.
 
5) Raskin NH, Schwartz RK : Ice pick-like pain. Neurology 30 : 203-205, 1980.
 
6) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7), 1988.
 
7) Sjaastad O, et al : The Vaga study ; epidemiology of headache I : the prevalence of ultrashort paroxysms. Cephalalgia 21 : 207-215, 2001.
PubMed
8) Pareja JH, et al : Idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia 16 : 93-96, 1996.
 
9) Guerrero AL, et al : Incidence and influence on referral of primary stabbing headache in an outpatient headache clinic. J Headache Pain 12 : 311-313, 2011.
 
10) 手塚博幸 : Idiopathic stabbing headache. 神経内科 47 : 245-250, 1997.
 
11) Pareja JH, Sjaastad O : Primary stabbing headache. Handb Clin Neurol 97 : 453-457, 2010.
 
12) 日本神経学会・日本頭痛学会 (監) : 慢性頭痛の診療ガイドライン201 (3慢性頭痛の診療ガイドライン作成委員会編), p 242-244, 医学書院, 2013.
 
13) Franca MC Jr, et al : Gabapentin-responsive idiopathic stabbing headache. Cephalalgia 24 : 993-996, 2004.
PubMed
14) Piovesan EJ, et al : COX-2 inhibitor for the treatment of idiopathic stabbing headache secondary to cerebrovascular diseases. Cephalalgia 22 : 197-200, 2002.
PubMed
P.763 掲載の参考文献
1) Pareja JA, et al : Numular headache : a coin-shaped cephalgia. Neurology 58 : 1678-1679, 2002.
PubMed
2) 国際頭痛学会・頭痛分類委員会 : 国際頭痛分類第2版 (ICHD-II). 日頭痛会誌 39 : 164-165, 2004.
 
3) Pareja JA, et al : Nummular headache update. Curr Neurol Neurosci Rep 12 : 118-124, 2012.
PubMed
4) Dai W, et al : Nummular headache : peripheral or central? One case with reappearance of nummular headache after focal scalp was removed, and literature review. Cephalalgia 33 : 390-397, 2013.
PubMed
5) Porta-Etessam J, et al : Multifocal nummular headache with trophic changes. Headache 50 : 1612-1613, 2010.
PubMed
6) Jaggi AS, Singh N : Role of different brain areas in peripheral nerve injury-induced neuropathic pain. Brain Res 1381 : 187-201, 2011.
PubMed
7) Dusitanond P, Young W : Botulinum toxin type A's efficacy in nummular headache. Headache 48 : 1379, 2008.
PubMed
8) Gracely RH, et al : Painful neuropathy : altered central processing maintained dynamically by peripheral input. Pain 51 : 175-194, 1992.
PubMed
9) Fernandez-de-Las-Penas C, et al : Depression and anxiety is not related to nummular headache. J Headache Pain 10 : 441-445, 2009.
 
10) Moon J, et al : Case series of sixteen patients with nummular headache. Cephalalgia 30 : 1527-1530, 2010.
PubMed
11) Pareja JA, et al : Epicrania fugax : an ultrabrief paroxysmal epicranial pain. Cephalalgia 28 : 257-263, 2008.
PubMed
12) Pareja JA, et al : Idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia 16 : 93-96, 1996.
PubMed
13) Trucco M : Nummular headache : another headache treated with gabapentine. J Headache Pain 8 : 137-138, 2007.
PubMed
14) Mathew NT, et al : Botulinum toxin type A for the treatment of nummular headache : four case studies. Headache 48 : 442-447, 2008.
PubMed
15) Danno D, et al : Three cases of nummular headache effectively treated with Neurotropin(R). Intern Med 52 : 493-495, 2013.
 
P.767 掲載の参考文献
1) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
4) Dodick W, et al : The hypnic ("alarm clock") headache syndrome. Cephalalgia 18 : 152-156, 1998.
 
5) Lanteri-Minet M, Donnet A : Hypnic headache. Curr Pain Headache Rep 14 : 309-315, 2010.
PubMed
6) Ghiotto N, et al : Report of eight new cases of hypnic headache and mini-review of the literature. Funct Neurol 17 : 211-219, 2002.
PubMed
7) Evers S, Goadsby PJ : Hypnic headache : clinical features, pathophysiology, and treatment. Neurology 60 : 905-909, 2003.
PubMed
8) 福原葉子ほか : 睡眠時頭痛 (hypnic headache) の本邦3症例. 臨床神経 46 : 148-153, 2006.
 
9) Donnet A, Lanteri-Minet M : A consecutive series of 22 cases of hypnic headache in France. Cephalalgia 29 : 928-934, 2009.
PubMed
10) Holle D, et al : Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia 30 : 1435-1442, 2010.
PubMed
11) Pinessi L, et al : Hypnic headache syndrome : association of the attacks with REM sleep. Cephalalgia 23 : 150-154, 2003.
PubMed
12) De Simine R, et al : Hypnic headache : an update. Neurol Sci 27 (Suppl 2) : S144-148, 2006.
 
13) Manni R, et al : Hypnic headache : PSG evidence of both REM-and NREM-related attacks. Neurology 62 : 1411-1413, 2004.
PubMed
14) Holle D, et al : Hypothalamic gray matter volume loss in hypnic headache. Ann Neurol 69 : 533-539, 2011.
PubMed
15) Diener H-C, et al : Hypnic headache : clinical course and treatment. Curr Treat options Neurol 14 : 15-26, 2012.
PubMed
16) Lisotto C, et al : Focus on therapy of hypnic headache. J Headache Pain 11 : 349-354, 2010.
 
P.769 掲載の参考文献
1) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 24 (Suppl 1) : 1-160, 2004.
 
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
3) Kavuk I, et al : Epidemiology of chronic daily headache. Eur J Med Res 8 : 236-240, 2003.
PubMed
4) Grande RB, et al : Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia 29 : 1149-1155, 2009.
PubMed
5) Diaz-Mitoma F, et al : Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet 329 : 411-414, 1987.
 
6) Li D, Rosen TD : The clinical characteristics of new daily persistent headache. Cephalalgia 22 : 66-69, 2002.
 
7) Meineri P, et al : New daily persistent headache : clinical and serological characteristics in a retrospective study. Neurol Sci 25 : s281-s282, 2004.
 
8) Robbins MS, et al : Clinical and prognostic subforms of new daily-persistent headache. Neurology 74 : 1358-1364, 2010.
PubMed
9) Takase Y, et al : Clinical features, effectiveness of drug-based treatment, and prognosis of new daily persistent headache (NDPH) : 30 cases in Japan. Cephalalgia 24 : 955-959, 2004.
PubMed
10) 小畔美弥子ほか : 新規発症持続性連日性頭痛の臨床的検討. 日頭痛会誌 35 : 71-75, 2009.
 
11) Rozen TD, et al : Cervical spine joint hypermobility : a possible predisposing factor for new daily persistent headache. Cephalalgia 26 : 1182-1185, 2006.
PubMed
12) Rosen T, Swidan SZ : Elevation of CSF tumor necrosis factorαlevels in new daily persistent headache and treatment refractory chronic migraine. Headache 47 : 1050-1055, 2007.
 
13) Kung E, et al : New daily persistent headache in the paediatric population. Cephalalgia 29 : 17-22, 2009.
PubMed
14) Peng KP, et al : New daily persistent headache : Should migrainous features be incorporated? Cephalalgia 31 : 1561-1569, 2011.
PubMed
15) Vanast WJ : New daily persistent headaches. Definition of a benign syndrome. Headache 26 : 318, 1986.
 
P.775 掲載の参考文献
1) 日本頭痛学会 : 国際頭痛分類 (第2版日本語版) 5. 頭頸部外傷による頭痛. 日頭痛会誌 31 : 42-49, 2004.
 
2) Keidel M, Ramadan N : The Headaches (ed by Olesen J, et al), p 765-770, Lippincott & Wilkins. Philadelphia, 2000.
 
3) Kelly JP, Rosenberg JH : Diagnosis and management of concussion in sports. Neurology 48 : 575-580, 1997.
PubMed
4) Landy PJB : Neurological sequelae of minor head and neck injuries. Injury 29 : 129-206, 1998.
 
5) Haas DC : Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia 16 : 486-493, 1996.
PubMed
6) Martelli MF, et al : Posttraumatic headache : neuropsychological and psychological effects and treatment implications. J Head Trauma Rehabil 14 : 49-69, 1999.
PubMed
7) Nampiaparampil DE : Prevalence of chronic pain after traumatic brain injury : a systematic review. JAMA 300 : 711-719, 2008.
PubMed
8) Bono G, et al : Whiplash injuries : clinical picture and diagnosis workup. Clin Exp Rheumatol 18 : S23-S28, 2000.
PubMed
9) Evans RW, et al : The physician survey on the postconcussion and whiplash syndromes. Headache 34 : 268-274, 1994.
PubMed
10) Hagstrom Y, Carlsson J : Prolonged functional impairments after whiplash injury. Scand J Rehabil Med 28 : 139-146, 1996.
PubMed
11) Hanson MB, et al : Medical treatment of headache after suboccipital acoustic tumour removal. Laryngoscope 108 : 1111-1114, 1998.
PubMed
12) Hagell P : Postoperative pain control after craniotomy. J Neurosci Nurs 31 : 47-49, 1999.
PubMed
13) 永関慶重 : 【頭痛最前線-よりよき頭痛診療をめざして】 二次性頭痛の診断と治療 頭頸部外傷による頭痛. 医学のあゆみ 243 : 1203-1207, 2012.
 
14) 永関慶重 : 当院における頭頸部外傷による頭痛の臨床的特徴. 日頭痛会誌 43 : 63-68, 2013.
 
15) 脳脊髄液減少症の診断・治療の確立に関する研究班 (ウェブサイト) (厚生労働省こころの健康科学研究), 主任研究者 : 嘉山孝正.
 
P.782 掲載の参考文献
1) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
2) Easton JD, et al : Definition and evaluation of transient ischemic attack : a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council ; Council on Cardiovascular Surgery and Anesthesia ; Council on Cardiovascular Radiology and Intervention ; Council on Cardiovascular Nursing ; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40 : 2276-2293, 2009.
PubMed
3) Connolly ES Jr, et al ; American Heart Association Stroke Council ; Council on Cardiovascular Radiology and Intervention ; Council on Cardiovascular Nursing ; Council on Cardiovascular Surgery and Anesthesia ; Council on Clinical Cardiology : Guidelines for the management of aneurysmal subarachnoid hemorrhage : a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 43 : 1711-1737, 2012.
PubMed
4) Inagawa T : Delayed diagnosis of aneurysmal subarachnoid hemorrhage in patients : a community-based study. J Neurosurg 115 : 707-714, 2011.
PubMed
5) Gottesman RF, et al : Clinical characteristics of symptomatic vertebral artery dissection : a systematic review. Neurologist 18 : 245-254, 2012.
PubMed
6) Katsuno M, Kobayashi S : Diagnosis of vertebral artery dissection with basiparallel anatomical scanning magnetic resonance imaging. J Nippon Med Sch 78 : 367-373, 2011.
PubMed
7) Takemoto K, et al : The new MRI modalities "BPAS and VISTA" for the diagnosis of VA dissection. Acta Neurochir Suppl 112 : 59-65, 2011.
PubMed
P.786 掲載の参考文献
1) 日本頭痛学会 (新国際分類普及委員会) ・厚生労働科学研究 (慢性頭痛の診療ガイドラインに関する研究班) 共訳 : 国際頭痛分類第2版 (ICHD-II). 日頭痛会誌 31 (1) : 2004.
 
2) 松下浩子ほか : 特発性頭蓋内圧亢進症. 小児科 42 : 825-831, 2001.
 
3) Greer M : Neurological Surgery (ed by Youmans JR), p 3179-3195, WB Saunders, Philadelphia, 1982.
 
4) Brodsky MC, Vaphiades M : Magnetis resonance imaging in pseudotumor cerebri. Ophthalmology 105 : 1866-1893, 1998.
 
5) Krishna R : Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy. J Neuroophthalmol 18 : 53-55, 1998.
PubMed
6) Phillips PH, et al : Pseudotumor cerebri in children. JAAPOS 2 : 33-38, 1998.
 
7) Youroukos S, et al : Idiopathic intracranial pressure in children. J Child Neurol 15 : 453-457, 2000.
 
8) 鈴木弘子ほか : 小児特発性頭蓋内圧亢進症の臨床および画像的検討. 脳と発達 33 : 319-322, 2001.
Medical*Online
9) 中村和幸 : 頭蓋内圧亢進性頭痛. 小児科臨床ピクシス 12小児の頭痛 (椎原弘章編), p 138-139, 中山書店, 2009.
 
P.792 掲載の参考文献
1) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
2) Forsyth PA, Posner JB : Headaches in patients with brain tumors : a study of 111 patients. Neurology 43 : 1678-1683, 1993.
PubMed
3) Vazquez-Barquero A, et al : Isolated headache as the presenting clinical manifestation of intracranial tumors : a prospective study. Cephalalgia 14 : 270-272, 1994.
PubMed
4) Kirby S, Purdy RA : Headaches and brain tumors. Neurol Clin 32 : 423-432, 2014.
PubMed
5) Ray BS, Wolf HG : Experimental studies on headache : pain-sensitive structures of the head and their significance. Arch Surg 41 : 813-856, 1940.
 
6) 黒岩義之 : 頭痛の基礎と臨床-その正しい対応のために-, p 215-225, 医薬ジャーナル社, 1996.
 
7) 間中信也 : 図説頭痛 : 診療の手引き, p 45-66, 篠原出版, 1986.
 
8) 河井信行, 田宮隆 : 脳腫瘍による頭痛の種々. Mebio 25 : 52-59, 2008.
Medical*Online
9) Nishioka H, et al : Headache associated with Rathke's cleft cyst. Headache 46 : 1580-1586, 2006.
PubMed
10) De Witt Hamer PC, et al : High risk of acute deterioration in pateients harboring symptomatic colloid cysts of the third ventricle. J Neurosurg 96 : 1041-1045, 2002.
 
11) Kahn K, Finkel A : It is a tumor-current review of headache and brain tumor. Curr Pain Headache Rep 18 : 421-428, 2014.
PubMed
12) 池田幸穂 : 二次性頭痛の現状と展望-脳腫瘍. 日頭痛会誌 40 : 59-62, 2013.
 
13) Nelson S, Taylor LP : Headaches in brain tumor patients : primary or secondary? Headache 54 : 776-785, 2014.
 
14) Ikeda Y, Matsumoto K : Peritumoral brain edema-pathogenesis and therapeutic implications-. Showa Univ J Med Sci 11 : 149-154, 1989.
 
15) Ikeda Y, et al : Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema. J Neurosurg 79 : 716-721, 1993.
PubMed
P.796 掲載の参考文献
1) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl 1) : 1-160, 2004. 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007.
 
2) Leniger T, et al : Seizure-associated headache in epilepsy. Epilepsia 42 : 1176-1179, 2001.
PubMed
3) 藤田光江 : 小児慢性反復性頭痛の研究 第2編 : てんかん性頭痛の診断における頭痛時脳波の意義について. 日小児会誌 97 : 83-92, 1993.
 
4) From the Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 : 489-501, 1981.
PubMed
5) 藤田光江 : 頭痛がてんかんの一つの症状になりうるか? 日頭痛会誌 40 : 129-133, 2013.
 
6) Laplante P, et al : Headache as an epileptic manifestation. Neurology 33 : 1493-1495, 1983.
PubMed
7) Dainese F, et al : Ictal headache : headache as first ictal symptom in focal epilepsy. Epilepsy Behav 22 : 790-792, 2011.
PubMed
8) Swaiman KF, Frank Y : Seizure headaches in children. Dev Med Child Neurol 20 : 580-585, 1978.
PubMed
9) Lewis DW, Qureshi F : Acute headache in children and adolescents presenting to the emergency department. Headache 40 : 200-203, 2000.
 
10) Forderreuther S, et al : Headache associated with epileptic seizures : epidemiology and clinical characteristics. Headache 42 : 649-655, 2002.
PubMed
11) Ito M, et al : Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia 24 : 23-28, 2004.
PubMed
12) Ito M, et al : Multi-center study on post-ictal headache in patients with localization-related epilepsy. Psychiatry Clin Neurosci 57 : 385-389, 2003.
 
13) Bernasconi A, et al : Lateralizing value of peri-ictal headache : A study of 100 patients with partial epilepsy. Neurology 56 : 130-132, 2000.
 
P.799 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) Taylor FR, Larkins MV : Headache and Chiari I malformation : clinical presentation, diagnosis, and controversies in management. Curr Pain Headache Rep 6 : 331-337, 2002.
PubMed
3) Wu YW, et al : Pediatric Chiari I malformations : do clinical and radiologic features correlate? Neurology 53 : 1271-1276, 1999.
 
4) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
5) Greenlee JD, et al : Chiari I malformation in the very young child : the spectrum of presentations and experience in 31 children under age 6 years. Pediatrics 110 : 1212-1219, 2002.
PubMed
6) 藤井本晴ほか : 脊髄空洞症を伴った小児Chiari I型奇形15症例の臨床的検討. 小児の脳神経 23 (1) : 11-16, 1998.
Medical*Online
P.804 掲載の参考文献
1) 日本頭痛学会・国際頭痛分類普及委員会訳 : 国際頭痛分類 第2版 新訂増補日本語版, p 76-92, 医学書院, 2007.
 
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
4) Olesen J, et al : The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15 : 94-100, 1995.
PubMed
5) 相川直樹ほか : 救急レジデントマニュアル, 第5版, p 314-316, 医学書院, 2013.
 
6) Yokoyama T, et al : Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12 : 1227-1233, 2003.
PubMed
7) Yokoyama M, et al : Associations between headache and stress, alcohol drinking, exercise, sleep, and comorbid health conditions in a Japanese population. J Headache Pain 10 : 177-185, 2009.
 
8) Yokoyama M, et al : Interactions between migraine and tension-type headache and alcohol drinking, alcohol flushing, and hangover in Japanese. J Headache Pain 13 : 137-145, 2012.
PubMed
9) Yokoyama M, et al : Hangover headache in Japanese male workers. Cephalalgia 25 : 988, 2005.
 
10) Yokoyama M, et al : Hangover susceptibility in relation to aldehyde dehydrogenase-2 genotype, alcohol flushing and mean corpuscular volume in Japanese workers. Alcohol Clin Exp Res 29 : 1165-1171, 2005.
PubMed
11) 前川和彦, 相川直樹 : 今日の救急治療指針, 第2版, p 751-754, 医学書院, 2012.
 
P.809 掲載の参考文献
1) Westergaard ML, et al : Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates : a systematic review. Cephalalgia 34 : 409-425, 2014.
PubMed
2) Kavuk I, et al : One-year prevalence and socio-cultural aspects of chronic headache in Turkish immigrants and German natives. Cephalalgia 26 : 1177-1181, 2006.
PubMed
3) Evers S, Marziniak M : Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9 : 391-401, 2010.
PubMed
4) Diener H-C, Limmroth V : Medication-overuse headache : a worldwide problem. Lancet Neurol 3 : 475-483, 2004.
PubMed
5) Paemeleire K, et al : Medicatoin-overuse headache in patients with cluster headache. Neurology 67 : 109-113, 2004.
 
6) Cevoli S, et al : Family history for chronic headache and drug overuse as a risk factor for migraine. Headache 48 : 412-418, 2009.
 
7) Calabresi P, Cupini LM : Medication-overuse headache : Similarities with drug addiction. Trends Pharmacol Sci 26 : 62-68, 2005.
PubMed
8) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24 (Suppl 1) : 1-160, 2004.
 
9) Silberstein SD, et al : The International Classification of Headache Disorders, 2nd edition (ICHD-II) -revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 25 : 460-465, 2005.
PubMed
10) Headache Classification Committee, et al : New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26 : 742-746, 2006.
PubMed
11) 日本頭痛学会・国際頭痛分類普及委員会 (訳) : 国際頭痛分類 第2版 新訂増補日本語版, p 159-160, 医学書院, 2007.
 
12) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
13) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
14) Rossi P, et al : Advice alone vs. structured detoxification programmes for medication overuse headache : a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 26 : 1097-1105, 2006.
PubMed
15) 慢性頭痛の診療ガイドライン作成委員会 : 慢性頭痛の診療ガイドライン2013 (日本神経学会・日本頭痛学会監), 医学書院, 2013.
 
16) Boe MG, et al : Prednisolone does not reduce withdrawal headache : a randomized, double-blind study. Neurology 69 (1) : 26-31, 2007.
 
17) Diener HC, et al : Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29 : 1021-1027, 2009.
PubMed
P.813 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) 日本食品標準成分表2010 STANDARD TABLES OF FOOD COMPOSITION IN JAPAN-2010-, 文部科学省. [http://www.mext.go.jp/component/b_menu/shingi/toushin/icsFiles/afieldfile/2011/01/25/1299012_6.pdf]
 
4) 日本神経学会, 日本頭痛学会 (監) : 慢性頭痛の診療ガイドライン2013 (慢性頭痛の診療ガイドライン作成委員会編), 医学書院, 2013.
 
5) Silberstein SD, et al : Tramadol/acetaminophen for the treatment of acute migraine pain : findings of a randomized, placebo-controlled trial. Headache 45 (10) : 1317-1327, 2005.
PubMed
6) Somerville BW : The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22 : 355-365, 1972.
PubMed
7) Sacco S, et al : Migraine in women : the roleof hormones and their impact on vascular diseases. J Headache Pain 13 : 177-189, 2012.
 
P.819 掲載の参考文献
1) Bigal ME, et al : Etiology and distribution of headaches in two Brazilian primary care units. Headache 40 (3) : 241-247, 2000.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, p 114-123, p 184-186, 医学書院, 2014.
 
3) 糸山泰人ほか : 細菌性髄膜炎の診療ガイドライン作成委員会編集 : 細菌性髄膜炎の診療ガイドライン. 神経治療学 24 (1) : 69-132, 2007.
 
4) Solbrig MV, et al : Bacterial infections. In : Neurology in Clinical Practice, Vol. 2, p 1317-1351, Butterworth-Heinemann, Woburn, 2000.
 
5) Lakeman FD, Whitley RJ : Diagnosis of herpes simplex encephalitis : application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 171 (4) : 857-863, 1995.
 
6) 西條政幸 : 日本で流行するダニ媒介性ウイルス感染症 (SFTS) とダニ媒介性脳炎. 医学のあゆみ 247 (8) : 701-702, 2013.
Medical*Online
7) Kaiser R : Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol 291 (Suppl 33) : 58-61, 2002.
 
8) Andersen M : Management of cerebral infection. J Neurol Neurosurg Psychiatry 56 : 1243-1258, 1993.
 
9) Verdon R, et al : Tuberculous meningitis in adults : review of 48 cases. Clin Infect Dis 22 (6) : 982-988, 1996.
PubMed
10) 中嶋秀人 : 感染症の治療の進歩. 神経治療 30 : 397-402, 2013.
Medical*Online
11) Auluck A : Maxillary necrosis by mucormycosis. A case report and literature review. Med Oral Patol Oral Cir Bucal 12 (5) : E360-364, 2007.
PubMed
P.829 掲載の参考文献
1) 国際頭痛分類第2版 (ICHD-II). 日頭痛会誌 31 : 13-188, 2004.
 
2) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
4) Wilson MH et al : The cerebral effects of ascent to high altitudes. Lancet Neurol 8 (2) : 175-191, 2009.
PubMed
5) Burtscher M, et al : Risk factors for high-altitude headache in mountaineers. Cephalalgia 31 : 706-711, 2011.
PubMed
6) Atkinson V, Lee L : An unusual case of an airplane headache. Headache 44 : 438-439, 2004.
PubMed
7) Mainardi F1, et al : Headache attributed to airplane travel ('airplane headache') : clinical profile based on a large case series. Cephalalgia 32 (8) : 592-599, 2012.
 
8) Kristiansen HA, et al : Sleep apnoea headache in the general population. Cephalalgia 32 : 451-458, 2012.
PubMed
9) Antoniazzi AL, Corrado AP : Dialysis headache. Curr Pain Headache Rep 11 : 297-303, 2007.
PubMed
10) Lance JW, Hinterberger H : Symptom of pheochromocytoma with particular reference to headache, correlated with catecholamine production. Arch Neurol 33 : 281-288, 1976.
PubMed
11) Thomas JE, et al : The neurologist's experience with pheochromocytoma. A review of 100 cases. JAMA 197 : 754-758, 1966.
PubMed
12) Hinchey J, et al : A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 : 494-500, 1996.
 
13) Cruz-Flores S, et al : Brainstem involvement in hypertensive encephalopathy : clinical and radiological findings. Neurology 62 : 1417-1419, 2004.
PubMed
14) Shintani S, et al : Reversible brainstem hypertensive encephalopathy (RBHE) : Clinicoradiologic dissociation. Clin Neurol Neurosurg 110 : 1047-1053, 2008.
PubMed
15) Tepper DE, et al : Headache attributed to hypothyroidism. Curr Pain Headache Rep 11 : 304-309, 2007.
PubMed
16) Torelli P, Manzoni GC : Fasting headache. Curr Pain Headache Rep 14 : 284-291, 2010.
PubMed
P.834 掲載の参考文献
1) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl) : 61-62, 1987.
 
2) Headache Classification Subcommittee of the International Headache Society : The International classification of headache disorders, 2nd edition (ICHD-2). (訳 : 国際頭痛分類 第2版 新訂増補日本語版, 医学書院, 2007. )
 
3) Headache Classification Committee of the International Headache Society (IHS) : The International classification of headache disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
4) MacRae DL : Bony abnormalities at the craniospinal junction. Clin Neurosurg 16 : 356-375, 1969.
 
5) Gobel H, Edmeads JG : Disorders of the skull and cervical spine. In : The Headaches, 2nd ed (ed by Olesen J, et al), p 891-898, Lippincott Williams & Wilkins, Philadelphia, 2000.
 
6) 寺本純 : 臨床頭痛学, p 384-386, 診断と治療社, 2005.
 
7) 長谷麻子ほか : 頭痛のみを症状とした環軸椎亜脱臼の1例. 頭痛研会誌 23 : 39-40, 1996.
 
8) 湯田康正ほか : C2脊髄神経ブロック・下顎神経ブロックにより軽快した難治性頭痛の1例. 頭痛研会誌 21 : 24-26, 1994.
 
9) 川井康嗣ほか : C2脊髄神経後枝内側枝のブロック・高周波凝固による頸性頭痛の治療. 日頭痛会誌 25 : 41-43, 1997.
 
10) Freund BJ, Schwartz M : Treatment of chronic cervical associated headache with botulinum toxin A : a pilot study. Headache 40 : 231-236, 2000.
PubMed
11) Sarkozi J, Fam AG : Acute calcific retropharyngeal tendonitis : an usual cause of neck pain. Arthritis Rheum 27 : 708-710, 1984.
 
12) 寺本純 : 頭痛に対するボツリヌス治療. 神経内科 66 : 280-286, 2007.
 
13) 寺本純 : 慢性緊張型頭痛に対するボツリヌス療法の適応. 神経内科 75 : 497-503, 2011.
 
P.839 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (HIS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
2) Yamamoto T, et al : Tajimi study report 2 : prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology 112 : 1661-1669, 2005.
 
3) Sawaguchi S, et al : Prevalence of primary angle closure and primary angle-closure glaucoma in a southwestern rural population of Japan : the Kumejima Study. Ophthalmology 9 (6) : 134-142, 2014.
 
4) 加島陽二 : 眼窩蜂巣炎. 眼科 54 : 1470-1475, 2012.
 
5) Rootman J : Adenoid cystic carcinoma. In : Diseases of the Orbit, 2nd ed, p 351-356, Lippincott Williams & Wilkins, Philadelphia, 2003.
 
6) Wakakura M, et al : Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 43 : 133-138, 1999.
 
7) 抗アクアポリン4抗体陽性視神経炎診療ガイドライン作成委員会 : 抗アクアポリン4抗体陽性視神経炎診療ガイドライン. 日眼会誌 118 : 446-460, 2014.
 
8) Tychsen L, et al : Trochleitis with superior oblique myositis. Ophthalmology 91 : 1057-1059, 1984.
 
9) Yanguela J, et al : Primary trochlear headache. Neurology 62 : 1134-1140, 2004.
PubMed
P.845 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) 泰地秀信 : 頭痛の分類. ENTONI 137 : 1-4, 2012.
Medical*Online
4) Chow AW, et al : IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 54 : 1041-1045, 2012.
 
5) 泰地秀信 : 耳鼻科領域の頭痛. 医学のあゆみ 243 : 1249-1253, 2012.
Medical*Online
P.849 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) Schiffman E, et al : Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications : Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache 28 : 6-27, 2014.
PubMed
3) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
P.855 掲載の参考文献
1) Spierings EL, et al : Precipitating and aggravating factors of migraine versus tension-type headache. Headache 41 : 554-558, 2001.
PubMed
2) Holm JE, et al : Migraine and stress : a daily examination of temporal relationships in women migraineurs. Headache 37 (9) : 553-558, 1997.
 
3) Jette N, et al : Comorbidity of migraine and psychiatric disorders-a national population-based study. Headache 48 (4) : 501-516, 2008.
PubMed
4) Breslau N, et al : Headache and major depression : is the association specific to migraine? Neurology 54 : 308-313, 2000.
PubMed
5) 山田和夫 : 身体化障害の診断と治療. 精神科 4 : 95-100, 2004.
 
6) Penzien DB, et al : Behavioral management of recurrent headache : three decades of experience and empiricism. Appl Psychophysiol Biofeedback 27 : 163-181, 2002.
PubMed
7) Nestoriuc Y, Martin A : Efficacy of biofeedback for migraine : a meta-analysis. Pain 128 : 111-127, 2007.
 
P.858 掲載の参考文献
1) Manzoni GC, Torelli P : Epidemiology of typical and atypical craniofacial neuralgias. Nurol Sci 26 : s65-67, 2005.
 
2) Gaddum DR, Ashwin V : Trigeminal and glossopharyngeal neuralgia. Neurol Clin 32 : 539-552, 2014.
 
3) Jannetta PJ : Microsurgery of cranial nerve cross-compression. Clin Neurosurg 26 : 607-615, 1979.
PubMed
4) 松島俊夫, Rohoton AL Jr : 神経血管減圧術のための後頭蓋窩血管ならびにMRI解剖. 顕微鏡下手術のための脳神経外科解剖 XVI (水野純一編), p 143-150, サイメッド・パブリケーションズ, 2014.
 
5) 森岡孝人ほか : 症候性三叉神経痛. 臨牀と研究 63 : 2243-2248, 1986.
 
6) Siegfried J : Trigeminal neuralgia and other facial pain-diagnosis and therapy. Ther Umsch 54 : 83-86, 1997.
PubMed
7) 石橋秀昭, 松島俊夫 : 三叉神経痛の診断. LiSA 4 (5) : 424-427, 1997.
 
8) 松島俊夫, 峯田寿裕 : 神経血管圧迫症候群-特に神経血管減圧術の現況-. 脳神経外科 36 : 303-313, 2008.
 
9) 松島俊夫, 増岡淳 : 三叉神経痛の診断は, MRI, MRAだけでできるか? 脳神経検査のグノーディ・セアウトン-この検査では, ここが見えない-Part 1 MRI編 (小川彰編), p 182-184, シナジー, 2010.
 
10) Barker FG II, et al : The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med 334 : 1077-1083, 1996.
 
11) Kondo A : Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm. Neurosurgery 49 : 46-51, 1997.
 
12) McLaughlin MR, et al : Microvascular decompression of cranial nerves : lessons learned after 4400 operations. J Neurosurg 90 (1) : 1-8, 1999.
PubMed
13) 松島俊夫 : 後頭蓋窩の微小外科解剖と手術, p 101-108, サイメッド・パブリケーションズ, 2006.
 
14) Fujimaki T, et al : Percutaneous retrogasserian glycerol injection in management of trigeminal neuralgial : ong-term follow-up results. J Neurosurg 73 (2) : 212-216, 1990.
 
P.864 掲載の参考文献
1) Weisenburg T : Cerebello-pontine tumor diagnosed for six years as tic douloureux ; the symptoms of irritation of the ninth and twelfth cranial nerves. J Am Med Ass 54 : 1600-1604, 1910.
 
2) Sicard R, Robineau V : Algie velo-pharyngee-essentielle : traitment chirurgical. Rev Neurol 36 : 256-257, 1920.
 
3) Van Hecke O, et al : Neuropathic pain in the general population : a systematic review of epidemiological studies. Pain 155 (4) : 654-662, 2014.
PubMed
4) Phuong H-L, et al : Glossopharyngeal neuralgia due to an epidermoid tumour in the cerebellopontine angle. J Clin Neurosci 11 (7) : 758-760, 2004.
 
5) Laha RK, Jannetta PJ : Glossopharyngeal neuralgia. J Neurosurg 47 (3) : 316-320, 1977.
PubMed
6) Lister JR, et al : Microsurgical anatomy of the posterior inferior cerebellar artery. Neurosurgery 10 (2) : 170-199, 1982.
PubMed
7) Hiraishi T, et al : 3D Computer graphics simulation to obtain optimal surgical exposure during microvascular decompression of the glossopharyngeal nerve. Neurosurg Rev 36 (4) : 629-635, 2013.
PubMed
8) 松島俊夫ほか : 舌咽神経痛に対する神経血管減圧術-術前診断法, 原因圧迫血管, 顆窩経由法と手術成績-. ペインクリニック 24 (12) : 1641-1647, 2003.
 
9) Matsushima T, et al : Surgical treatment of glossopharyngeal neuralgia as vascular compression syndrome via transcondylar fossa (supracondylar transjugular tubercle) approach. Acta Neurochir (Wien) 142 (12) : 1359-1363, 2000.
PubMed
10) Kawashima M, et al : Microvascular decompression for glossopharyngeal neuralgia through the transcondylar fossa (supracondylar transjugular tubercle) approach. Neurosurgery 66 (6 Suppl Operative) : 275-280, 2010.
 
11) Sampson JH, et al : Microvascular decompression for glossopharyngeal neuralgial : ong-term effectiveness and complication avoidance. Neurosurgery 54 (4) : 884-889, 2004.
 
12) Ferroli P, et al : Microvascular decompression for glossopharyngeal neuralgia : a long-term retrospectic review of the Milan-Bologna experience in 31 consecutive cases. Acta Neurochir (Wien) 151 (10) : 1245-1250, 2009.
PubMed
13) Kandan SR, et al : Neuralgia of the glossopharyngeal and vagal nerves : long-term outcome following surgical treatment and literature review. Br J Neurosurg 24 (4) : 441-446, 2010.
PubMed
14) Gaul C, et al : Diagnosis and neurosurgical treatment of glossopharyngeal neuralgia : clinical findings and 3-D visualization of neurovascular compression in 19 consecutive patients. J Headache Pain 12 (5) : 527-534, 2011.
 
15) Xiong N-X, et al : Vagoglossopharyngeal neuralgia treated by microvascular decompression and glossopharyngeal rhizotomy : clinical results of 21 cases. Stereotact Funct Neurosurg 90 (1) : 45-50, 2012.
PubMed
P.869 掲載の参考文献
1) 馬見塚勝郎ほか : 手術からみるあたまの神経・血管解剖 8 微小血管減圧術. 三叉神経と顔面神経の責任血管. Brain Nursing 22 (12) : 1214-1221, 2006.
 
2) 森田明夫 : 脳幹-基礎から臨床までupdate 脳幹の機能 顔面の感覚および運動. Clin Neurosci 27 (12) : 1364-1366, 2009.
 
3) 白藤達雄 : 神経痛という言葉. 東洋医学とペインクリニック 24 (2) : 75-82, 1994.
 
4) 谷本均, 丹生健一 : 私の処方箋 頭頸部領域の神経痛. JOHNS 27 (9) : 1478-1480, 2011.
 
P.873 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) Presbury S : What is neuralgia? [www.worldwidehealth.com]
 
3) MedHelp-neuralgia : Review date : September 07, 2006, Reviewed by : Kenneth Gross MD, Neurology, North Miami, FL . Review provided by VeriMed Healthcare Network.
 
4) Haanpaa M, et al : NeuPSIG guidelines on neuropathic pain assessment. Pain 152 : 14-27, 2011.
PubMed
5) Bogduk N : On the definitions and physiology of back pain, referred pain, and radicular pain. Pain 147 : 17-19, 2009.
PubMed
6) Truini A, et al : Pathophysiology of pain in postherpetic neuralgia : a clinical and neurophysiological study. Pain 140 : 405-410, 2008.
PubMed
7) Seddon HJ : Three types of nerve injury. Brain 66 : 237-288, 1943.
 
8) Sunderland S : The anatomy and physiology of nerve injury. Muscle Nerve 13 : 771-784, 1990.
PubMed
9) 北見公一 : 後頭神経痛とはどのような病態か? 日頭痛会誌 35 (2) : 113, 2008.
 
10) National Institute of Neurological Disease and Stroke (NINDS) : occipital neuralgia information page. [www.ninds.nih.gov/disorders/occipitalneuralgia/occipitalneurlgia.htm]
 
11) Biondi DM : Cervicogenic headache : a review of diagnostic and treatment strategies. J Am Osteopath Assoc 105 (Suppl 2) : s16-22, 2005.
 
12) Barna S, Hashmi M : Occipital neuralgia. Pain Management ROUNDS, Volume 1, Issue 7, 2004.
 
13) 北見公一 : 頭痛診療up to date. 脳外科における頭痛. Modern Physician 31 : 2011-2018, 2011.
 
14) 北見公一 : 頸原性頭痛 (cervicogenic headache) の見直し. 日頭痛会誌 37 (1) : 17-20, 2010.
 
15) 北見公一 : 頭頸部の痛みの外科治療. 脳神経外科医療の最先端シリーズNo. 12 機能的脳神経外科 (高倉金朋ほか監), p 194-200, 先端医療社, 2002.
 
P.878 掲載の参考文献
1) Trobe JD : Optic neuropathies. In : Clinical Decisions in Neuro-Ophthalmology, 3rd ed (ed by Burde RM, et al), p 27-40, Mosby, St. Louis, 2002.
 
2) Optic Neuritis Study Group : The 5-year risk of MS after optic neuritis : experience of the Optic Neuritis Treatment Trial. Neurology 49 : 1404-1413, 1997.
 
3) Beck RW, et al : A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326 : 581-588, 1992.
PubMed
4) Optic Neuritis Study Group : High-and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Arch Ophthalmol 121 : 944-949, 2003.
 
5) Optic Neuritis Study Group : Neurologic impairment 10 years after optic neuritis. Arch Neurol 61 : 1386-1389, 2004.
 
6) Smith CH : Optic neuritis. In : Walsh & Hoyt's Clinical Neuro-Ophthalmology, 6th ed (ed by Miller NR, et al), p 293-347, Lippincott Williams & Wilkins, Philadelphia, 2005.
 
7) Monson DM, Smith JR : Acute zonal occult outer retinopathy. Surv Ophthalmol 56 : 23-35, 2011.
PubMed
8) Pane A, et al : Optic neuropathy. In : The Neuro-Ophthalmology Survival Guide, p 40-91, Mosby Elsevier, Edinburgh, 2007.
 
9) Jacobs LD, et al : Multiple Sclerosis Collaborative Research Group (MSCRG) : Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39 : 285-294, 1996.
 
10) PRISMS (Prevention of Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis) Study Group : Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352 : 1498-1504, 1998.
 
11) Interferon beta-1b in the treatment of multiple sclerosis : final outcome of the randomized controlled trial. IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 45 : 1277-1285, 1995.
 
12) Weinshenker BG, et al : A randomized trial of plasma exchange in acute CNS inflammatory demyelinating disease. Ann Neurol 46 : 878-886, 1999.
PubMed
13) Ruprecht K, et al : Plasma exchange for severe optic neuritis : treatment of 10 patients. Neurology 63 : 1081-1083, 2004.
PubMed
14) Wingerchuk DM, Weinshenker BG : Neuromyelitis optica. Curr Treat Options Neurol 10 : 55-66, 2008.
PubMed
15) Papeix C, et al : Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 13 : 256-259, 2007.
PubMed
P.883 掲載の参考文献
1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
2) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
3) Weber RB, et al : Pathology of oculomotor nerve palsy in diabetics. Neurology 20 : 835-838, 1970.
PubMed
4) Ashbury AK, et al : Oculomotor palsy in diabetes mellitus : A clinico-pathologic study. Brain 93 : 555-556, 1970.
 
5) Kobayashi R, et al : Clinical studies of ocular motility disturbances : Part 2. Ischemic motor nerve palsy risk factors. Jpn J Ophthalmol 41 : 115-119, 1997.
 
6) Jacobson DM, et al : Risk factors for ischemic ocular motor nerve palsies. Arch Ophthalmol 112 : 961-966, 1994.
PubMed
7) Wilker SC, et al : Pain in ischemic ocular motor cranial nerve palsies. Br J Ophthalmol 93 : 1657-1659, 2009.
PubMed
8) Teuscher AU, Meienberg O : Ischaemic oculomotor nerve palsy. Clinical features and vascular risk factors in 23 patients. J Neurol 232 : 144-149, 1985.
PubMed
9) Rush JA, Younge BR : Paralysis of cranial nerves III, IV, and V. Cause and prognosis in 1,000 cases. Arch Ophthalmol 99 : 76-79, 1981.
 
10) Berlit P : Isolated and combined pareses of cranial nerve III, IV, and VI. A retospective study of 412 patients. J Neurol Sci 103 : 10-15, 1991.
 
11) Tamhankar MA, et al : Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes. Ophthalmology 120 : 2264-2269, 2013.
PubMed
12) Green WR, et al : Neuro-ophthalmogic evaluation of oculomotor nerve paralysis. Arch Ophthalmol 72 : 154-167, 1964.
 
13) Kwan ESK, et al : A cliniconeuroradiologic approach to third cranial nerve palsies. AJNR 8 : 459-468, 1987.
 
14) Zorrilla E, Kozak GP : Ophthalmoplegia in diabetes mellitus. Ann Intern Med 67 : 968-976, 1967.
PubMed
15) Baltolami R : The origin of pain in'ischemic-diabetic'third-nerve palsy. Arch Neurol 50 : 795, 1993.
 
16) Keane JR : Third nerve palsy : Analysis of 1400 personally-examined inpatients. Can J Neurol Sci 37 : 662-670, 2010.
PubMed
P.888 掲載の参考文献
1) Tolosa E : Periarteritic lesions of the carotid siphon with the clinical features of a carotid infraclinoidal aneurysm. J Neurol Neurosurg Psychiatry 17 : 300-302, 1954.
PubMed
2) Hunt WE, et al : Painful ophthalmoplegia-its relation to indolent inflammation of the cavernous sinus. Neurology 11 : 56-62, 1961.
 
3) Lakke JPWF : Superior orbital fissure syndrome-report of a case caused by local pachymeningitis-. Arch Neurol 7 : 289-300, 1962.
 
4) Smith JL, Taxdal DS : Painful ophthalmoplegia. The Tolosa-Hunt syndrome. Am J Ophthalmol 61 : 1466-1472, 1966.
PubMed
5) Hunt WE : Tolosa-Hunt syndrome : one cause of painful ophthalmoplegia. J Neurosurg 44 : 544-549, 1976.
PubMed
6) Kline LB, Hoyt WF : The Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry 71 : 577-582, 2001.
PubMed
7) 後藤文男ほか : Tolosa-Hunt症候群の全国集計 (第1報). 厚生省特定疾患「ウイリス動脈輪閉塞症に関する」研究班, 昭和56年度研究報告書, p 51-59, 1981.
 
8) Yousem DM, et al : MR imaging of Tolosa-Hunt syndrome. Am J Neuroradiol 53 : 1181-1184, 1990.
 
9) La Mantia L, et al : Tolosa-Hunt syndrome : critical literature review based on IHS 2004 criteria. Cephalalgia 26 : 772-781, 2006.
PubMed
10) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
11) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
12) Colnaghi S, et al : ICHD-II diagnostic criteria for Tolosa-Hunt syndrome in idiopathic inflammatory syndromes of the orbit and/or the cavernous sinus. Cephalalgia 28 : 577-584, 2008.
PubMed
13) Kline LB : The Tolosa-Hunt syndrome. Surv Ophthalmol 27 : 79-95, 1982.
PubMed
P.892 掲載の参考文献
1) Raeder JG : "Paratrigeminal" paralysis of oculo-pupillary sympathetic. Brain 47 : 149-158, 1924.
 
2) Solomon S : Raeder syndrome. Arch Neurol 58 : 661-662, 2001.
PubMed
3) Shoja MM, et al : Johan Georg Raeder (1889-1959) and paratrigeminal sympathetic paresis. Childs Nerv Syst 26 : 373-376, 2010.
PubMed
4) Goadsby PJ : "Paratrigeminal" paralysis of the oculopupillary sympathetic system. J Neurol Neurosurg Psychiatry 72 : 297-299, 2002.
PubMed
5) Boniuk M, Schlezinger NS : Raeder's paratrigeminal syndrome. Am J Ophthalmol 54 : 1074-1084, 1962.
PubMed
6) Sjaastad O, et al : Raeder's syndrome : "anhidrosis", headache, and a proposal for a new classification. Funct Neurol 9 : 215-234, 1994.
 
7) 柿木隆介ほか : Raeder症候群 (Raeder's paratrigeminal syndrome) -1例報告と文献的考察-. 神経内科 12 : 559-565, 1980.
 
8) 五十嵐久佳ほか : Raeder症候群の1例と文献的考察. 神経内科 28 : 601-604, 1988.
 
9) Solomon S, Lustig JP : Benign Raeder's syndrome is probably a manifestation of carotid artery disease. Cephalalgia 21 : 1-11, 2001.
 
10) Vijayan N, Watson C : Pericarotid syndrome. Headache 18 : 244-254, 1978.
PubMed
11) Mokri B : Raeder's paratrigeminal syndrome. Original concept and subsequent deviations. Arch Neurol : 395-399, 1982.
PubMed
12) Healy JF, et al : Raeder syndrome associated with lesions of the internal carotid artery. Radiology 141 : 101-104, 1981.
PubMed
13) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
PubMed
14) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
P.897 掲載の参考文献
1) Carlow TJ : Oculomotor ophthalmoplegic migraine : is it really migraine? J Neuroophthalmol 22 : 215-221, 2002.
 
2) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders : 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
3) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 (9) : 629-808, 2013.
 
4) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, 医学書院, 2014.
 
5) Akimoto J, et al : Neuromuscular hamartoma is a possible primary pathology of oculomotor ophthalmoplegic migraine. Cephalalgia 32 (2) : 171-174, 2011.
PubMed
6) Menovsky T, et al : Endoscope-assisted supraorbital craniotomy for lesions of the interpeduncular fossa. Neurosurgery 44 : 106-112, 1999.
PubMed
7) Kawamoto S, et al : Neuromuscular choristoma of the oculomotor nerve. Case report. Neurosurgery 60 : 777-778, 2007.
 
8) Chen PK, Wang SJ : Ophthalmoplegic migraine : Migraine variant or cranial neuralgia? Cephalalgia 32 : 515-517, 2012.
 
9) Ambrosetto P : "Ophthalmoplegic migraine : Migraine variant or cranial neuralgia?" by PK Chen and SJ Wang. Cephalalgia 33 (3) : 216, 2012.
 
10) Margari L, et al : Ophthalmoplegic migraine : migraine or oculomotor neuropathy? Cephalalgia 32 (16) : 1208-1215, 2012.
 
11) Chen PK, Wang SJ : Response to Dr. Ambrosetto. Cephalalgia 33 (4) : 284, 2012.
 
P.902 掲載の参考文献
1) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders : 2nd edition. Cephalalgia 24 (Suppl 1) : 9-160, 2004.
 
2) 渡邉素子ほか : 歯科心身医療外来における初診患者1210名の臨床統計的検討. 日歯心身 27 (1-2) : 37-43, 2012.
 
3) Tammiala-Salonen T, et al : Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol 21 : 67-71, 1993.
 
4) Bergdahl M, Bergdahl J : Burning mouth syndrome : prevalence and associated factors. J Oral Pathol Med 28 : 350-354, 1999.
PubMed
5) Hakeberg M, et al : Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci 105 (6) : 539-543, 1997.
PubMed
6) Sardella A, et al : Burning mouth syndrome : a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 12 (2) : 152-155, 2006.
PubMed
7) Minguez-Sanz MP, at al : Etiology of burning mouth syndrome : a review and update. Med Oral Patol Oral Cir Bucal 16 (2) : e144-148, 2011.
 
8) 豊福明 : "歯科心身症"としての舌痛症. 日歯心身 21 : 43-48, 2006.
 
9) Takenoshita M, et al : Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities. Neuropsychiatr Dis Treat 6 : 699-705, 2010.
PubMed
10) Jaaskelainen SK : Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol 123 (1) : 71-77, 2012.
PubMed
11) 豊福明 : 歯科口腔領域の慢性疼痛. ペインクリニック 29 : 391-399, 2008.
 
12) Scala A, et al : Update on burning mouth syndrome : overview and patient management. Crit Rev Oral Biol Med 14 (4) : 275-291, 2003.
PubMed
13) Patton LL, et al : Management of burning mouth syndrome : systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (Suppl) : S39. e1-e13, 2007.
 
14) Charleston L 4th : Burning mouth syndrome : a review of recent literature. Curr Pain Headache Rep 17 (6) : 336, 2013.
PubMed
15) Sun A, et al : Burning mouth syndrome : a review and update. J Oral Pathol Med 42 (9) : 649-655, 2013.
PubMed
16) 市村恵一 : 舌痛症の治療. ENTONI 113 : 76-84, 2010.
 
17) Bergdahl J, et al : Cognitive therapy in the treatment of patients with resistant burning mouth syndrome : a controlled study. J Oral Pathol Med 24 (5) : 213-215, 1995.
PubMed
18) Yamazaki Y, et al : An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 (1) : e6-11, 2009.
PubMed
19) Kato Y, et al : Milnacipran dose-effect study in patients with burning mouth syndrome. Clin Neuropharmacol 34 (4) : 166-169, 2011.
PubMed
20) 都温彦 : 心身医学的アプローチによる舌疼痛治療への方向付け. 歯界展望 43 : 1037-1042, 1974.
 
P.907 掲載の参考文献
1) 国際頭痛学会・頭痛分類委員会著, 日本頭痛学会 (新国際分類普及委員会) ・厚生労働科学研究 (慢性頭痛の診療ガイドラインに関する研究班) 共訳 : 国際頭痛分類第2版 (ICHD-II). 日頭痛会誌 31 : 142-151, 2004.
 
2) Headache Classification Committee of the International Headache Society : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.
 
3) 矢谷博文 : 非歯原性歯痛の原疾患. 口腔顔面痛の診断と治療ガイドブック (日本口腔顔面痛学会編), p 144-147, 医歯薬出版, 2013.
 
4) Mueller D, et al : Prevalence of trigeminal neuralgia and persistent idiopathic facial pain : a population-based study. Cephalalgia 31 : 1542-1548, 2011.
 
5) Agostoni E, et al : Atypical facial pain : clinical considerations and differential diagnosis. Neuro Sci 26 (Suppl 2) : s71-74, 2005.
 
6) Sardella A, et al : An up-to-date view on persistent idiopathic facial pain. Minerva Stomatol 58 : 289-299, 2009.
PubMed
7) 井川雅子, 山田和夫 : 口腔内特発性疼痛のとらえ方と三環系抗うつ薬の効果. 日口腔顔面痛会誌 3 : 21-30, 2010.
 
8) Forssell H, et al : Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology 69 : 1451-1459, 2007.
PubMed
9) 住谷昌彦 : 神経障害性疼痛とはなにか. 医学のあゆみ 247 : 311-316, 2013.
Medical*Online
10) Nimmuan C, et al : How many functional somatic syndromes? J Psychosom Res 51 : 549-557, 2001.
 
11) 平川奈緒美 : 非定型顔面痛. ペインクリニック診断・治療ガイド 痛みからの解放とその応用第5版 (大瀬戸清茂監修), p 280-282, 日本医事新報社, 2013.
 
12) 日本頭痛学会・国際頭痛分類委員会 (訳) : 国際頭痛分類 第3版 beta版, p 154-168, 医学書院, 2014.
 
13) 和嶋浩一 : 顎関節症, 口腔顔面痛から頭痛治療を考える. ペインクリニック 31 : 452-462, 2010.
 
14) Pembroke CA, et al : Persistent unilateral facial pain in lung cancer patients with mediastinal nodal involvement. Lung Cancer 82 : 173-175, 2013.
PubMed
15) Benoliel R, Sharav Y : Chronic orofacial pain. Curr Pain Headache Rep 14 : 33-40, 2010.
PubMed
16) Abrahamsen R, et al : Hypnosis in the management of persistent idiopathic orofacial pain-clinical and psychosocial findings. Pain 136 : 44-52, 2008.
PubMed
P.912 掲載の参考文献
1) Tasker RR, et al : The history of central pain syndromes, with observations concerning pathophysiology and treatment. In : Pain and Central Nervous System Disease : The Central Pain Syndromes (ed by Casey KL), p 31-58, Raven Press, New York, 1991.
 
2) Bouhassira D, et al : Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136 : 380-387, 2008.
PubMed
3) 平戸政史 : 視床痛の病態生理 I. 視床痛の発生要因. 北関東医学 40 : 505-519, 1990.
 
4) Bonica JJ : Introduction : Semantic, epidemiologic, and educational issues. In : Pain and Central Nervous System Disease : The Central Pain Syndromes (ed by Casey KL), p 13-29, Raven Press, New York, 1991.
 
5) Roberts WJ : A hypothesis on the physical basis for causalgia and related pains. Pain 24 : 297-311, 1986.
 
6) Woolf CJ, et al : Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355 : 75-78, 1992.
PubMed
7) Blomqvist A, et al : Cytoarchitectonic and immunohistochemical characteriztion of a specific pain and temperature relay, the posterior portion of the ventral medial nucleus, in the human thalamus. Brain 123 : 601-619, 2000.
 
8) Lenz FA, et al : Thermal and pain sensations evoked by microstimulation in the area of human ventrocaudal nucleus. J Neurophysiol 70 : 200-212, 1993.
PubMed
9) Craig AD : A new version of the thalamic disinhibition hypothesis of central pain. Pain Forum 7 : 1-14, 1998.
 
10) Head H, et al : Sensory disturbances from cerebral lesions. Brain 34 : 102-254, 1911.
 
11) Hirato M, et al : Pathophysiology of central (thalamic) pain : combined change of sensory thalamus with cerebral cortex around central sulcus. Stereotact Funct Neurosurg 62 : 300-303, 1994.
PubMed
12) Lenz FA, et al : Characteristics of somatotopic organization and spontaneous neuronal activity in the region of the thalamic principle sensory nucleus in patients with spinal cord transection. J Neurophysiol 72 : 1570-1587, 1994.
 
13) Hirato M, et al : Electrical spinal, internal capsular or cortical stimulation therapy for central (thalamic) pain. Pain Res 21 : 17-24, 2006.
 
14) Flor H, et al : Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature 375 : 482-484, 1995.
PubMed
15) Ramachandran VS, et al : Touching the phantom limb. Nature 377 : 489-490, 1995.
PubMed

書評

最近チェックした商品履歴

Loading...